Sommaire

• • ·Title page

    Page :A1

    
• • ·TOC

    Page :A2

    
• • ·2005 AAAAI Meeting announcement

    Page :A3

    
• • ·Adherence with inhaled corticosteroids in asthma patients receiving fluticasone propionate/salmeterol in a single inhaler versus add-on salmeterol inhaler or add-on montelukast

    Page :S1

    T. Delea, R.H. Stanford, M. Hagiwara, G. Oster

    
• • ·The efficacy of anti-inflammatory treatment in mild intermittent bronchial asthma

    Page :S1

    T. Shimoda, R. Kishikawa, S. Shoji, S. Nishima

    
• • ·Ciclesonide is effective in protecting against exercise-induced bronchoconstriction

    Page :S1

    P.J. Subbarao, M. Duong, J. Otis, G. Obminski, E. Adelroth, S. Pedersen, M. Inman, P.M. O'Byrne

    
• • ·Earlier use of nebulized inhaled corticosteroids is associated with fewer asthma exacerbations in young children

    Page :S1

    K.R. Murphy, D.A. Bukstein, L.M. Katz, L. McDermott, L.S. Stern, P.A. Patel

    
• • ·Minimizing facial and ocular deposition of nebulized budesonide: Importance of facemask design

    Page :S2

    S. Sangwan, A. Shah, G.C. Smaldone

    
• • ·Treatment failure is reduced in patients initiating therapy with fluticasone propionate/salmeterol in a single inhaler as compared with other inhaled corticosteroid asthma treatments

    Page :S2

    A.A. Riedel, C.R. Harley, D.A. Stempel, R.H. Stanford

    
• • ·Incidence of asthma exacerbations by season and the effects of treatment with fluticasone propionate/salmeterol (FSC) or fluticasone propionate (FP) compared with montelukast

    Page :S2

    H. Nelson, S. Yancey, A. Emmett, L. Sutton, P. Dorinsky

    
• • ·Therapeutic equivalence of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

    Page :S2

    A.H. Morice, D. Osmanliev, L. Arheden, O. Beckman

    
• • ·Minocycline treatment results in reduced oral steroid requirements and suppresses IgE responses in adult asthma

    Page :S3

    R. Joks, A. Daoud, G. Taningco, C.J. Gloria, K. Orloff, M.R. Hammerschlag, S. Weiss, M. Gelling, P.M. Roblin, M. Nowakowski, H.G. Durkin

    
• • ·Once-daily ciclesonide is as effective as twice-daily budesonide in maintaining lung function and asthma control in patients with asthma

    Page :S3

    D.A. Gadgil, P. Niphadkar, K.T. Jagannath, J.M. Joshi, N. Awad, S.K. Chhabra, S. Hellbardt, R. Engelstätter

    
• • ·Comparable safety of a novel budesonide/formoterol pMDI versus budesonide/formoterol turbuhaler® in adolescents and adults with asthma

    Page :S3

    A.H. Morice, L. Hochmuth, A. Puterman, L. Arheden, O. Beckman

    
• • ·Ciclesonide 80 μg or 160 μg once-daily is as effective as fluticasone propionate 88 μg twice-daily in the treatment of persistent asthma

    Page :S4

    H. Magnussen, J. Hofman, B. Novakova, B. Kaczmarek-Czeczotka, T. Koci, P. Staneta, M. Hellwig, R. Engelstätter

    
• • ·Safety and tolerability of inhaled budesonide in children in the START trial

    Page :S4

    M. Silverman, S. Pedersen, A.L. Sheffer, P.V. Diaz

    
• • ·Plasma protein binding (PPB) of corticosteroids (CS): Reappraisal of its significance in systemic pharmacological activity

    Page :S4

    P.T. Daley-Yates, A.J. Harker, S. Taylor, M.J. Daniel

    
• • ·Fluticasone propionate HFA improves asthma control in pre-school age children with asthma

    Page :S4

    R.W. Sugerman, A.M. Teper, G. Girardi, C.A. Scott, D.S. Clements, W. Wu, C. Crim

    
• • ·Assessment of the effective daily dose for mometasone furoate dry powder inhaler in the treatment of persistent asthma

    Page :S5

    H. Staudinger, D. Gates, W. Kuo, L. Shneyer, K. Heithoff

    
• • ·Onset of improvements of lung function with mometasone furoate dry powder inhaler (MF-DPI) in ICS-Naïve patients with asthma

    Page :S5

    B. Prenner, R. Berkowitz, G.W. Bensch, B.N. Lutsky

    
• • ·Omalizumab significantly improves quality of life in patients with severe persistent asthma

    Page :S5

    B. Chipps, J. Corren, A. Finn, S. Hedgecock, H. Fox, M. Blogg

    
• • ·Improvements in health-related quality of life with once-daily (evening) or twice-daily dosing of mometasone furoate dry powder inhaler (MF-DPI) in children with asthma

    Page :S5

    M. Noonan, M.E. Ruff, P. Chervinsky, W. Berger

    
• • ·Rates of asthma exacerbations are not affected by beta₂-adrenergic receptor genotype in patients with persistent asthma

    Page :S6

    P. Dorinsky, S. Yancey, L. Edwards, L. Sutton, H. Ortega

    
• • ·A unique asthma phenotype characterized by frequent asthma exacerbations

    Page :S6

    B. Macomber, R. Covar, G. Whelan, S. Szefler

    
• • ·A simple algorithm to rapidly determine asthma severity classification (SC) in the emergency department (ED)

    Page :S6

    R.B. Boychuk, K.M. Kiyabu, C.J. DeMesa, L.G. Yamamoto

    
• • ·Once-daily treatment with ciclesonide is effective and well-tolerated in children with persistent asthma

    Page :S6

    G. Shapiro, G. Bensch, R. Lanier, L. Sher, M. Lloyd, S. Kundu, J. Fish, J. Williams, D. Banerji

    
• • ·Patient-friendly dry powder inhaler for Pumactant in seasonal allergic asthma

    Page :S7

    R.J. Dockhorn

    
• • ·The blocking effect of essential controller medications during aspirin challenge in patients with aspirin-exacerbated respiratory disease

    Page :S7

    A.A. White, D.D. Stevenson, R.A. Simon

    
• • ·Role of food allergy in children with asthma

    Page :S7

    A. Krogulska, K. Wąsowska-Królikowska, B. Trzeźwińska

    
• • ·Direct modulation of airway reactivity by the Chinese anti-asthma herbal formula ASHMI

    Page :S7

    K.D. Srivastava, Z.M. Zou, H.A. Sampson, H. Dansky, X.M. Li

    
• • ·Asthma cases in the emergency department (ED) in relation to environmental and meteorological factors in Brooklyn, New York

    Page :S8

    W.Y. Mak, B. Silverman, A.T. Schneider

    
• • ·Changes in asthma medication use during pregnancy

    Page :S8

    A.K. Degala, G. Wegienka, S.L. Havstad, E.M. Zoratti

    
• • ·Relationship between elevated body mass index and asthma

    Page :S8

    M. Michelis, P. Sorace, G. Walco

    
• • ·Predictors of emergency room utilization among inner-city school children

    Page :S8

    A. Arrey-Mensah, M. Mvula, C. Moore

    
• • ·Anti-inflammatory effects of modern histamine H₁-receptor antagonists in atopic asthma

    Page :S9

    D.K.C. Lee, K.C. Khoo, B.J. Lipworth

    
• • ·Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease

    Page :S9

    S. Ying, B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, D. Cousins, D. Robinson, G. Zhang, J. Zhao, T.H. Lee, C. Corrigan

    
• • ·Comparison of quality of life of asthmatic: Aspirin-intolerant asthma vs atopic asthma

    Page :S9

    S.A. Zenokhov, I.V. Sidorenko, V.K. Treskunov, T.V. Zakharzhevskaya

    
• • ·Bronchus suis masquerading as asthma

    Page :S9

    M. Reddy, R. Faust, E.A. Secord, M. Pansare

    
• • ·Histamine and an H3/H4 receptor antagonist may modulate IgE and nitric oxide production

    Page :S10

    R.A. Khanferyan, D.V. Lesik, L.M. DuBuske

    
• • ·Changing outcome of childhood asthma with increased use of inhaled corticosteroids

    Page :S10

    Y. Noma, T. Fujisawa, H. Katsumata, M. Nagao, J. Atsuta, K. Iguchi, H. Kamiya

    
• • ·Decreasing dose of corticosteroid to 1/kg/day in hospitalized asthmatic children after day one does statistically alter lengths of stay nor readmission rates

    Page :S10

    J.C. Vassallo, E. Barbieri, E.A. Secord

    
• • ·Lung inflammation, goblet cell hyperplasia, cytokine and chemokine production are reduced by a Chinese herbal formulation in a rat model of asthma

    Page :S10

    R.Y.T. Sung, Y.O. Wong, W.Y. Chan, K. Li, Y. Zhao, A.M. Li, T.F. Fok, K.P. Fung

    
• • ·Onset and duration of single-dose protection of montelukast against exercise-induced bronchospasm

    Page :S11

    O. Johnson, J. van Adelsberg, D.S. Pearlman, T. Loeys, G. Philip, T.F. Reiss

    
• • ·Concordance of MBL protein concentrations, functional activities, and genotypes in a healthy control population

    Page :S11

    J. Yu, J.D. Hester, J.F. Halsey

    
• • ·Monitoring of genetic polymorphisms in toll-like receptors 2, 4, 5, and 9 with real-time PCR assays

    Page :S11

    J.D. Hester, J.F. Halsey

    
• • ·Monthly intravenous methylprednisolone as an alternative treatment for patients with severe asthma on long-term daily oral prednisone

    Page :S11

    F.R. Oliveira, L.M. Silva, E.O.S. Vianna, S.H.P. Oliveira, F.Q. Cunha, L.K.P. Arruda, W. Sarti

    
• • ·Selective effects of glucocorticoids (GC) on epithelial responses

    Page :S12

    N. Zhang, Q.A. Troung-Tran, R.P. Schleimer

    
• • ·CpG DNA inhibits interferon-gamma-induced interleukin-6 production and lipopolysaccharide responsiveness in human conjunctival epithelial cells (HCEC)

    Page :S12

    J.R. Perez, J. Talreja, D.J. Stechshulte, K.N. Dileepan

    
• • ·The pro-inflammatory effect of protease activated receptor (PAR) activation on human monocytes and macrophages

    Page :S12

    H.R. Currie, G.A. Stewart, A.S. McWilliam

    
• • ·In vivo expression of toll-like receptor-2 on conjunctival epithelial cells is increased in atopic keratoconjunctivitis

    Page :S12

    E.B. Cook, J.L. Stahl, F.M. Graziano, N.P. Barney

    
• • ·Airway epithelial acute phase responses

    Page :S13

    A.Q. Truong-Tran, N. Zhang, M. Radtke, R.P. Schleimer

    
• • ·The effect of melatonin alone or in combination with cytokines and mitogens on LAK cell generation and cytotoxicity

    Page :S13

    Ö. Özdemir, M. Buyukavci, R. Sorensen, C. Moore, S. Savasan

    
• • ·The growth of T lymphocytes from endobronchial biopsies of asthmatic subjects using IL-2 or IL-2 plus IL-15

    Page :S13

    M.W.G. Lethbridge, J.C. Ratoff, T.P. Vos, D.M. Kemeny, B.J. O'Connor

    
• • ·Detection of CC16 in sputum: A potential biomarker of COPD small airways damage

    Page :S13

    F. Braido, A. Riccio, L. Guerra, C. Gamalero, A. Zolezzi, B. De Giovanni, G.W. Canonica

    
• • ·Lateralized neocortical control of T export from rat thymus: Increased export after left Temporo-Parieto-Occipito (TPO) cortical stimulation medicated by sympathetic pathways in upper spinal cord

    Page :S14

    Y.A. Moshel, V.E. Amassian, H.G. Durkin

    
• • ·Adhesion of human lung microvascular endothelial cells (HLMVEC) is decreased by conditioned media (CM) from D.pteronyssinus-treated confluent human type II alveolar epithelial cells (cA549) containing elevated TGFb1

    Page :S14

    A. Capetandes, J. Zimmermann, M. Frieri

    
• • ·CCR6 as a peripheral tissue trafficking marker

    Page :S14

    J.N. Francis, S.J. Till, G.K. Banfield, I. Sabroe, S.R. Durham

    
• • ·(S)-Albuterol increases CysLT1R expression and VEGF mRNA by normal human lung fibroblasts (NHLF)

    Page :S14

    M. Frieri, A. Capetandes

    
• • ·PAR-2 regulates chemokine synthesis in nasal epithelial cells (EC)

    Page :S15

    F. Ahlers, F. Sachse, W. Stoll, C. Rudack

    
• • ·Endotoxin exposure during pregnancy suppresses the postnatal allergic sensitization, but not airway responsiveness in the mouse

    Page :S15

    N. Blümer, U. Herz, M. Wegmann, H. Renz

    
• • ·Effect of chlamydia pneumoniae (Cpn) infection on cytokine profiles of PBMC from asthmatics and healthy subjects

    Page :S15

    S. Kohlhoff, P. Roblin, A. Kutlin, S. Strigl, R. Joks, R. Joks, M. Nowakowski, M.R. Hammerschlag

    
• • ·Interleukin-15 induces superior cytotoxic lymphokine activated killer cells in vitro with higher perforin, granzyme B, and cytokine expressions

    Page :S15

    Ö. Özdemir, R. Sorensen, A. Ochoa, S. Savasan

    
• • ·B cell superantigen-induced immune complex peritonitis

    Page :S16

    A. Anderson, R. Sporici, D.F. LaRosa, A.I. Levinson

    
• • ·Prevalence of cystic fibrosis in children who present with nasal polyposis

    Page :S16

    E.J. Schmitt, W. Neaville, T. Pongdee

    
• • ·Anti-cyclic citrullinated peptide (CCP) testing: Relevance in rheumatoid arthritis and other autoimmune disorders

    Page :S16

    J.M. Popov, M. Glovsky, K. Tokoro, O. Zhukov, F. Zarabpouri, K. Qu, A. Sferruzza

    
• • ·Immune response in tubulin induces hearing loss in mice

    Page :S16

    M.H. Kermany, Z. Bin, K. Mohammad, Z. Bin, J. Lee

    
• • ·Autoimmune sensitization after SQ injection of collagen for cosmetic surgery

    Page :S17

    T.M. Nsouli, R. Rothenberg, C. Schluckebier, H. Castro, J. Malka-Rais, M. Sheehan, J. Bellanti

    
• • ·Macrophage activation syndrome associated with posterior reversible encephalopathy syndrome

    Page :S17

    P. Buddiga, M. Pedra-nobre, H. Jyonouchi, A. Wolff, L. Bielory

    
• • ·TNF-alpha inhibitors in treatment of refractory sarcoidosis with severe CNS involvement

    Page :S17

    O. Belostotsky, A.S. Diamond, G. Marder

    
• • ·TCR and CD28 expression in patients with chronic hepatitis B and C

    Page :S17

    L. Titov, U.V. Tarasiuk, D.A. Charnashey, L.S. Jmurovskaya, L.M. DuBuske

    
• • ·Four antibiotics-dependent neutrophil antibodies cause devastating neutropenia in a child

    Page :S18

    H.S. Wi, S.A. Shin, J.W. Oh, H.B. Lee

    
• • ·Kikuchi necrotizing lymphadenitis with clinical features consistent with forme fruste SLE

    Page :S18

    Y.K. Persaud, S. Sood, B. Silverman, B. Aygun, A.T. Schneider

    
• • ·The treatment of autoimmune hypoglycemia with IVIG

    Page :S18

    S.S. Wallace, H. Tcheurekdjian, Z. Madhun, R.W. Hostoffer

    
• • ·Systemic lupus erithematous (SLE) masquerading as juvenile dermatomyositis (JDM)

    Page :S18

    M.E. Gonzalez-Serrano, M.E. Gonzalez-Serrano, T.A. Staines-Boone, S.E. Espinosa-Padilla, F.J. Espinosa-Rosales

    
• • ·Novel human interleukin (IL)-4 and -13 vaccines

    Page :S19

    Z. Peng, Q. Liu, Y. Ma, A.B. Becker, K.T. HayGlass

    
• • ·Effects of standard treatment of acute coronary syndromes on macrophage activity as measured by serum neopterin

    Page :S19

    D.T. Johnston, N. Raio, M. Gagos, L. Ragolia, D. Shenouda, K.P. Marzo, M. Davis-Lorton, J. Deleon

    
• • ·Antiendotoxin immunity in patients with diabetic retinopathy

    Page :S19

    A.I. Kopayenko, V.A. Beloglazov, A.I. Gordienko, N.V. Khimich, A.A. Bakova, A.A. Rozovenko, L.M. DuBuske

    
• • ·Immune reconstitution syndrome presenting as diffused angioedema

    Page :S19

    W. Maek-a-nantawat, H. Chantaphakul, K. Ruxrungtham

    
• • ·Comparative incidence of skin test reactivity to Periplaneta americana (American cockroach), Blatella germanica (German cockroach), and a 1:1 mix of Periplaneta americana and Blatella germanica in San Francisco bay area patients (SF)

    Page :S20

    P. Strub, F. Bocobo, D. German

    
• • ·CD40 stimulation of human B lymphocytes upregulates cysteinyl-leukotriene receptor 1 expression and function

    Page :S20

    M. Rola-Pleszczynski, J. Lamoureux, J. Stankova

    
• • ·Climatic variables affecting winter mold spore counts in Newark, NJ

    Page :S20

    J.B. Hein, A. Wolff

    
• • ·Indoor levels of fungal spores in Central Florida homes without obvious moisture problems

    Page :S20

    P.J. DeMarco, R. Codina, A.S. Bagg, R.W. Fox, R.F. Lockey

    
• • ·Aerobiology and morphology of myxomycete spores

    Page :S21

    S.O. Surratt, E. Levetin

    
• • ·Quantifying emissions of grass pollen and pollen fragments

    Page :S21

    G. Lu, M.M. Glovsky, J. House, R.C. Flagan, P.E. Taylor

    
• • ·Total seasonal ragweed is inversely correlated with seasonal rainfall

    Page :S21

    C.S. Barnes, F. Hu, F. Pacheco, J. Portnoy

    
• • ·A survey on species of Aspergillus in the atmosphere of hospital premises

    Page :S21

    B. Vittal, N. Udaya Prakash

    
• • ·Comparison of pollen concentrations between Tulsa and Cushing, OK

    Page :S22

    M.S. Larsen-Purvis, E. Levetin

    
• • ·Sodium sulfite induces basophil degranulation through induction of oxidative stress

    Page :S22

    C.R. Collaco, D.J. Hochman, E.G. Brooks

    
• • ·An investigation on aeroallergens in the public schools of the Texas Panhandle

    Page :S22

    N. Ghosh, D. Mahapatra, E. Caraway, C. Saadeh, M. Gaylor, D.W. Smith

    
• • ·Atmospheric prevalence and allergenic potency of castor bean pollen in Chennai, India

    Page :S22

    V. Raju, U. Nyayiru Kannaian, T. Janaki, B. Srinivasan, V. Balamuri Pandu Ranga

    
• • ·Laboratory investigation of 12 military personnel diagnosed with severe acute pneumonitis

    Page :S23

    A.C. Miranowski, P.A. Greenberger

    
• • ·Mercury induced IL-4 production: Implication for the role of protein kinase C in TH2 differentiation

    Page :S23

    G. de Vos, S. Abotaga, J. Vernatter, D. Rosenstreich

    
• • ·Development of a novel air quality sensor

    Page :S23

    J.A. Bernstein, R. Govind

    
• • ·The positive correlation of increasing asthma cases to increasing diesel vehicles in St. Vincent and the Grenadines

    Page :S23

    H. Bacchus, F. Zaldivar, C.D. Schwindt

    
• • ·Smoking does not impact allergic rhinitis

    Page :S24

    P. Bousquet, C. Cropet, B. Allaf, N. Janin, F. Neukirch, J. Bousquet

    
• • ·New onset asthma following airbag deployment

    Page :S24

    D.W. Hambrook, V. Masci, J.N. Fink

    
• • ·Environmental tobacco smoke (ETS) exposure during childhood—Dimension, exposure patterns, and relation to allergic airway diseases

    Page :S24

    M. Kulig, T. Keil, S. Roll, S. Lau, U. Wahn

    
• • ·Allergic workers suffer more often from indoor air problems

    Page :S24

    K.E. Reijula

    
• • ·Active smoking and self-reported unhealthy conditions at work as risk factors of asthma

    Page :S25

    A. Emelyanov, G. Sergeeva, G. Fedoseev, N. Ivanova, T. Zibrina, I. Zukanova, I. Maximenko

    
• • ·The comparison with juniper/cedar pollen counting and the pollinosis patients in Fukuoka city, Japan, and Galveston, Texas

    Page :S25

    R. Kishikawa, P.D. Jantzi, T.M. Horiuti, R.M. Goldblum, E. Koto, T. Shimoda, S. Shoji, E.G. Brooks, S. Nishima

    
• • ·Pediatric hypersensitivity pneumonitis due to non-occupational exposure to Aureobasidium pullulans

    Page :S25

    J. Temprano, P.S. Hutcheson, B.A. Becker, A. Dixit, R.G. Slavin

    
• • ·Correlation of allergic symptoms with pollen counts

    Page :S25

    C.E. Lowe, M. Amado, P. Dowling, C. Barnes

    
• • ·Dermatitis caused by indoor mold exposure

    Page :S26

    W.J. Rockwell, J. Santilli

    
• • ·Allergenic thermophilic fungi from house dust of asthmatics

    Page :S26

    B. Srinivasan, U. Nyayiru Kannaian, V. Balamuri Pandu Ranga

    
• • ·Metal working fluids (MWF) contaminated with bacteria induce allergic inflammation in an experimental murine model

    Page :S26

    M.C. Zacharisen, C.S. Barrios, V.P. Kurup, H. Choi, J.N. Fink, K.J. Kelly

    
• • ·Clinical significance of cosensitization to arthropods in atopic inner city children

    Page :S26

    R. Ayuso, J. Maloney, A. Nowak-Wegrzyn

    
• • ·Predictive value of a specific IgG assay for diisocyanate asthma (DA) is strongly influenced by chemical-protein antigen characteristics

    Page :S27

    P. Campo, A.V. Wisnewski, A. Cartier, Z.L. Lummus, J.L. Malo, L.P. Boulet, D.I. Bernstein

    
• • ·Serum specific IgG to cytokeratin may be a diagnostic marker for toluene diisocyanate-induced asthma

    Page :S27

    Y. Ye, J. Choi, S. Lee, D. Nahm, S. Kim, S. Kim, C. Suh, H. Park

    
• • ·Specific IgE and IgG4 anti Rat Urinary Proteins in sera from subjects professionally exposed to rat allergens and endotoxins

    Page :S27

    F. Lieutier-Colas, A. Casset, M. Chapman, P. Meyer, L. Guilloux, G. Pauli, F. de Blay

    
• • ·Sensitization rate of Empynase (Pronase) in exposed workers at hospital and identification of its allergen

    Page :S27

    J. Bahn, K. Eom, S. Jang, D. Kim, K. Jung, H. Kim, S. Kim, C. Seo, D. Nahm, H. Park

    
• • ·Occupational rhinitis and asthma induced by corneal antigens in surgeons and close surgical assistants following Lasik

    Page :S28

    J.C. Muiño, M.A. Ordoñez, V. Reviglio, M. Ferrero, M.D. Romero, C.P. Juárez

    
• • ·Asthma due to a household pet bird (orange-cheeked waxbill)

    Page :S28

    M. Fernandez-Nieto, S. Quirce-Gancedo, B. Bartolome, E. Compes, J. Sastre

    
• • ·Rhinoconjunctivitis and asthma caused by agapornis birds

    Page :S28

    A. Vereda, M. de las Heras, B. Bartolomé, M. Fernandez, M. Lluch, J. Cuesta, J. Sastre

    
• • ·Occupational asthma from algae powder exposure

    Page :S28

    L.P. Boulet

    
• • ·Occupational asthma (OA) to lactoserum in a baker

    Page :S29

    A. Cartier, C. Lemière, J. Malo

    
• • ·Assessment of nasal flora and respiratory function tests of bakery workers working under modern conditions

    Page :S29

    H. Issever, B. Hapcioglu, K. Ozdilli, E. Kocyigit, H. Kaymakcalan, Y. Yegenoglu, O. Ozturk, S. Agkoc, A. Topuzoglu, N. Onoglu, E. Isik, S. Susever, B. Calak, B. Gurtekin

    
• • ·Aeroallergen sensitization in patients with eosinophilic esophagitis

    Page :S29

    M.B. Levy, J.L. Oldham, S.L. Werlin, B.A. Trost, C.D. Rudolf, K.J. Kelly

    
• • ·Occupational asthma due to ammonium persulphate in hairdressers

    Page :S29

    G. Moscato, P. Pignatti, M.R. Yacoub, L. Perfetti

    
• • ·Relationship between asthma on Barbados and African dust in the trade winds

    Page :S30

    J.M. Prospero, E. Blades, G. Mathison, M. Lavoie, H. Thani

    
• • ·African dust, pollen, and fungal spores as possible airborne allergens over Barbados

    Page :S30

    E.D. Blades, G.E. Mathison, M. Lavoie, J.M. Prospero, H. Thani, D. Kimes, E. Levine

    
• • ·The innate immune surfactant protein (SP)-D plays a protective role in ozone (O₃)-induced airway inflammation in mice

    Page :S30

    A. Haczku, F. Poulain, R. Mathias, Y. Cao, M. Grous, M. Salmon

    
• • ·The importance of sensitivity to cultivated sorghum antigens in patients with asthma and rhinitis from the rural and near rural area of Río IV—Argentina

    Page :S30

    M.A. Sanabria, M.J. Gregorio, M. Ferrero, M.D. Romero-Piffiguer, M.A. Ordoñez, J.C. Muiño

    
• • ·TRPV1 gene expression in nasal epithelial cells declines with age

    Page :S31

    A. Tarun, D. Shusterman

    
• • ·Sensitization to latex through a swim cap

    Page :S31

    J.M. Kelso, F.L. Lin, R.T. Jones, J.W. Yunginger

    
• • ·Allergic lipstick cheilitis due to propyl gallates

    Page :S31

    A.M. Cisteró-Bahima, M. San Miguel-Moncín, R. Alonso, L. Ferré-Ybarz, M. Basagaña, S. Monzón

    
• • ·Coconut allergy in two children of Asian origins and identification of the IgE binding components

    Page :S31

    M.I. Kidon, S. Lim, A. Loo, A. Wee, S. Ling, W. Liew, W. Chiang, F. Chew

    
• • ·Study of in vitro crossreactivity by determining specific IgE in patients with immediate adverse reactions to cephalosporins

    Page :S32

    M.J. Torres, C. Mayorga, J.L. Rodriguez-Bada, E. Perez-Inestrosa, M.I. Montañez, R. Suau, A.G. Romano, M. Blanca

    
• • ·An allergic reaction to Play-Doh in a child with wheat hypersensitivity

    Page :S32

    P.P. Ponda, S.H. Sicherer

    
• • ·Soy sauce retains allergenicity through the fermentation/production process

    Page :S32

    S.L. Hefle, D.M. Lambrecht, J.A. Nordlee

    
• • ·Influence of a boosting in the recognition and specificity of IgE antibodies in patients with immediate allergic reaction to betalactams

    Page :S32

    G. Canto, J.L. Rodriguez-Bada, C. Mayorga, M.J. Torres, R. R-Pena, C. Antunez, J.A. Cornejo-Garcia, T. Fernandez, M. Blanca

    
• • ·Study of in vitro T-cell response to penicillins

    Page :S33

    J. Fernandez, A. Esteban, M. Torres

    
• • ·Use of copper to reduce peanut allergenicity

    Page :S33

    S. Chung, E.T. Champagne

    
• • ·HLA Class II and peanut allergy

    Page :S33

    Z. Charlop-Powers, S. Lillie, W.G. Shreffler, S.H. Sicherer

    
• • ·Physiological digestion of peanut proteins in the swine model of food allergy

    Page :S33

    R.A. Kopper, C.M. West, R.M. Helm

    
• • ·High environmental exposure to peanut in infancy as a risk factor for peanut allergy

    Page :S34

    A.T. Fox, G. Lack

    
• • ·Relative frequencies of cytokine expressing CD4 and CD8 cells induced in mice by peanut allergen

    Page :S34

    I. Kimber, P.A. Wachholz, R.J. Dearman

    
• • ·Spontaneous, IgE-associated food allergy in dogs as a model of human peanut allergy

    Page :S34

    B. Hammerberg, H.A. Jackson, W. Burks, J. Paps

    
• • ·Effect of Chinese herbal formulas on T cell responses in patients with peanut allergy or asthma

    Page :S34

    J. Ko, P.J. Busse, L.P. Shek, S. Noone, H.A. Sampson, X. Li

    
• • ·Is the low prevalence of peanut allergy in Israel due to hypoallergenic peanut products?

    Page :S35

    S.J. Maleki, S.L. Hefle, H. Cheng, Y. Katz, G. Du Toit, G. Lack

    
• • ·Effects of ImmuSoy as a food supplement for altering peanut allergic reactions

    Page :S35

    T. Zhang, W. Pan, M. Takebe, H.A. Sampson, X. Li

    
• • ·Eliciting doses (ED) for peanut in children with and without previous reactions to peanut

    Page :S35

    A.E. Flinterman, S.G.M. Pasmans, C.A.F. Bruijnzeel-Koomen, M.O. Hoekstra, A.C. Knulst

    
• • ·Patients find low dose threshold challenges useful in the management of their peanut allergy

    Page :S35

    L.A. Gudgeon, J.B. Trewin, K.E.C. Grimshaw, J.O. Hourihane

    
• • ·Predicting the resolution of peanut allergy in children using skin prick testing and RAST: A systematic review

    Page :S36

    E.C. TePas, S.J. Bae

    
• • ·Accidental ingestions in peanut allergic children

    Page :S36

    J.W. Yu, A. Clarke, N. Verreault, N. Nicolas, L. Joseph, Y. St. Pierre, R. Kagan

    
• • ·Effectiveness of guidelines designed to reduce peanut substances in primary school classrooms in Montreal, Canada

    Page :S36

    D.K. Banerjee, R.S. Kagan, E. Turnbull, L. Joseph, Y. St-Pierre, C. Dufresne, K. Gray-Donald, A.E. Clarke

    
• • ·Monitoring of peanut allergic patients with serum peanut-specific IgE

    Page :S36

    R. Borici-Mazi, J.A. Mazza, D.W. Moote, K. Payton

    
• • ·Th2 adjuvanticity of soluble peanut extract

    Page :S37

    W.G. Shreffler, R.R. Castro, Y. Kucuk, A.W. Burks, H.A. Sampson

    
• • ·Quality of life of children with peanut allergy

    Page :S37

    N. Verreault, R. Kagan, J. Yu, N. Nicolas, Y. St-Pierre, L. Joseph, J. O'B Hourihane, A. Clarke

    
• • ·Crude peanut extracts depleted of Ara h 2 retain the ability to cross-link IgE from allergic subjects

    Page :S37

    R.A. McDermott, H.S. Porterfield, S.C. Dreskin

    
• • ·Compliance with guidelines for the treatment of accidental ingestion in patients with life-threatening allergies in a camp setting

    Page :S37

    S.P. DaVeiga, M.D. McColgan, J.M. Becker

    
• • ·Identification of soybean allergens with sera from subjects having a positive DBPCFC or history of anaphylaxis to soy

    Page :S38

    T. Holzhauser, B. Ballmer-Weber, C. Bindslev-Jensen, J. Scibilia, G. Zisa, C. Ortolani, D. Mittag, O. Petrovskaya, S. Utsumi, R. Goodman, S. Vieths

    
• • ·Successful therapy with omalizumab for imported fire ant anaphylaxis

    Page :S38

    A. Majmundar, D. Khan

    
• • ·Basophil activation marker expression in subjects undergoing sting challenges: Novel biomarkers of anaphylaxis?

    Page :S38

    K. Vasagar, D. Golden, N. Bhatt, A. Viksman, S. Parihar, A. Parihar, I. Fiorentino, S.S. Saini

    
• • ·Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine

    Page :S38

    O.P. Patel, M.R. Simon

    
• • ·Anaphylaxis to venom of Tetraponera ruflonigra ant: A case report

    Page :S39

    K. Wanotayan, N. Malainual, T. Sassa-deepang, S. Boonchoo, O. Jirapongsananuruk, P. Vichyanond

    
• • ·Epidemiology of anaphylaxis in Siriraj Hospital

    Page :S39

    W. Bunsawansong, O. Jirapongsananuruk, N. Visitsunthorn, P. Vichyanond

    
• • ·Anaphylaxis: A 35 year cases collection

    Page :S39

    C. Direkwattanachai, W. Teawsomboonkit

    
• • ·Anaphylaxis to starch

    Page :S39

    I. Veksler-Offengenden, R.J. Dattwyler

    
• • ·Lack of knowledge regarding anaphylaxis in an at-risk pediatric population

    Page :S40

    M. Khedkar, R.K. Rana, A.M. Szema

    
• • ·A registry of self-reported seafood allergy: Reaction characteristics of the first 1000 registrants

    Page :S40

    S.H. Sicherer, T. Stivers, C. Belcher, A. Muñoz-Furlong, T. Furlong

    
• • ·A questionnaire to measure quality of life in families with a food-allergic child

    Page :S40

    B.L. Cohen, S. Noone, A. Muñoz-Furlong, S.H. Sicherer

    
• • ·Cardiopulmonary resuscitation (CPR) in patients with acute anaphylaxis taking beta-blockers

    Page :S40

    M.M. Alam, G. Alvarez del Real, F.H. Hsieh

    
• • ·Evaluating the results of teaching Epi-Pen use in an allergy clinic

    Page :S41

    S. Huang

    
• • ·Problem based leaning tools (PBLT) results in improved ACGME patient care general competencies in allergy/immunology programs

    Page :S41

    A. Khadavi, B. Silverman, A. Schneider

    
• • ·Rate of immunization and patient education with splenectomy

    Page :S41

    D. Komjathy, C. Ibrahim, C. Lauter

    
• • ·What do parents really know? A qualitative study to assess asthma education

    Page :S41

    P.S. Vasek

    
• • ·Towards excellence in asthma management (TEAM): A model to address care gaps in chronic diseases management

    Page :S42

    R.L. Thivierge, E. Dorval, M. Turgeon, M. Labrecque, L.P. Boulet

    
• • ·The reliability of the Diskus Adherence Logger (DAL)

    Page :S42

    D. Bogen, A.J. Apter

    
• • ·Structured allergy training for health professionals improves quality of life in patients with perennial rhinitis: Randomised controlled trial

    Page :S42

    A. Sheikh, S. Khan-Wasti, D. Price, L. Smeeth, M. Fletcher, S.M. Walker

    
• • ·At what age can a child swallow a pill?

    Page :S42

    N.K. Ostrom, E.O. Meltzer, M. Welch

    
• • ·Post graduate education in allergy and immunology

    Page :S43

    J. Mehrabi, B. Espiritu

    
• • ·CD48 is an allergen-induced gene regulated by IL-3 controlling chemokine expression in allergic eosinophilic airway inflammation

    Page :S43

    A. Munitz, I. Bachelet, M. Khodoun, F.D. Finkelman, M.E. Rothenberg, F. Levi-Schaffer

    
• • ·C-C chemokine Eotaxin/CCL11 induces human lung fibroblast migration and enhances extracellular matrix metabolism in vitro: A new role for Eotaxin/CCL11 in tissue repair and airway remodeling

    Page :S43

    I. Puxeddu, N. Berkman, R. Bader, R. Reich, F. Levi-Schaffer

    
• • ·The cationic amino acid transporter 2 regulates innate and allergen-induced adaptive immune responses in the lung

    Page :S43

    N. Zimmermann, M. Doepker, K. Stringer, C. MacLeod, L. Ellies, M. Rothenberg

    
• • ·Cloning and functional characterization of cynomolgus monkey (Macaca fascicularis) CC Chemokine Receptor 1

    Page :S44

    S. Gupta, C. Kutzleb, S.S. Maronde, A. Kapp, U. Forssmann, J. Elsner

    
• • ·Effects of carbon monoxide on airway reactivity and nitric oxide production in the absence of IL-10

    Page :S44

    S.B. Kapadia, L.K. Kohut, H. Liu, J.M. Sethi, A.M.K. Choi, W.J. Calhoun, B.T. Ameredes

    
• • ·Allergen challenge induces a Th1 signature characterized by upregulation of IFN-γ induced GTPase family of proteins

    Page :S44

    N.G. Dharajiya, A. Estrada, B. Choudhury, R. Alam, B. Clancy, S. Sur

    
• • ·Regulation of the soluble receptor for TNF⍺ on conjunctival epithelial cells and correlation with ICAM-1 upregulation by TNF⍺ and IgE-activated conjunctival mast cells

    Page :S44

    J.L. Stahl, E.B. Cook, N.P. Barney, F.M. Graziano

    
• • ·A murine model to study the in vivo T helper cell polarizing capacity of pollen-associated lipid mediators (PALMs) during primary sensitization

    Page :S45

    J. Gutermuth, C. Traidl-Hoffmann, J. Ring, H. Behrendt, T. Jakob

    
• • ·Effect of Toll-like receptor ligands on survival of human bronchial epithelial cells

    Page :S45

    H. Nagase, K. Hirai, T. Adachi, J. Nakano, K. Yamamoto, N. Yamashita, K. Ohta

    
• • ·IL-16 C-terminal peptide expression in vivo decreases inflammation, IL-4, and mucus production in a murine model of asthma

    Page :S45

    N.A. Parada, J. Urdaneta-Jaimes, M. Pollman, J. Lasky, M. Friedman, G.W. Hoyle

    
• • ·TSG-6 deficiency impairs airway inflammation and hyaluronan deposition in an ova-induced pulmonary inflammation model

    Page :S45

    S. Swaidani, C. de la Motte, C. Fulop, T.G. Glant, M.A. Aronica

    
• • ·Mechanisms of food antigen-induced subcutaneous hypersensitivity responses and Th₂-type pulmonary inflammation

    Page :S46

    V.E. Smart, P.S. Foster, K. Matthaei, T.J.V. Higgins, S.P. Hogan

    
• • ·Experimental rhinovirus (RV) infection increases the activity of human tissue kallikrein (hTK) in the BAL fluid of allergic subjects

    Page :S46

    S.C. Christiansen, J. Eddleston, G.R. Jenkins, R.B. Sarnoff, S.S. Chambers, J.M. Gwaltney, B.L. Zuraw

    
• • ·Relationship between dendritic cells and activated eosinophils in the induced sputum of asthmatics

    Page :S46

    Y.I. Koh, J.B. Lee, I.S. Choi

    
• • ·Anti-CCR3 reduces CD34⁺/Sca-1⁺airway cells in allergen-induced airway inflammation

    Page :S46

    M. Rådinger, A. Johansson, M. Sjöstrand, J. Lee, J. Lötvall

    
• • ·Prostaglandin D₂-induced eosinophilic airway inflammation is mediated by CRTH2 receptor

    Page :S47

    Y. Shiraishi, K. Asano, T. Nakajima, K. Niimi, Y. Suzuki, T. Shiomi, K. Sayama, T. Oguma, E. Ikeda, H. Hirai, K. Yamaguchi, A. Ishizaka

    
• • ·Evolution of aspirin hypersensitivity in allergic and non-allergic types of rhinitis

    Page :S47

    E. Nizankowska, M. Swierczynska, A. Szczeklik

    
• • ·Altered trafficking of cells during acute pulmonary allergic and viral inflammatory stimuli in rats with the chronic postbronchiolitis asthma-like phenotype

    Page :S47

    R.L. Sorkness, L.A. Rosenthal, T. Pier, S.P. Amineva, R.J. Szakaly, R.F. Lemanske

    
• • ·Specific induction of RELM-β in a murine asthma model

    Page :S47

    S. Kierstein, A. Haczku, S.A. Keilbaugh, G. Vass, X. Yang, I.G. Redai, G.D. Wu

    
• • ·The effect of daily apolipoprotein A-1 mimetic therapy on inflammation in a murine model of asthma

    Page :S48

    S. Deenamsetty, K.S. Konduri, S.D. Nandedkar, K. Pritchard

    
• • ·Modification of sensitization methods can induce allergic inflammation in the lungs of allergy-resistant Sprague Dawley rats

    Page :S48

    Y.O. Wong, R.Y.T. Sung, Q.H. Yang, W.Y. Chan, K. Li, Y. Zhao, A.M. Li, T.F. Fok, K.P. Fung

    
• • ·Effects of Montelukast sodium on development and differentiation of human mast cells and eosinophils

    Page :S48

    D. Morgan, E.S. Schulman

    
• • ·Eotaxin release from human airway smooth muscle cells treated with albuterol enantiomers

    Page :S48

    C. Codispoti, W.J. Calhoun, B.T. Ameredes

    
• • ·The effect of D-4F, an apolipoprotein A-1 mimetic, on 15-lipoxygenase expression in experimental asthma

    Page :S49

    K.S. Konduri, S.D. Nandedkar, S. Deenamsetty, K.A. Pritchard

    
• • ·Olopatadine and Patanol effect TNF-⍺ and IL-1β production in LPS-activated peripheral blood monocytes

    Page :S49

    J.A. Poole, C. O'Relley, L.J. Rosenwasser

    
• • ·Normal human lung fibroblasts (NHLF) stimulated with conditioned media (CM) from D. pteronyssinus-treated confluent type II alveolar epithelial A549 Cells (cA549) show decreased adhesion and increased aggregation

    Page :S49

    N.S. Horne, A. Capetandes, M. Frieri

    
• • ·Characteristic features of allergic airway inflammation in a murine model of infantile asthma

    Page :S49

    H. Mayuzumi, K. Tokuyama, Y. Ohki, H. Koyama, T. Takizawa, H. Arakawa, H. Mochizuki, A. Morikawa

    
• • ·Olopatadine inhibits histamine-stimulated IL-8 release from human nasal epithelial cells in vitro

    Page :S50

    F.M. Graziano, J.L. Stahl, N.P. Barney, E.B. Cook

    
• • ·S-ICAM-1 in patients with chronic (perennial) allergic rhinitis with or without bronchial hyperresponsiveness and with asthma

    Page :S50

    M. Gorska-Ciebiada, M. Ciebiada, A. Zakrzewska, P. Gorski, I. Grzelewska-Rzymowska

    
• • ·Effect of nasal steroid treatment on airway inflammation measured by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma

    Page :S50

    C. Pedroletti, J. Lundahl, K. Alving, G. Hedlin

    
• • ·An extract of Pencillium chrysogenum induces dose-dependent allergic asthma responses in mice

    Page :S50

    Y. Chung, N.H. Coates, M.E. Viana, L.B. Copeland, M.K. Selgrade, M.D.W. Ward

    
• • ·A comparison of cytokine responses in respiratory syncytial virus and adenovirus infections in vitro

    Page :S51

    J.S. Yoon, M.H. Lee, H.H. Kim, J.T. Kim, J.S. Lee

    
• • ·RV1A and dsRNA highly induce a biphasic expression of MIP-3⍺/CCL20 in human bronchial epithelial cells (hBECs)

    Page :S51

    J.M. Bellak, K. Hanson, R.A. Brockman-Schneider, H. Dagher, J.E. Gern

    
• • ·Effect of macrophage inflammatory protein-1⍺ on airway inflammation of asthma in mouse model

    Page :S51

    C. Li, W. Zhang, X. Chen, L. Xie, Q. He, X. Hu, J. Li, M. Li, R. Wu, Z. Zhang

    
• • ·Inhibition of human cyclooxygenase-1 by Dermatophagoides allergenic extracts

    Page :S51

    M. Sanchez-Borges, M. Ouellet, M. Percival, A. Capriles-Hulett, F. Caballero-Fonseca

    
• • ·Local, systemic, and distant cytokine induction by selective nasal versus bronchial allergen provocation in a mouse model of airway allergy

    Page :S52

    G. Hens, P. Hellings, I. Meyts, B. Verbinnen, E. Dilissen, M. Adé, D. Bullens, J. Ceuppens

    
• • ·High level of MCP-3 in nasal lavages is a distinct feature of patient with aspirin asthma

    Page :S52

    M. Kupczyk, I. Kupryś-Lipińska, W. Szymczak, B. Kuźmińska, P. Górski, P. Kuna

    
• • ·Hyperresponsiveness to nasal challenge with histamine in mice

    Page :S52

    J.J. Klemens, V. Kirtreesakul, R.M. Naclerio

    
• • ·High level of RANTES in nasal lavages is a distinct feature of patient with aspirin asthma

    Page :S52

    I. Kupryś-Lipińska, M. Kupczyk, W. Szymczak, B. Kuźmińska, M. Kurowski, P. Górski, P. Kuna

    
• • ·Topical vapocoolant spray: Effect on skin test wheal and flare responses

    Page :S53

    K.H. Waibel, R.K. Katial

    
• • ·Study on Dermatophagoides pteronyssinus allergens fingerprinting by two-dimensional immunoblotting

    Page :S53

    J. Sun, H. Zhang, W. Ying, X. Qian

    
• • ·IgE immunoblot reactivity in allergic fungal sinusitis

    Page :S53

    P.S. Hutcheson, M.S. Schubert, R.G. Slavin

    
• • ·Maintenance of allergenicity of grass extract after combination with dust mite or mold extracts

    Page :S53

    B. Malde, K. Lenchner, C.A. Saltoun, K.E. Harris, L.C. Grammer

    
• • ·Characterization of ocular reactions during aspirin challenge in patients with aspirin exacerbated respiratory disease

    Page :S54

    P.K. Mehra, S.A. Trauger, G. Siuzdak, M.H. Freidlaender, D.D. Stevenson

    
• • ·Objective evaluation of allergic reactions in the eye using the EES (erythema, edema, sensation) method

    Page :S54

    M.H. Friedlaender, L.J. Sharf, D. Breshears

    
• • ·Factors affecting the allergic response to ragweed allergen challenge

    Page :S54

    A.K. Ellis, J.D. Ratz, A. Day, E. Rafeiro, J.H. Day

    
• • ·Mediator release of neuropeptides after nasal provocation in perennial rhinitis patients

    Page :S54

    R. Gawlik, K. Schultz, L.M. DuBuske

    
• • ·The laser Doppler flowmetry for estimation the skin prick tests before and after application of antileucotrienes

    Page :S55

    K. Klos, A. Zakrzewski, J. Kruszewski, K. Sulek, M. Dudziak

    
• • ·Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome

    Page :S55

    M.I. Fogg, J.M. Spergel

    
• • ·Evaluation of prick skin tests (PSTs) to predict the outcome of double-blind, placebo-controlled food challenge (DBPCFC) to egg when egg-specific serum IgE is low

    Page :S55

    A.K. Knight, W. Shreffler, H. Sampson, S. Sicherer, S. Noone, A. Nowak-Wegrzyn

    
• • ·Validity of laboratory-based allergy diagnosis in daily practice

    Page :S55

    H. Malandain, H. Susini De Luca

    
• • ·Skin prick test for anti-thymocyte globulin does not predict immediate ATG-related adverse events

    Page :S56

    P.L. Lugar, J. Parrino, N. Young, J. Chinen

    
• • ·Production of Th2-, Th1-, and regulatory cytokines in allergic rhinitis

    Page :S56

    M. Wagenmann, A. Chaker, K. Scheckenbach

    
• • ·The role of the high affinity IgE receptor in allergic rhinitis in mice

    Page :S56

    S. Miyahara, N. Miyahara, K. Takeda, S. Matsubara, E.W. Gelfand

    
• • ·Expression of cysteinyl leukotriene (Cys-LT) receptors 1 and 2 in the nasal mucosa in perennial allergic and non-allergic rhinosinusitis

    Page :S56

    X.Q. Wu, A.C. Myers, C.J. Reynolds, A.C. Goldstone, A. Togias, A.M. Sanico

    
• • ·Hyper-immunoglobulinemia E, G, and A in nasal polyp tissue

    Page :S57

    T.P.J. Van Zele, P. Gevaert, G. Holtappels, P. Van Cauwenberge, C. Bachert

    
• • ·Risk factors for adenoidal regrowth post-adenoidectomy: Comparison between allergic and non-allergic etiologies

    Page :S57

    S. Kung, S.J. McGeady, E. Yousef

    
• • ·Nasal eosinophils display the best correlation with symptoms, pulmonary function, and inflammation in allergic rhinitis

    Page :S57

    G. Ciprandi, A. Vizzaccaro, I. Cirillo, M. Tosca, A. Massolo, G. Passalcqua, G. Passalacqua

    
• • ·Staphylococcus aureus and pseudomonas aeruginosa are principal pathogens of acute exacerbations following endoscopic sinus surgery

    Page :S57

    M.Y. Desrosiers, H. Al-Shemari, W. Abou-Hamad, A. Hussain, M. Poisson, M. Libman

    
• • ·Early intervention with budesonide in recent onset mild persistent asthma in children: START trial results

    Page :S58

    S. Pedersen, Y.Z. Chen, C.J. Lamm, W. Busse, R. Pauwels, W.C. Tan, P. O'Byrne

    
• • ·In vitro IL-8 production by epithelial cells from nasal mucosa and polyp tissue: Modulation by IL-1B, TNF-a, and dexamethason

    Page :S58

    P.W. Hellings, E. Verbeke, M. Jorissen, C.M. van Drunen, J.L. Ceuppens, W.J. Fokkens

    
• • ·Proteomic analysis of normal human nasal mucus

    Page :S58

    B. Casado, L.K. Pannell, P. Iadarola, J.N. Baraniuk

    
• • ·Children and asthma in America 2004 survey

    Page :S58

    A.L. Fuhlbrigge, K.J. Davis, T. Guilbert, J. Spahn, D. Peden

    
• • ·Effects of dexamethasone and B-agonist enantiomers on glucocorticoid receptor translocation

    Page :S59

    B.T. Gibson, S. Friday, S. Watkins, B.T. Ameredes, W.J. Calhoun

    
• • ·Increased non-canonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes

    Page :S59

    B. Ng, F. Yang, D.P. Huston, Y. Yan, Y. Yang, Z. Xiong, L.E. Peterson, H. Wang, X. Yang

    
• • ·Improved exacerbation rates and asthma control in current and former smokers treated with salmeterol/fluticasone propionate: Results of the GOAL study

    Page :S59

    H.A. Boushey, S. Pedersen, E. Bateman, T. Clark, W. Busse, J. Bousquet, R. Pauwels

    
• • ·B cell apoptosis induced by gp120 in HIV-1 infected individuals is inhibited by SDF-1⍺

    Page :S60

    C.L. Nance, W.T. Shearer

    
• • ·Splenectomized patients make IgG antibodies to 23-valent non-conjugated pneumococcal vaccine despite having reduced circulating CD27⁺ memory B cells

    Page :S60

    H.A. Wasserstrom, J.B. Bussel, L.C.L. Lim, N.T. Guerrero, M.H. Wissert, L. Radigan, C. Cunningham-Rundles

    
• • ·Constitutive expression of interleukin 14 (IL-14) in transgenic mice leads to enhanced responses to vaccinations and autoimmunity

    Page :S60

    C. Xu, C. Zhang, L. Shen, D.E. Skyes, H. Zeng, S. Tang, P.D. Soloway, S. Brooks, S. Sharma, R.J. Ford, Y. Lin-Lee, J. Horn, L. Martin, L. Ludwig, P. Liang, J.L. Ambrus

    
• • ·Dog exposure in early childhood reduces atopic dermatitis and wheezing at age 3

    Page :S60

    J.D. Bufford, C.L. Reardon, J. Kohls, Z. Li, R. Gangnon, K.A. Roberg, C. Tisler, E. Anderson, D. DaSilva, P.A. Eggleston, R.F. Lemanske, J.E. Gern

    
• • ·Can differences in endotoxin exposure explain cat tolerance or the inner-city asthma epidemic?

    Page :S61

    J.A. Platts-Mills, N.J. Custis, M.G. Murphy, A.A. Irani, J.A. Woodfolk, T.A.E. Platts-Mills

    
• • ·Outcome at 7 years of intervention measures on the primary prevention of asthma in high-risk children

    Page :S61

    A.B. Becker, A. Ferguson, W.T.A. Watson, H. Ward, M. Chan-Yeung

    
• • ·CD14 polymorphisms, endotoxin and Der p 1 exposures and sensitisation to dust mite in the manchester asthma and allergy study

    Page :S61

    A. Simpson, S. John, F. Jury, R. Niven, A. Woodcock, W. Ollier, A. Custovic

    
• • ·A registry of self-reported seafood allergy: Demographic and allergic characteristics of the first 1000 registrants

    Page :S62

    T. Furlong, T. Stivers, C. Belcher, A. Muñoz-Furlong, S.H. Sicherer

    
• • ·Levels of circulating peanut-specific precursor T cells reflect peanut allergy status

    Page :S62

    V.H. Turcanu, G. Lack

    
• • ·Oral tolerance protocols improve the rate of recovery of cow milk and egg allergies: Randomized study in 60 children with cow's milk allergy and 90 children with egg allergy

    Page :S62

    M. Morisset, D. Moneret-Vautrin, L. Guénard, J. Cuny, P. Frentz, R. Hatahet, C. Hanss, E. Beaudouin, N. Petit, S. Frémont, G. Kanny

    
• • ·Usefulness and safety of a ready-to-use atopy patch test (APT) (Diallertest®) versus a reference test (Finn Chamber®) during cow's milk allergy in children

    Page :S62

    N. Kalach, P. Soulaines, D. De Boissieu, C. Dupont

    
• • ·Evaluation of home telemanagement in adult asthma patients

    Page :S63

    J. Finkelstein, A. Joshi, P. Amelung

    
• • ·Improving asthma treatment and quality of life in a managed care population

    Page :S63

    D. Peruccio, B. Bauer, S. Delaronde

    
• • ·Preliminary results of the Puff City Program for urban teens with asthma

    Page :S63

    C.L.M. Joseph, S. Stringer, D.R. Ownby, E. Peterson, S. Hoerauf, W. Gibson-Scipio, C.C. Johnson, J. Elston-Lafata, E. Saunders, U. Pallonen, J. Caison-Sorey, N.M. Clark, M. Dereski, K. Wildenhaus, R. Vinuya, V. Strecher

    
• • ·EZ Breathers: A partnership to improve asthma management using a combination of staff education and home visits in a head start population

    Page :S63

    C.S. Kelly, J.C. Taylor-Fishwick, L. Harrison, C. Collins-Odoms, J. Hixson

    
• • ·Suppression of established experimental asthma by Toll-like receptor 7 activation

    Page :S64

    S. Sel, S. Sel, M. Wegmann, H. Garn, G. Alber, H. Renz

    
• • ·Inhibition of airways hyperresponsiveness by a chimeric STAT-6 peptide in a murine model of allergic rhinitis and asthma

    Page :S64

    Y. Wang, C. McCusker, E. Fixman

    
• • ·STAT4 deficiency exaggerates airway hyperresponsiveness (AHR) after repeated ovalbumin (OVA) challenge

    Page :S64

    S. Matsubara, T. Kodama, K. Takeda, N. Miyahara, A. Joetham, C. Taube, A. Dakhama, J. Park, T. Koya, E.W. Gelfand

    
• • ·Prolonged effect of Flt3-L plasmid to protect against allergic airway inflammation and airway hyperresponsiveness

    Page :S64

    J.H. Edwan, J.E. Talmadge, D.K. Agrawal

    
• • ·Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT)

    Page :S65

    T.B. Casale, J.N. Kline, W.W. Busse, Z.K. Ballas, M. Mokhtarani, V. Seyfert-Margolis, K. Bateman, M.H. Moss, R.G. Townley

    
• • ·Pharmacokinetics of radiolabelled PAR j 1 administered intranasally to allergic and healthy subjects

    Page :S65

    G. Passalacqua, V. Altrinetti, G. Mariani, P. Falagiani, G. Mistrello, R. Brizzolara, G.W. Canonica, M. Bagnasco

    
• • ·Grass pollen tablets for sublingual immunotherapy in seasonal allergic rhinitis (SAR)

    Page :S65

    M.A. Calderón, S. Rak, S.R. Durham

    
• • ·Evaluation of safety and clinical efficacy of higher dose immunotherapy with AIC (immunostimulatory DNA conjugated with Amb a 1) in patients with ragweed-induced seasonal allergic rhinitis (SAR)

    Page :S65

    A.R. Vaishnav, S.B. Whaley, R. Hamilton, D. Levitt, P.S. Creticos

    
• • ·Allergen provocation of eosinophil-less mice demonstrates that the presence of eosinophils is required for the development of pulmonary immune responses

    Page :S66

    J.J. Lee, S.I. Ochkur, G. Cieslewicz, D. Dimina, M.P. McGarry, K.R. O'Neill, C. Protheroe, R.S. Pero, E. Lenkiewicz, D.C. Colbert, S.J. Ackerman, C.G. Irvin, N.A. Lee

    
• • ·The FIP1-like-1 (FIP1L1)- Platelet-Derived Growth Factor Receptor Alpha (PDGFR alpha) fusion gene cooperates with IL-5 to induce a hypereosinophilic syndrome (HES)-like disease in a murine model

    Page :S66

    Y. Yamada, M.E. Rothenberg, A.W. Lee, H. Saito-Akei, E.B. Brandt, D.A. Williams, J.A. Cancelas

    
• • ·Individual and combined gene deletions reveal that the eotaxin chemokines and CCR3 fundamentally regulate allergen-induced pulmonary eosinophilia

    Page :S66

    S.M. Pope, N. Zimmermann, K.F. Stringer, M.L. Karow, M.E. Rothenberg

    
• • ·The CCL14 derivative NNY-CCL14 prevents the recruitment of eosinophils and lymphocytes and airway hyperresponsiveness in allergic airway inflammation

    Page :S66

    J. Elsner, B. Fuchs, R. Bälder, S.E. Escher, A. Heitland, W. Forssmann, A. Braun, U. Forssmann

    
• • ·Asthma ambassadors—A home visiting program in public housing programs in Southeastern Virginia

    Page :S67

    J.C. Taylor-Fishwick, C.S. Kelly, F.D. Butterfoss, L. Harrison, J. Hixson, L. Smith

    
• • ·Subcutaneous infusion of immune globulin in an infant with severe combined immunodeficiency (SCID)

    Page :S67

    D.A. Sedlak, R.H. Buckley

    
• • ·Improved asthma outcomes achieved through a synergistic relationship of pharmacology and education in a high risk population

    Page :S67

    K.S. Rance, C.A. Trent

    
• • ·Enhancing awareness of asthma and asthma symptoms in Dallas schools

    Page :S67

    D. Santoyo, N. Gimpel, N. Gorham, D. Jimenez, B. Lewis, L.C. Roy, R. Gruchalla

    
• • ·A small molecule compound (AVP-13358) in Phase I clinical development suppresses experimental allergy in animals via a distinctly Novel mechanism

    Page :S68

    M.L. Richards, J. Ludwig, H. Banie, R.Y. Soneff, D. Marcantonio, A. Chatterjee, W. Scholz, J.C. Sircar

    
• • ·The bronchoalveoloar lavage as a tool to differentiate asthma and severe COPD

    Page :S68

    R. Caillet- Bois, M.D. Romero, M. Ferrero, J.C. Muiño

    
• • ·Exhaled nitric oxide as a marker of change in asthma related quality of life

    Page :S68

    A. Michils, M. Tamboura, A. Van Muylem

    
• • ·Associations between five polymorphisms in IL-13 and IL-4R⍺ and asthma-related clinical phenotypes in Korean children

    Page :S68

    H. Kim, S. Lee, J. Kim, B. Kim, H. Seo, M. Kang, S. Jang, S. Lee, E. Shin, S. Hong

    
• • ·Thirty years generation gap dramatically increased prevalence of asthma and the other allergic diseases in Japan

    Page :S69

    A. Akasawa, M. Narita, Y. Ohya

    
• • ·Increased sensitization to indoor versus outdoor allergens in inner-city asthmatic children

    Page :S69

    D. Rastogi, J. Kairam, M. Reddy

    
• • ·What does an allergy assessment bring to the primary care consultation for patients with asthma or rhinitis?

    Page :S69

    H.E. Smith, C. Hogger, C. Lallement, D. Crook, A.J. Frew

    
• • ·Leukolysin, a potential marker for airway remodeling in asthma

    Page :S69

    J.B. Sweet, C. Liebeler, J. Nie, D. Pei, M.N. Blumenthal

    
• • ·Clinical significance of serum eosinophil-derived neurotoxin (EDN) in childhood asthma

    Page :S70

    K. Kim, E. Kim, S. Choi, B. Kwon, M. Sohn, K. Kim

    
• • ·Inverse relationship of plasma C5a levels to allergic disease activity in pediatric but not adult populations

    Page :S70

    C. Charlot, C. Bowser, M. Castro, N. Mathur, O. Asimolowo, H. Drew, F. Hajee, S.M. Chice, M. Rao, M. Nowakowski, R. Joks

    
• • ·Use of IgE testing in diagnosing asthma

    Page :S70

    H.S. Volpp, W.B. Klaustermeyer, M.L. Kurohara

    
• • ·Allergen-induced immune responses in non-allergic asthma

    Page :S70

    K. Yamazaki, G.W. Volcheck, H. Kita

    
• • ·Early manifestations of near-fatal asthma newly diagnosed in children

    Page :S71

    H.B. Lee, S.A. Shin, J.W. Oh

    
• • ·A 17-year study of the prevalence of asthma and allergic diseases among children in Saudi Arabia

    Page :S71

    a. S. Al-Frayh

    
• • ·Airway inflammation and methacholine hyperresponsiveness in athletes with asthma-like symptoms and asthmatic patients

    Page :S71

    A. Moreira, L. Delgado, M. Capão-Filipe, J. Fonseca, M. Castel-Branco

    
• • ·Fungi—The most frequent cause of severe chronic bronchial asthma

    Page :S71

    T. Hofman, A.M. Hofman, A. Urbanowicz

    
• • ·Activation of protease activated receptors -1, -2, and -4 but not -3 induce pulmonary surfactant production and release from type II pneumocytes

    Page :S72

    N. Asokananthan, P.T. Graham, A.S. Mc William, G.A. Stewart, G.A. Stewart

    
• • ·Enviromental aeroallergens in the Valley of Mexico

    Page :S72

    D. Aguilar

    
• • ·Montelukast decreases serum endothelin-1 levels in pediatric asthma patients

    Page :S72

    F. Kopřiva, A. Janošťáková

    
• • ·Cutaneous sensitization to dermatophagoides (DP and DF) in asthmatic children in Lambayeque, Peru

    Page :S72

    F. Maticorena, V. Pupuche, H. Naval, W. Presentación

    
• • ·Eupatilin blocks mediator release via tyrosine kinase inhibition of initial stage in activated guinea pig lung mast cells

    Page :S73

    E. Kwon, J. Kim, J. Ro

    
• • ·Daclizumab in vitro inhibits the secretion of pro-asthmatic and pro-inflammatory cytokines by activated T cells

    Page :S73

    T.R. Sornasse, W. Hong, R. Schreck, Y. Zhang, J. Sheridan, J. Shi, J. Woo, T. Tsao, V. Vexler

    
• • ·Neovastat inhibits airway inflammation and hyperresponsiveness in a murine model of asthma

    Page :S73

    S. Lee, S. Kim, S. Kwon, S. Jung

    
• • ·293 Creating a standardized cockroach extract

    Page :S73

    P.A. Eggleston, A.H. Liu, J.A. Pongracic, S. Sarpong, R. James, P.J. Gergen, H. Mitchell, J.E. Slater

    
• • ·IgE immunotherapy efficiently reduces an IgE-mediated local anaphylactic reaction

    Page :S74

    A. Jansson, M. Fant, L. Hellman, A. Kalvesten, E. Landstrom, A.C. Magnusson, B. Ohman, S. Persson, B. Xu

    
• • ·Expression of CD163 on peripheral blood monocytes in allergic asthma patients during specific immunotherapy (SIT)

    Page :S74

    K. Kowal, S. Zukowski, L.M. DuBuske, A. Bodzenta-Lukaszyk

    
• • ·Protollin adjuvanted birch pollen extract prevents airway hyperresponsiveness and airway inflammation in a mouse model of allergic asthma

    Page :S74

    C.R. Rioux, N. Karp, H. Koohsari, N. Bellerose, K. Dubé, D.S. Burt, J.G. Martin, Q.A. Hamid

    
• • ·Pharmacoeconomics of allergen immunotherapy in allergic rhinitis and asthma

    Page :S74

    R. Ariano, P. Berto, D. Tracci, C. Incorvaia, F. Frati

    
• • ·Evaluation of BGC administration as an adjuvant to specific immunotherapy in mite-allergic asthmatic patients

    Page :S75

    A. Cohon, L. Arruda, J. Kalil

    
• • ·Omalizumab significantly reduces asthma exacerbations in patients with severe persistent asthma: A pooled analysis

    Page :S75

    W. Berger, N. Ostrom, M. Soler, S. Hedgecock, H. Fox, M. Blogg

    
• • ·A hospital-based retrospective cohort study of allergen immunotherapy as a preventive treatment for new onset asthma

    Page :S75

    C. Russo, W.K. Al-Delaimy, M. Sarvà, R. Polosa

    
• • ·Omalizumab is well tolerated in adolescent/adult patients (≥12 Years) with moderate-to-severe persistent asthma

    Page :S75

    J. Corren, T. Casale, B.Q. Lanier, M. Blogg, C. Reisner, N. Gupta

    
• • ·Safety of semirush immunotherapy: A pilot study

    Page :S76

    E. Cervantes-Trujano, B.V. Alvarez-Arana, H.E. Guidos-Morales, S. Orozco-Martínez, J.G. Huerta-López

    
• • ·Omalizumab, an anti-IgE antibody, significantly reduces emergency visits in patients with severe persistent asthma: A pooled analysis

    Page :S76

    P. Korenblat, E. Meltzer, W. Busse, S. Hedgecock, H. Fox, M. Blogg

    
• • ·Omalizumab does not improve pulmonary function or Lessen medical therapy in patients with mild to severe persistent asthma after 6 months of treatment

    Page :S76

    E. Hahn, M. Vo, I. Hussain

    
• • ·Omalizumab add-on therapy significantly reduces asthma exacerbations in patients with inadequately controlled severe persistent asthma despite GINA 2002 step 4 therapy: INNOVATE

    Page :S76

    P. Korenblat, R. Levy, R. Slavin, S. Hedgecock, H. Fox, K. Surrey

    
• • ·A novel mutation of intron 22 in a 5-month-old girl with Jak3-deficient SCID

    Page :S77

    C.M. Mjaanes, R.R. Quinones, E.W. Gelfand

    
• • ·A near fatal adenoviral infection caused by a previously unrecognized SH2D1A mutation

    Page :S77

    D.R. Doshi, Z.K. Ballas, Y. Tabata, L. Filipovich, N. Zavazava

    
• • ·CD4+CD25^high T regulatory cells in SCID patients post-bone marrow transplantation (BMT)

    Page :S77

    E.O. Sajaroff, K.E. Coyne, R.H. Buckley

    
• • ·Novel Rag1 mutations leading to Omenn Syndrome

    Page :S77

    M.J. Butte, C.E. Briggs, F.A. Bonilla

    
• • ·X-linked Chronic Granulomatous Disease presenting in a 16 year old female secondary to skewed X chromosome inactivation

    Page :S78

    M. Singla, E.M. Lewis, S. Sergeant, P.P. Koty, L.C. McPhail

    
• • ·Neurological manifestations in severe combined immunodeficiency secondary to adenosine deaminase deficiency: Three case reports and review of the literature

    Page :S78

    Y. Nofech-Mozes, C.M. Roifman

    
• • ·Late-onset intractable hypocalcemia in an adult with recently diagnosed 22q11.2 deletion syndrome

    Page :S78

    K. Carel, E.W. Gelfand

    
• • ·Mucocutaneous Candidiasis and vulvo vaginitis: Clinical and immunologic aspects

    Page :S78

    A.G. Palma-Carlos, L. Palma-Carlos

    
• • ·Severe mononucleosis in a girl with progression to lymphoma–Epstein Barr Virus (EBV)-associated lymphoproliferative disease (LPD) that mimics X-linked lymphoproliferative disease (XLPD)

    Page :S79

    J.T. Kayser, H. Heslop, K. McClain, M.K. Dishop, S. May, L.M. Noroski

    
• • ·Clinically relevant neutrophil superoxide defect in a patient with hairy cell leukemia

    Page :S79

    J. Radi, S. Macleish, R.W. Hostoffer

    
• • ·Combined immunodeficiency in a patient with chromosome 1q42.1q42.3 deletion

    Page :S79

    H.A. Song, L. Yel, A. Baysan, T. Young, S. Gupta

    
• • ·A case of Ataxia-Telangiectasia diagnosed after adenoidectomy

    Page :S79

    A.L. Cox, P. Ponda, P. Logalbo, V.R. Bonagura

    
• • ·The impact of pneumococcal vaccines in adult patients with sinopulmonary infections and low pneumococcal antibody titers—Pilot observation

    Page :S80

    L. Yao, P. Kumar

    
• • ·Outside the bubble: An atypical presentation of severe combined immunodeficiency disease (SCIDs)

    Page :S80

    D.G. DeMerell, J.M. El-Dahr

    
• • ·Caseating granulomatous disease in common variable immunodeficiency treated with infliximab

    Page :S80

    A.Z. Hatab, Z.K. Ballas

    
• • ·Idiopathic CD4+ lymphopenia in conjuction with alopecia areata: A case report

    Page :S80

    J.H.C. Friesen

    
• • ·Gammaglobulin infusion causing headache—Can sucrose be the culprit?

    Page :S81

    D. Sun, I. Hussain, S. Odenwald, K. Wehmeier

    
• • ·Hypogammaglobulinemia and recurrent Stevens-Johnson syndrome: A case report

    Page :S81

    L.B. Moreno, B. Kaplan

    
• • ·Recurrent respiratory papillomatosis (RRP): Disease severity associates with enhanced T_H2-like dendritic cell chemokine (DC-CK1) plasma expression

    Page :S81

    D.W. Rosenthal, H. Schmidtmayerova, B.M. Steinberg, J.A. Devoti, L. Hatam, A. Vambutas, V.R. Bonagura

    
• • ·X-linked lymphoproliferative disease with Growth Hormone deficiency

    Page :S82

    A.A. Alangari, A. Abobaker, H. Kanegane, T. Miyawaki

    
• • ·Disseminated mycobacterium avium complex infection in a patient with complete interferon gamma receptor deficiency

    Page :S82

    C.M. Mosby, R. Patel, H. Aguila, G. McSherry, H. Jyonouchi

    
• • ·Immune defects associated with dysmorphic disorders

    Page :S82

    S.A. Mahmoud, M. Lowery-Nordberg, H. Chen, T. Thurmon, S. Ursin, S.L. Bahna

    
• • ·Streptococcal pneumoniae sepsis in splenectomized patients with Autoimmune Lymphoproliferative Syndrome (ALPS)

    Page :S82

    C.J. Geaney, J.K. Dale, F. Dugan, V. Rao, T.A. Fleisher, S.E. Straus

    
• • ·Epstein-Barr Virus (EBV) infection of natural killer (NK) cells and hypersensitivity to mosquito bites: A different facet of X-linked lymphoproliferative disorder (XLP)?

    Page :S83

    T.G. McCormick, S. Gottschalk, T. Okamura, M. Gresik, M. Dishop, S. Pacheco

    
• • ·Atypical bare lymphocyte syndrome due to MHC Class II insufficiency

    Page :S83

    K.A. DeMuth, D. Mitchell, C. Koenig, W. Zhao, A. Irani

    
• • ·Pulmonary outcomes are more severe among HIV-infected children with pneumocystis pneumonia than in children with primary immunodeficiency

    Page :S83

    K.S. Brauer, N. Tangsinmankong, J.W. Sleasman, S. Skoda Smith

    
• • ·Effects of radiation and latent virus on immune responses in a space flight model

    Page :S83

    W.T. Shearer, S. Zhang, J.M. Reuben, B. Lee, J.S. Butel

    
• • ·Hyper IgE syndrome with polidase deficiency: A case report

    Page :S84

    G.S.H. Hassoun, S. Pollack

    
• • ·Complications of pregnancy and common variable immunodeficiency

    Page :S84

    S. Macleish, R.W. Hostoffer

    
• • ·Common variable immunodeficiency associated with bilateral birdshot retinochoroidopathy

    Page :S84

    A. Marks, L.J. Singerman, R. Hostoffer

    
• • ·Spectrum of illness in pediatric common variable immunodeficiency

    Page :S84

    P.R. Ogershok, W.T. Corder, M.B. Hogan, J.E. Welch, N.W. Wilson

    
• • ·The prevalence of selective IgA deficiency in patients with IgE hypogammaglobulinemia

    Page :S85

    A. Nahum, Y. Levy, N. Segal, Y. Monselisse, Y.L. Danon

    
• • ·Sarcoid, infectious disease, or immunodeficiency?

    Page :S85

    S.N. Hassan, F.C. Schmalstieg

    
• • ·Transient deficiency of complement factor D function in infancy

    Page :S85

    G.K. Deogun, M.M. Frank, A. Irani, H. Jiang, A.T. Gewurz

    
• • ·Unusual infections in a mother and son with G6PD and a defective oxidative burst

    Page :S85

    M.L. Heltzer, K.E. Sullivan

    
• • ·Functional anti-nerve growth factor antibodies in commercial intravenous gammaglobulin

    Page :S86

    R.J. Warrington, K. Lewis

    
• • ·Subcutaneous immunoglobulin (SCIG) therapy: Review of 51 patients

    Page :S86

    J. Kirmse, C.R. Weiler

    
• • ·Three suitable antigens for delayed-type hypersensitivity (DTH) skin testing in a tropical country like Thailand

    Page :S86

    K. Siripassorn, P. Charoenwongse, K. Ruxrungtham

    
• • ·Natural killer cell impairment in a patient with pachyonychia congenita

    Page :S86

    D.D. Siri, S.O. Gubernick, M.R. Sher, J.W. Sleasman

    
• • ·Allergome—A database of allergenic molecules: Structure and data implementations of a web-based resource

    Page :S87

    A. Mari, V. Mari, A. Ronconi

    
• • ·Predicting and cataloging putative fungal allergens from the fungal protein sequences in the GenBank

    Page :S87

    S.S. Joshi, C.Y. Kong, F.T. Chew

    
• • ·Characterization of the enzymatic activities present in extracts of various mites

    Page :S87

    M.S. Morgan, L.G. Arlian

    
• • ·Functional study of the cockroach allergen Bla g 2

    Page :S87

    S. Wünschmann, M.D. Chapman, A. Gustchina, A. Wlodawer, M. Li, A. Pomés

    
• • ·Catalogue of the major transcripts of the storage mite, Aleuroglyphus ovatus: Revealing the putative allergenic repertoire

    Page :S88

    S.F.R. Ramjan, A.H.B. Loo, Y.P. Lim, F.T. Chew

    
• • ·Solution structure and epitope mapping of a major Group 13 allergen from the house dust mites, Dermatophagoides farinae

    Page :S88

    S.L. Chan, S.T. Ong, T.C. Ong, F.T. Chew, Y.K. Mok

    
• • ·Analysis of the crystal structure of rproDer p 1 with emphasis on differences in antibody binding of Pro/Mature Der p 1

    Page :S88

    K. Meno, P.B. Thorsted, H. Ipsen, O. Kristensen, M. Gajhede, K. Lund

    
• • ·The major mite allergen from Dermatophagoides pteronyssinus, Der p 2, is a sterol binding protein

    Page :S88

    K. Reginald, M.R. Wenk, F.T. Chew

    
• • ·Identification of nDer p 3 as the serine protease activity associated with purified nDer p 1 from house dust mite extract

    Page :S89

    J. Sauer, P.B. Thorsted, K. Mutenda, H. Ipsen, K. Lund

    
• • ·Hypoallergenic variants of Art v 1, the major mugwort pollen allergen

    Page :S89

    G. Gadermaier, A. Dedic, B. Jahn-Schmid, C. Ebner, F. Ferreira

    
• • ·Expression and characterization of Bet v 1 variants created by gene shuffling

    Page :S89

    M. Wallner, A. Stöcklinger, L. Vogel, B. Bohle, P. Hammerl, H. Breiteneder, K. Hoffmann-Sommergruber, S. Vieths, J. Thalhamer, F. Ferreira

    
• • ·Molecular biodiversity of conifers might be used to design specific immunotherapy

    Page :S89

    L. Xie, T. Midoro-Horiuti, C. Schein, W. Braun, R.M. Goldblum

    
• • ·Purification and structural analysis of the novel glycoprotein allergen Cyn d 24 from the Bermuda grass pollen

    Page :S90

    L. Chow, L. Chiu, K. Khoo, S. Su

    
• • ·Molecular cloning and characterization of a group 5 paralogue from Blomia tropicalis

    Page :S90

    Y.F. Gao, X.Z. Bi, H.S. Shang, D.Y. Wang, F.T. Chew

    
• • ·Recombinant weed pollen allergens for diagnosis of ragweed and mugwort allergies

    Page :S90

    N. Wopfner, R. Asero, G. Gadermaier, G. Hubinger, P. Gruber, F. Ferreira

    
• • ·Cloning of the major cedar pollen allergens Jun a 1 and Cry j 1 and expression of recombinant proteins

    Page :S90

    G. Schmidt, F. Ferreira

    
• • ·The identification and characterization of an IgE-inducing protein in Metarhizium anisopliae extract

    Page :S91

    M.D.W. Ward, L.B. Copeland, M.J. Donohue, J.A. Shoemaker

    
• • ·Localization of recently discovered allergens in Dermatophagoides pteronyssinus

    Page :S91

    J.R. Gattuso, B.J. Hales, W.R. Thomas, X.Z. Bi, F.T. Chew, E.R. Tovey

    
• • ·Copepods: Worldwide sources of allergens—Partial sequences of three unique proteins

    Page :S91

    R. Muthiah, S. Kagen, R.S. Burton

    
• • ·Blo t 5, the major allergen from dust mite Blomia tropicalis, is secreted from the mite stomach and gut epithelial and is associated with gut and fecal contents

    Page :S91

    X.Z. Bi, Y.F. Gao, F.T. Chew

    
• • ·Seafood extracts: Raw or boiled for the diagnosis of allergic patients?

    Page :S92

    A. Ferrer, J. Huertas, J. Carnés, M. Casanovas, E. Fernández-Caldas

    
• • ·Shrimp derived glucosamine is well-tolerated in shrimp allergic individuals

    Page :S92

    J.F. Villacis, J.M. El-Dahr, L. Wild, D. DeMerell, D.F. Soteres, L.R. Bucci, S.B. Lehrer

    
• • ·IgE antibody activity of shrimp allergic subjects to inhalant and food allergens

    Page :S92

    M.W. Reder, L.G. Wild, J.M. El-Dahr, J. Villacis, D. Demerell, D. Soteres, L. Bucci, S.B. Lehrer

    
• • ·Identification of salmon roe allergens and consideration of cross-reactivity between salmon roe and chicken egg

    Page :S92

    Y. Kondo, M. Kakami, M. Kawamura, Y. Nakajima, I. Tsuge, A. Urisu, T. Yasuda

    
• • ·Allergenicity of 10 apple varieties

    Page :S93

    E. Fernández-Caldas, J. Carnés, A. Ferrer, M. Casanovas

    
• • ·Relationship of kiwi fruit allergens to clinical characteristics

    Page :S93

    J.S.A. Lucas

    
• • ·Identification of profilin as an almond nut allergen

    Page :S93

    P.D. Tawde, Y.P. Venkatesh, F. Wang, S.S. Teuber, S.K. Sathe, K.H. Roux

    
• • ·Identification of allergenic cross-reactive proteins in cashew and pistachio nut

    Page :S93

    P.D. Tawde, S.S. Teuber, S.K. Sathe, K.H. Roux

    
• • ·Peak Nasal Inspiratory Flow and Total Nasal Symptom Score for placebo nasal spray in an allergic rhinitis Environmental Exposure Chamber study

    Page :S94

    H. Margalias, P. Patel, M. Hilmer, D. Dubins, M. Brubaker, M. Wall, M. Drake, S. Beezley

    
• • ·Follow-up of immunological reactivity in 27 patients allergic to nuts and seeds

    Page :S94

    J. Rodriguez, P. Poza, J.F. Crespo

    
• • ·Allergenicity of Hev b4 major protein is largely determined by its carbohydrate

    Page :S94

    E. Sunderasan, A. Bahari, S.A.M. Arif, Z. Zainal, H.Y. Yeang

    
• • ·Characterisation of personal Der p 1 exposure from upper bedding, when placed in a clean environment

    Page :S94

    J.Y. Lau, J.K. Sercombe, E.R. Tovey

    
• • ·Mold damage in homes and atopic wheezing in infants

    Page :S95

    S. Cho, T. Reponen, D.I. Bernstein, S. Stanforth, M. Villareal, L. Levin, A. Storrs, K. Wilson, G. LeMasters

    
• • ·Intra-nasal air sampling in homes: Relationships with reservoir allergen concentrations and asthma severity

    Page :S95

    R.B. Gore, N. Truman, L. Curbishley, A. Woodcock, A. Custovic, S.J. Langley

    
• • ·Relationship between allergen and endotoxin exposure and allergic sensitization in Cyprus

    Page :S95

    N. Nicolaou, P. Yiallouros, S. Pipis, P. Ioannou, A. Simpson, A. Custovic

    
• • ·Community leadership in preventing asthma—CLIP asthma: Allergen sensitivity and exposure relationships in Dallas schoolchildren with asthma and asthma-like symptoms

    Page :S95

    R.S. Gruchalla, V. Gan, N. Gimpel, T. Pongdee, D. Khan, L.C. Roy

    
• • ·Preschool allergen exposure and asthma prevalence in Head Start centers

    Page :S96

    T.T. Perry, J. Bufford, S.M. Jones, J.G. Parker, C. Feild, M. Flick, D. Brooks, R.G. Hamilton, P.A. Vargas

    
• • ·Caregiver-reported environmental control measures in homes of inner city children with asthma

    Page :S96

    N.N. Hansel, J.A. Krishnan, C. Rand, N. Durkin, C. Patino, P.A. Eggleston, G.B. Diette

    
• • ·Prevalence and predictors of indoor exposure to mouse allergen in metropolitan Boston

    Page :S96

    W. Phipatanakul, D.R. Gold, M. Muilenberg, D.L. Sredl, S.T. Weiss, J.C. Celedon

    
• • ·Home environmental factors as predictors of allergic symptoms

    Page :S96

    M.C. Amado, K. Kennedy, C. Barnes, J. Portnoy

    
• • ·Feasibility of using subject-collected dust samples in epidemiological and clinical studies of indoor allergens

    Page :S97

    M. Sever, S.J. Arbes, B. Vaughn, J. Mehta, J.T. Lynch, H. Mitchell, J.A. Hoppin, H.L. Spencer, D.P. Sandler, D.C. Zeldin

    
• • ·Comparison of results for rapid and EIA based dust mite determinations

    Page :S97

    F. Pacheco, C.S. Barnes, L. Johnson, K. Kennedy, J. Portnoy

    
• • ·The relationship between fungal sensitization and month of birth distribution in children with allergy

    Page :S97

    E. Kim, K. Kim, B. Kwon, S. Choi, M. Sohn, K. Kim

    
• • ·Development of an amplified ELISA for Der p 1

    Page :S97

    T. O'Meara, J.Y. Lau, E.R. Tovey

    
• • ·Interaction of fungi with dust mite Dermatophagoides farinae

    Page :S98

    A. Dixit, R.D. Lewis, K. Ong, D.A. Backer, M. MacDonald

    
• • ·Bet v 1 monitoring in outdoor air

    Page :S98

    J.T. Buters, W.G. Kreyling, H. Behrendt

    
• • ·Novel technique allows simultaneous recognition of many genera of environmental fungi and conidia as allergen sources

    Page :S98

    J.K. Sercombe, B.J. Green, E.R. Tovey

    
• • ·Sodium hypochlorite inhibits viability and allergenicity of mold on building materials

    Page :S98

    K.A. Pacheco, J.W. Martyny, R.J. Harbeck, E.A. Barker, M. Sills, S. Arbuckle, L.S. Newman

    
• • ·Allergist referrals for systemic reactions to imported fire ants: A community survey in an endemic area

    Page :S99

    S. Bhutani, D. Khan

    
• • ·Comparison of polyclonal and monoclonal antibody methods for detecting cockroach antigen in dust samples

    Page :S99

    J.A. Bernstein, A. Bajwa, A. Ierymenko, I.L. Bernstein

    
• • ·Effect of co-exposure of recombinant cockroach and dust mite allergen on airway hyperresponsiveness in mice

    Page :S99

    S.B. Sarpong, J. Awich

    
• • ·Successful administration of a one-day imported fire ant (IFA) rush immunotherapy protocol in two children

    Page :S99

    A.L. Parker, E.A. Meier, L.L. Hagan

    
• • ·A new 67 kDa recombinant Aedes aegypti salivary allergen rAed a 4 in the diagnosis of mosquito allergy

    Page :S100

    A.N. Beckett, F.E.R. Simons, C. Li, T. Zhang, Z. Peng

    
• • ·Titres of IgE ab to mite and cat allergens in patients with asthma or atopic dermatitis: Use of Streptavidin CAP

    Page :S100

    N.J. Custis, E.A. Erwin, J.A. Woodfolk, J. Crane, K. Wickens, T.A.E. Platts-Mills

    
• • ·Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels as markers of disease activity in childhood atopic dermatitis

    Page :S100

    T. Song, Y. Shin, B. Kwon, S. Choi, M. Sohn, K. Kim

    
• • ·Atopic dermatitis is strongly associated with IgE-mediated food allergy in infants attending a dermatology department

    Page :S100

    D.J. Hill, R.G. Heine, C.S. Hosking, J.C. Su, G.A. Varigos, J.B. Carlin

    
• • ·Effect of mattress and pillow encasings on children with atopic dermatitis

    Page :S101

    B. Kim, C. Kim, S. Kim

    
• • ·“Early Onset” predicts strong genetic predispositions in patients with atopic dermatitis

    Page :S101

    M. Shinohara, H. Wakiguchi, H. Saito, K. Matsumoto

    
• • ·SPINK5 polymorphism and disease severity among Japanese children with atopic dermatitis

    Page :S101

    T. Kusunoki, I. Okafuji, T. Yoshioka, M. Saito, R. Nishikomori, T. Heike, M. Sugai, A. Shimizu, T. Nakahata

    
• • ·The predictive value of skin prick tests for the outcome of oral food challenges in children with atopic dermatitis

    Page :S101

    B. Niggemann, A. Verstege, A. Mehl, C. Rolinck-Werninghaus, M. Nocon, K. Beyer

    
• • ·Differential gene expression in peripheral blood CD4+ T-Cells of patients with atopic dermatitis

    Page :S102

    D. Hijnen, E. Knol, I. Kok, M. Groot Koerkamp, C. Bruijnzeel-Koomen, M. de Bruijn-Weller, E. Nijhuis

    
• • ·The clinical significance of food specific IgE/IgG4 in food specific atopic dermatitis

    Page :S102

    J. Oh, H. Ahn, S. Lee, G. Noh

    
• • ·Endogenous airway acidification in children with allergic rhinitis and atopic dermatitis

    Page :S102

    L.M. Brunetti, R. Tesse, R. Francavilla, M. Mastronardi, I. Colella, R. Micieli, L. Armenio

    
• • ·Influence of Staphylococcus aureus exotoxins on tacrolimus ointment treatment for moderate to severe atopic dermatitis in children

    Page :S102

    J. Huang, C. Liao

    
• • ·Tacrolimus cream 0.03% is safe and effective in the treatment of mild to moderate atopic dermatitis in adults

    Page :S103

    A.L. Levy, M. Sheehan, R. Roberts

    
• • ·Immunophenotyping of the chronic cutaneous infiltrate in patients with atopic dermatitis (AD)

    Page :S103

    G.N. Drannik, A.I. Kurchenko, L.M. DuBuske

    
• • ·Usefulness of atopy patch test in diagnosis of food allergy in children with atopic dermatitis

    Page :S103

    K. Wasowska-Królikowska, A. Krogulska, J. Dynowski

    
• • ·Pharmacokinetics of tacrolimus cream 0.03% in adult and pediatric patients with atopic dermatitis

    Page :S103

    E. del Pino, C. Mena, J.J. Goodman

    
• • ·Does the severity of atopic dermatitis (AD) correlate with eosinophlic cation protein (ECP) and serum IgE levels?

    Page :S104

    E. Yousef, K. Bowes

    
• • ·Is maternal history of asthma, atopic dermatitis, food allergy, or allergic rhinitis the predictor of the same allergic disease of her child?

    Page :S104

    Y. Ohya, M. Narita, A. Akasawa

    
• • ·Tolerance of NSAID-sensitive patients to etoricoxib

    Page :S104

    M. Sánchez-Borges, F. Caballero-Fonseca, A. Capriles-Hulett

    
• • ·Effect of anti-IgE therapy on atopic eczema symptoms in patients with asthma

    Page :S104

    P.G. Vigo, I. Hussain, K.R. Girgis, B.L. Pfuetze, M.E. Critchlow, J. Fisher

    
• • ·Neonatal onset multisystem inflammatory syndrome (NOMID)

    Page :S105

    D.F. German, A. Goodman, P. Strub, F. Bocobo

    
• • ·Clinical pharmacology of levocetirizine, the active enantiomer of cetirizine, in children age 6-11 years

    Page :S105

    E.R. Simons, S.S. Goritz, K.J. Simons

    
• • ·Evaluation of skin reactions to pimecrolimus cream 1% in patients allergic to propylene glycol

    Page :S105

    J.F. Fowler, D.J. Lorenz, A. Parneix-Spake

    
• • ·Progesterone associated angioedema and vasculitis

    Page :S105

    A.S. Bagg, D.K. Ledford, R.F. Lockey

    
• • ·Safety and efficacy of omalizumab in atopic dermatitis—A preliminary report

    Page :S106

    S. Maqbool, F. Hsieh, J. McDonnell, D. Vasas, D. Lang

    
• • ·Phenytoin-induced dress syndrome: A case report

    Page :S106

    M. Yazicioglu, D.A. Mentes, B. Turgut

    
• • ·Once-daily fexofenadine HCl 180 mg is effective for the treatment of CIU

    Page :S106

    E.W. Monroe, G. Gross, S. Meeves, Y. Liao, S.T. Varghese, G. Georges

    
• • ·Cyclosporin resistant atopic dermatitis and keratoconjunctivitis treated with mycophenolate

    Page :S106

    A.M. Dowden, D.R. Doshi, N. Zavazava

    
• • ·Efficacy and safety of etanercept in an integrated multistudy database of patients with psoriasis

    Page :S107

    A. Nayak, R. Zitnik

    
• • ·Proteins in the high molecular weight fraction of honeybee venom

    Page :S107

    M. Schmidt, E.T. Weimer, R.H. Sakell, D.R. Hoffman

    
• • ·Sequence and characterization of honeybee venom acid phosphatase

    Page :S107

    D.R. Hoffman, E.T. Weimer, R.H. Sakell, M. Schmidt

    
• • ·The protean cutaneous manifestions of chronic heavy metal overload in pediatric patients

    Page :S107

    P.K.L. Lam

    
• • ·Characterization of IgE-binding allergens in Samsum ant venom

    Page :S108

    T. Reunala, H. Brummer-Korvenkontio, K. Saarinen, L. Räsänen, G. Lestringant, D.R. Hoffman

    
• • ·The use of cellular in vitro assays in the diagnosis of hymenoptera venom allergy

    Page :S108

    K. Scherer, J.M. Weber, T.M. Jermann, A. Krautheim, D. Keefe, A.L. de Weck, A.J. Bircher

    
• • ·Treatment of bee venom allergic subjects with phospholipase A₂ T Cell epitope peptides results in iincreased expression of mRNA encoding suppressor of cytokine signalling (SOCS) 3 and a transient increase in allergen-specific IgG/G₄

    Page :S108

    M. Tarzi, S. Klunker, C. Texier, A. Verhoef, S.O. Stapel, C.A. Akdis, B. Maillère, A. Kay, M. Larché

    
• • ·Extended maintenance intervals during long-term venom immunotherapy (VIT)

    Page :S108

    D.B.K. Golden, D. Kelly, R.G. Hamilton

    
• • ·Concurrent latex and seminal fluid allergy

    Page :S109

    M.R. Rupp, G.D. Marshall, R.D. deShazo

    
• • ·Assessment of current practice in concomitant use of ace inhibitor and hymenoptera venom immunotherapy

    Page :S109

    P. Gogineni, J. Baldwin, E. Robinson, N.T. Gunaratnam

    
• • ·Side-effects of ultra rush insect venom immunotherapy—Retrospective study

    Page :S109

    A.C. Costa, R. Alves, S.L. Silva, E. Pedro, M.C. Santos, M.A.P. Barbosa

    
• • ·Genetic basis of the latex-fruit syndrome: Association with HLA-Class II alleles

    Page :S109

    C. Blanco, F. Sánchez-García, M.J. Torres-Galván, A.G. Dumpierrez, L. Almeida, J. Figueroa, N. Ortega, R. Castillo, M.D. Gallego, T. Carrillo

    
• • ·Microarray-based improvement of diagnosis for latex allergy

    Page :S110

    S. Wagner, C. Harwanegg, B. Wagner, C. Hafner, A. Mari, C. Ebner, R. Hiller, O. Scheiner, H. Breiteneder

    
• • ·Allergen specific induction of proinflammatory cytokines and chemokines in peripheral blood mononuclear cells of latex allergic patients

    Page :S110

    M. Lehto, K. Palosuo, A. Kotovuori, E. Varjonen, S. Lehtimäki, M. Majuri, T. Reunala, N. Kalkkinen, T. Palosuo, H. Alenius

    
• • ·Prevalence of IgE antibodies to extensively purified Hev b2, Hev b5, Hev b6.01, and Hev b13 in latex allergic patients in three geographic areas

    Page :S110

    T. Palosuo, M. Lehto, A. Kotovuori, N. Kalkkinen, C. Blanco, R.G. Hamilton, H. Alenius, T. Reunala, K. Turjanmaa

    
• • ·N-terminal hevein-like domains (4.3 kDa) but not 31 kDa endochitinases are responsible for IgE-mediated in vitro and in vivo reactions in latex-fruit syndrome

    Page :S110

    P. Karisola, A. Kotovuori, S. Poikonen, E. Niskanen, N. Kalkkinen, K. Turjanmaa, T. Palosuo, T. Reunala, H. Alenius, M. Kulomaa

    
• • ·Immunotherapy with a candidate extract of natural rubber latex (NRL)

    Page :S111

    S.L. Limb, R.G. Hamilton, K.C. Brown, J. Choi, N.F. Adkinson

    
• • ·Comparative evaluation of different in vitro diagnostic approaches versus skin test-diagnosed latex allergy

    Page :S111

    A. Mari, H. Breiteneder, S. Wagner

    
• • ·Absence of cross-reactivity between natural rubber latex from production lots of Hevea brasiliensis (Hev-b) and Parthenium argentatum (Guayule)

    Page :S111

    R.G. Hamilton, K. Cornish

    
• • ·Institution of latex safe environment significantly improves RAST and Symptoms' score in health care workers: Six year follow up study in a tertiary care center

    Page :S111

    S. Sharif, L. Fonacier, M. Davis

    
• • ·CpG treatment during the sensitization and elicitation critically regulates Th1/Th2 balance in a murine model of latex induced airway inflammation

    Page :S112

    R. Haapakoski, N. Fyhrquist-Vanni, H. Wolff, A. Lauerma, K. Turjanmaa, T. Reunala, T. Palosuo, H. Alenius

    
• • ·Comparison of baseline characteristics between Hispanic and non-Hispanic children in a low income school-based mobile asthma clinic (Breathmobile)

    Page :S112

    O. Liao, S. Galant, S. Amaro, I. Alves, T. Morphew

    
• • ·Differences in prevalence of latex allergy in head and neck versus visceral surgery

    Page :S112

    E. Hilgert

    
• • ·Expression of CD4+CD25+ marker and CXCR3, CCR4 chemokine receptors on peripheral blood lymphocytes during rush venom specific immunotherapy (VIT) in children

    Page :S112

    E. Cichocka-Jarosz, G. Lis, T. Szczerbinski, E. Zuba-Surma, M. Majka

    
• • ·Predicting asthma morbidity at three month follow-up among low-income African American children with severe persistent asthma

    Page :S113

    C.N. Mobley, M. Celano, L. Cummings, J. Linzer, K. Phillips

    
• • ·Identification of the need for early asthma intervention in St Vincent and the Grenadines

    Page :S113

    J. Ellis, H. Bacchus, C.D. Schwindt

    
• • ·Using Community-Based Participatory Research to recruit hispanics for asthma disparities research

    Page :S113

    D.P. Williams, R.I. Quartey, C.S. Rand, G.B. Diette

    
• • ·Usage patterns of immune globulin, intravenous (IGIV): Results from the Immune Deficiency Foundation (IDF) compassionate care program

    Page :S113

    J. Goldsmith, J. Scharpf, M. Schweitzer, D. Gill

    
• • ·Strategies for implementation of an asthma counseling intervention: From research to the “real world”

    Page :S114

    E. Thornton

    
• • ·Limited access to asthma equipment: Results of a pharmacy study

    Page :S114

    J.C. Taylor-Fishwick, C.S. Kelly, C. Collins-Odoms

    
• • ·Responsibility for asthma: Who's taking care?

    Page :S114

    L. Radecki, K.B. Weiss, L.M. Olson

    
• • ·Treating allergic rhinitis in comorbid allergic rhinitis and asthma patients reduces healthcare costs

    Page :S114

    S. Chang, S.R. Long, M.J. Leahy

    
• • ·Comparative study of the ability to use Metered Dose Inhaler pre and post reading instruction and verbal instruction with demonstration of pediatric residents and medical students

    Page :S115

    W. Wanwatsuntikul, P. Suntipraron, T. Thongkeaw, P. Chatchatee, J. Ngamphaiboon

    
• • ·Interactive education during summer camp for children with asthma improved adherence of self-management

    Page :S115

    N. Kojima, Y. Takeda, M. Akashi, T. Kamiya, M. Matsumoto, Y. Ohya, A. Akasawa

    
• • ·The protective effect of IL-13R⍺2 in Naive vs. sensitized mice

    Page :S115

    N.M. Qutna, R.G. Townley

    
• • ·Young adults with asthma dissatisfied with hospital care

    Page :S115

    R.J. Wolosin, J.L. Matthews

    
• • ·Association between Second-Hand Smoke Exposure (SSE) and enhanced peripheral blood mononuclear cell (PMNC) IL-13 production during infancy

    Page :S116

    D. Gentile, A. Patel, D. Skoner

    
• • ·Generation of the aspirin-exacerbated respiratory disease (AERD) phenotype by Th1/Th2 cytokines

    Page :S116

    L. Borish, K. Hise, J. Negri, R. Caughey, J.W. Steinke

    
• • ·Immune response in asthma: Down modulation by Schistosoma mansoni infection

    Page :S116

    M.I. Araujo, J.P. Figueiredo, R.R. Oliveira, M.C.F. Almeida, L.M. Alcantara, B. Hoppe, A. Schriefer, E.M. Carvalho, M. Medeiros

    
• • ·Deficient GM-CSF and Flt-3 ligand expression in bone marrow is associated with susceptibility to the development of an asthmatic phenotype

    Page :S116

    L.A. Rosenthal, R.J. Szakaly, R.L. Sorkness, R.F. Lemanske

    
• • ·Co-existence of IL-4R single nucleotide polymorphisms and HLA-DR2/DR5 in allergic bronchopulmonary aspergillosis

    Page :S117

    A.P. Knutsen, J.K. Smick, P.S. Hutcheson, R.G. Slavin

    
• • ·Role of NF-κB in eosinophilic lung inflammation in adenosine deaminase-null mice

    Page :S117

    J.M. Crawford, T.S. Chan, L.L. Chan

    
• • ·CCL5-deficient lung DC subsets promote greater CD8 T cell proliferation

    Page :S117

    M.H. Grayson, M.M. Rohlfing, M.S. Ramos, M.J. Holtzman

    
• • ·Tumor necrosis factor-alpha induces airway mucus cell production and collagen deposition in vivo

    Page :S117

    P.J. Busse, K. Srivastava, B. Schofield, L. Mayer, X. Li

    
• • ·Association between haplotypes of genetic polymorphisms of IL-13 and GM-CSF and atopy, airway hyperresponsiveness, and atopic asthma

    Page :S118

    S. Kim, H. Park, Y. Kwon, Y. Chung, T. Kim, H. Park, S. Oh, J. Bahn, J. Lee, H. Oh, E. Shin, J. Lee, Y. Chang, Y. Kim, S. Cho, K. Min, Y. Kim

    
• • ·Cord blood (CB) hemopoietic progenitor function and phenotype predict fever and wheeze in response to infection in infancy

    Page :S118

    R.L. Fernandes, M.M. Cyr, S. Prescott, B. Holt, P. Holt, J. Denburg

    
• • ·Synergistic effects of IL-5 and eotaxin-2 in the mouse lung mimics pathologies observed in asthma patients

    Page :S118

    S.I. Ochkur, C. Protheroe, T.L. Bichele, B. McElhinney, R.S. Pero, M.T. Borchers, K.R. O'Neill, D.C. Colbert, M.P. McGarry, Y. Janssen-Heininger, C.R. Irvin, H.H. Shen, N.A. Lee, J.J. Lee

    
• • ·Solubilization of human IL-13R⍺ 2 following allergen treatment in vitro

    Page :S118

    J.A. Masino, M.O. Daines, G.K. Khurana Hershey

    
• • ·Resistin-like molecule (RELM)-alpha and beta are cytokines with inflammatory and remodeling activity in Th2-associated asthmatic responses

    Page :S119

    A. Mishra, S.M. Pope, N.M. Nikolaidis, N. Zimmermann, M.E. Rothenberg

    
• • ·Cytokines inducing corticosteroid resistance (CR) modulate mitogen induced kinase phosphatase 1 (MKP-1) expression in peripheral blood mononuclear cells (PBMC): Implications for steroid resistant (SR) asthma

    Page :S119

    E. Goleva, D.Y.M. Leung

    
• • ·Agonist- and Th2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes

    Page :S119

    H. Shirasaki, K. Watanabe, N. Seki, M. Kikuchi, N. Konno, E. Kanaizumi, T. Himi

    
• • ·Alternative strategies for antagonism of IL-5

    Page :S119

    A.P. Nguyen, M. Martinez-Moczygemba, G. Tavana, J.P. Moore, R.A. Shanks, P. Rohani, D.P. Huston

    
• • ·Differences in Th1/Th2 cytokine response profiles during early childhood and their relationship to wheezing phenotypes

    Page :S120

    D.F.G. DaSilva, M.D. Evans, K.A. Roberg, C.J. Tisler, E.L. Anderson, T.E. Pappas, L.E. Pleiss, R.E. Gangnon, J.E. Gern, R.F. Lemanske

    
• • ·Developmental cytokine response profiles from birth to age three in a high-risk-for-atopy cohort [COAST (childhood origins of asthma)]

    Page :S120

    S.L. Friedlander, Z. Li, C.J. Tisler, D.F. Da Silva, K.A. Roberg, E. Anderson, R.E. Gangnon, J.E. Gern, R.F. Lemanske

    
• • ·IL-4 and IL-13 induce fibroblast-myofibroblast differentiation

    Page :S120

    V. Krymskaya, G. Vass, R.Z. Syed, R.A. Panettieri, A. Haczku

    
• • ·The lack of allergic inflammation in MK2-deficient mice is not due to the impairment of the immune response but is associated with aberrant endothelial function

    Page :S120

    M.M. Gorska, S. Stafford, Q. Liang, N. Dharajiya, S. Sur, M. Gaestel, R. Alam

    
• • ·Self-perpetuated activation of ERK1/2 in airway cells in the absence of allergen exposure in a mouse model of chronic asthma

    Page :S121

    R. Alam, Q. Liang, M. Gorska, S. Stafford

    
• • ·Endocytic pathways regulating down-regulation of the Interleukin-5 receptor

    Page :S121

    M. Moczygemba, J.T. Lei, C.J. Laurent, R. Xu

    
• • ·RSV infection in absence of STAT1 results in airway dysfunction, airway mucus, and augmented IL-17 and IL-23 expression

    Page :S121

    R.S. Peebles, J. Durbin, W. Zhou, R.D. Collins, S.B. Ho, J.K. Kolls, P.J. Dubin, J.R. Sheller, B.S. Graham, K. Hashimoto

    
• • ·IL-4 induces suppressor of cytokine signaling (SOCS)-3 expression in B cells by a mechanism dependent on activation of p38 MAPK

    Page :S122

    S.M. Canfield, Y. Lee, A. Schröder, P. Rothman

    
• • ·Allergen-induced lung proteome has an oxidative stress signature

    Page :S122

    C.C. Horner, S.J. Stafford, N. Dharajiya, S. Sur

    
• • ·Altered signal transduction responses to cytokines and chemoattractants in airway eosinophils vs blood eosinophils

    Page :S122

    M. Bates, N.N. Farrington, R.G. Heuser, P.J. Bertics

    
• • ·Structural elements of IL-13Ra2 and the inhibition of IL-13 signaling

    Page :S122

    M.O. Daines, G.K. Khurana Hershey

    
• • ·Generation of a novel, functional, fluorescent human glucocorticoid receptor

    Page :S123

    S.L. Friday, Y. Zhang, B.T. Ameredes, W.J. Calhoun

    
• • ·Siglec-8 mediates a different apoptotic pathway in the presence of IL-5

    Page :S123

    e. nutku, B. Bochner

    
• • ·IgE dependent activation of cord blood derived mast cells (CBMC) modulates TRAIL induced apoptosis but does not cause the release of intracellular TRAIL

    Page :S123

    B. Berent, H. Simon, F. Levi-Schaffer

    
• • ·NTAL and LAT regulation of degranulation and cytokine production by human mast cells (HMCs) after FcεRI and kit mediated activation

    Page :S123

    C. Tkaczyk, S. Iwaki, D.D. Metcalfe, A.M. Gilfillan

    
• • ·The relative effect of the truncated isoform of the FcεRIβ chain (β_T) on the FcεRI expression on human basophils

    Page :S124

    B.M. Jensen, K. Assing, L. Hummelshoj, C. Glue, P.S. Skov, L.K. Poulsen

    
• • ·Catalytic activity of ADAM33 towards IgE low affinity receptor (FceRII)

    Page :S124

    J. Meng, L.J. Rosenwasser

    
• • ·Major mountain cedar allergen, Jun a 1 has conformational as well as linear IgE epitopes

    Page :S124

    S. Varshney, T. Midoro-Horiuti, D.W. Bolen, W.S. Lawrence, C.M. Kearney, M. Watanabe, R.M. Goldblum

    
• • ·Skin testing and IgE levels in patients with severe or difficult-to-treat asthma

    Page :S124

    T. Haselkorn, B.E. Chipps, D.P. Miller, J.H. Lee

    
• • ·Parental history as a risk factor for childhood atopic sensitization is dependent on the gender of the child

    Page :S125

    A.J. Davis, S. Havstad, C. Johnson, D. Ownby, E. Zoratti

    
• • ·Is interstitial cystitis an allergic disorder?

    Page :S125

    B.D. Hill, J. Lee, S. Kim, A.W. James, T. Yoo

    
• • ·Sensitization to Lolium multiflorum, a major Brazilian grass that causes pollinosis in patients living in Southern Brazil

    Page :S125

    E.A. Taketomi, M.C. Sopelete, P.F.S. Moreira, D.A.O. Silva, C.M. Santos, A. Sá-Júnior, F.A.M. Vieira, S.J. Sung

    
• • ·Synergistic effect of beta2-agonist and glucocoricosteroid on IgE generation in vitro

    Page :S125

    M.L. Kowalski, M. Chalubinski, M. Jarzebska, J. Grzegorczyk

    
• • ·Salbutamol reduces nasal symptoms and mast cell mediator release induced by AMP challenge

    Page :S126

    D. Zeng, C. Russo, L. Spicuzza, V. Pontorno, R. Polosa

    
• • ·Comparison of nasal tissue concentrations in rabbits following administration of hypotonic and isotonic ciclesonide suspensions

    Page :S126

    M.A. Wingertzahn, H. Sato, R. Nave, T. Nonaka, T. Mochizuki, S. Takahama, S. Kondo

    
• • ·Effects of murine Th1/Th2 predisposition and allergen exposure on bacterial sinusitis

    Page :S126

    P. Khoury, V. Kirtreesakul, T. Luxameechanporn, J. Klemens, K. Thompson, R.M. Naclerio

    
• • ·Glucocorticoids downregulate COX-1 positive cells in nasal polyps

    Page :S126

    F.A. Ebbens, M. Maldonado, E.J.J. Groot de, I. Alobid, C.M. Drunen van, C. Picado, W.J. Fokkens, J. Mullol

    
• • ·Short-term safety, tolerability, and pharmacokinetics of desloratadine and fexofenadine in healthy adults identified as Desloratadine Slow Metabolizers (DSMs)

    Page :S127

    R.A. Blum, W. Kraft, J.A. Stewart, S. Meeves, G. Georges, S.J. Kovacs

    
• • ·Effect of intranasal corticosteroid therapy for perennial nonallergic rhinitis and perennial allergic rhinitis

    Page :S127

    J. Jung, J. Lee, J. Kim, J. Choi

    
• • ·A proof of concept trial demonstrating decongestant activity of an alpha₂ adrenergic receptor agonist in patients with Seasonal Allergic Rhinitis (SAR)

    Page :S127

    R. Berkowitz, F. McCafferty, M.E. Dato

    
• • ·Intranasal application of HDM/ISS conjugate attenuates the allergic symptoms in experimental allergic rhinitis sensitized to house dust mites

    Page :S127

    C. Rhee, J. Mo, K. Takabayashi, S. Quan, J. Park, I. Kim, E. Raz, C. Lee

    
• • ·Montelukast and desloratadine in the treatment of chronic (perennial) allergic rhinitis: A randomised, double blind, placebo controlled study

    Page :S128

    M. Ciebiada, M. Gorska-Ciebiada, L. DuBuske, P. Gorski

    
• • ·The burden of rhinitis in children with asthma

    Page :S128

    E. Civelek, C.N. Kocabas, C. Sackesen, F. Orhan, A. Tuncer, G. Adalioglu, B.E. Sekerel

    
• • ·Equivalence of pseudoephedrine and montelukast in the treatment of Seasonal Allergic Rhinitis (SAR)

    Page :S128

    F.M. Baroody, S. Mucha, M. deTineo, R.M. Naclerio

    
• • ·Patients' willingness to pay for intranasal corticosteroid therapy: The importance of sensory attributes

    Page :S128

    S. Shah, P.J. Mahadevia, C. Leibman, L. Kleinman, L. O'Dowd

    
• • ·Development of an animal model for allergic conjunctivitis: Influence of genetic factors and allergen concentration on the immune response

    Page :S129

    P. Giavina-Bianchi, J. Kalil, L.V. Rizzo

    
• • ·Impact on the quality of life of the addition of topical ocular anti-allergic therapy to existing systemic and/or nasal therapy in a population of allergic rhinitis patients using RQLQ and ACQLQ questionnaires

    Page :S129

    W. Storms, M. Beck, S. Kimura, T. Westbrook, W. Berger, S. Galant

    
• • ·Budesonide nasal washings improve outcome in refractory chronic hyperplastic sinusitis

    Page :S129

    D. Cheung, J. King, I. Hussain

    
• • ·Effects of antihistamines on human erythrocyte plasma membrane integrity and phosphatidylserine distribution In Vitro

    Page :S129

    G. Graff, J.M. Yanni, M.M. Momsen, P.C. Schmid, H.L. Brockman

    
• • ·Analyses of tear concentrations of epinastine after topical ophthalmic administration

    Page :S130

    D. Yu, D. Tang-Liu

    
• • ·Comparison of olopatadine nasal spray 0.6%, placebo and fluticasone propionate 0.05% in patients with Seasonal Allergic Rhinitis (SAR) symptoms

    Page :S130

    D.L. Spangler, R. Berkowitz, S. Shaver, C. Lutz, D. Bazelmans, G.M. Wall, M. Brubaker, M. Drake, L.G. Hogg, K. Crenshaw

    
• • ·Asthma outcomes and pharmacy refill data in minority asthmatic children

    Page :S130

    K.E. Mudd, M.E. Bollinger, V. Hsu, M. Donithan, A. Butz

    
• • ·Validation of caregiver report of pests and pets with allergen levels in baltimore city homes

    Page :S130

    J. Curtin-Brosnan, P.A. Eggleston, E.C. Matsui, K.A. Callahan, N.B. Durkin, G.B. Diette

    
• • ·Need for interdisciplinary intervention in an indigent suburban asthma population

    Page :S131

    E.M. Ambizas, M. Frieri

    
• • ·Poor and minority asthma in Argentina: A descriptive and intervention study

    Page :S131

    E. Malbrán, G.L. Rey, C.E. Malbrán, A. Malbrán

    
• • ·Control of the house dust mite, Dermatophagoides farinae, by neem seed extracts

    Page :S131

    H. Rembold

    
• • ·A comparison of U.S. vs. Louisiana asthmatics using the BRFSS survey

    Page :S131

    A.L. Sabel-Soteres, D.F. Soteres, B. Bates

    
• • ·Frequency of patient reported adverse reactions to antibiotics and selection of antibiotic for antibacterial prophylaxis in surgical procedures

    Page :S132

    P.J. Markus, B.J. Narr, M.A. Park, D.A. Danielson, K.A. Bachman, P.A. Harris, E. Frigas

    
• • ·Asthma education increases knowledge of rural parents and children with asthma and affects parents' reports of their child's asthma symptoms

    Page :S132

    C.J. Lewis, R.E. Thompson, A.M. Butz, K.L. Hill, K. Huss, L.L. Lewis-Boyer, M.L. Winkelstein

    
• • ·Obesity risk factors in the ISAAC (International Study of Asthma and Allergies in Childhood) in Mexico City

    Page :S132

    B. Del Rio-Navarro, A. Berber, J. Sienra-Monge

    
• • ·Use of respiratory protection among new employees of a mouse research and production facility

    Page :S132

    E.A. O'Neil, B.J. Paigen, P.A. Eggleston, G. Fosterling-Pearson, E.C. Matsui

    
• • ·Allergy immune response is modulated by DNA vaccination for cockroach allergy in mice

    Page :S133

    B. Zhou, J. Yang, J. Lee, B. Hill, D. Zaoping, S. Kanagant

    
• • ·Pharmacokinetics and short-term safety and tolerability of intranasally administered triamcinolone acetonide aqueous spray in 2-5 year old patients with Perennial Allergic Rhinitis (PAR) and adult patients with PAR

    Page :S133

    P.D. Cooper, J.D. Conner, P.J. Mustillo, V. Sekar, J. Garcia, G. Georges, S.J. Kovacs

    
• • ·Systemic exposure to triamcinolone acetonide (TAA): Assessment of a new Hydrofluoroalkane-134a (HFA) propelled nasal aerosol

    Page :S133

    B. Hafkin, S.J. Kovacs, D. Banerji, J. Garcia, R. Faruqi, G. Georges

    
• • ·Relationship among smoking tobacco and asthma

    Page :S133

    J.M. Jolly

    
• • ·A strong association of three genetic variants of CYSLTR1 with ASA-intolerant asthma phenotype

    Page :S134

    S. Kim, H. Park, J. Choi, J. Oh, C. Suh, D. Nahm

    
• • ·Daclizumab improves asthma control in patients with refractory asthma

    Page :S134

    H.S. Nelson, W.W. Busse, E. Israel, J.W. Baker, B.L. Charous, K.T. Kim, G.N. Gross, J. Corren, D. Young, R.S. Shames

    
• • ·Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-κB

    Page :S134

    S. Early, J.W. Steinke, E. Barekzi, L. Borish

    
• • ·Sustained long-term effect of a novel immunomodulatory oligonucleotide on airway hyperresponsiveness in a mouse model of allergic airway inflammation

    Page :S134

    D.K. Agrawal, J. Edwan, F. Zhu, D. Yu, E.R. Kandimalla, S. Agrawal

    
• • ·Polarized expression of GATA3 is not sufficient for CRTH2 and IL-4 gene activation in differentiated human Th2 clones

    Page :S135

    U. De Fanis, M. Bova, W. Lee, R.J. Kurnat, V. Casolaro

    
• • ·Recurrent Respiratory Papillomatosis (RRP): T_H2-like, T-cell polarization induced by Human Papillomavirus (HPV)-11, early protein-6 (E6)

    Page :S135

    B. Hadjiev, J.A. DeVoti, D.W. Rosenthal, A. Vambutas, B.M. Steinberg, V.R. Bonagura

    
• • ·Prophylaxis of respiratory syncytial virus infection with intranasal siRNA-nanoparticles of the NS1 gene In Vivo

    Page :S135

    W. Zhang, H. Yang, S. Behera, X. Kong, R.F. Lockey, S.S. Mohapatra

    
• • ·High resolution crystal structure of Bla g 2: A zinc binding cockroach allergen

    Page :S135

    A. Pomés, M. Li, S. Wünschmann, M.D. Chapman, A. Wlodawer, A. Gustchina

    
• • ·Patterns of respiratory viral infections correspond closely with early childhood wheezing phenotypes

    Page :S136

    T.E. Pappas, K.T. Sullivan Dillie, E.L. Anderson, D.F. DaSilva, M.D. Evans, L.E. Pleiss, K.A. Roberg, C.J. Tisler, J.E. Gern, R.F. Lemanske

    
• • ·Investigating IgE cross-reactive antibody responses in invertebrates: Use of recombinant tropomyosin from cockroach and Ascaris lumbricoides

    Page :S136

    A.B.R. Santos, V.S.F. Sales, V.P.L. Ferriani, M.D. Chapman, L.K. Arruda

    
• • ·Dog ownership is associated with less wheezing among high-risk infants during the first year of life

    Page :S136

    H.K. Kalra, P. Campo, D.I. Bernstein, L. Levin, R. Olds, T. Reponin, Z.L. Lummus, S.H. Cho, M. Villareal, G.M. LeMasters

    
• • ·Stability of epinephrine over five months at four different non-optimal storage conditions

    Page :S136

    M.M. Rawas-Qalaji, E.R. Simons, K.J. Simons

    
• • ·The penicillin skin test without benzylpenicilloyl-polylysine (Pre-Pen): Risk of reaction

    Page :S137

    A. Des Roches, L. Paradis, M. Primeau, S. Singer, J. Paradis

    
• • ·Compliance with pediatric asthma guidelines in general emergency departments

    Page :S137

    F.A. Qureshi, E.A. Vasser, J.C. Welch, S.S. Goldblatt, J.D. Mason, M.L. Lawson, D.J. Isaacman

    
• • ·Anaphylaxis in childhood—Risk factors for biphasic reactions

    Page :S137

    M. Tang, S.S. Mehr, D. Tey

    
• • ·Anaphylaxis admission patterns for food allergy in California

    Page :S137

    C.S. So, S.S. Teuber

    
• • ·Patients who use the emergency department as their usual source of asthma prescriptions

    Page :S138

    S. Clark, C.A. Camargo

    
• • ·Anti-interleukin-5 treatment in nasal polyposis

    Page :S138

    P. Gevaert, T. Van Zele, H. Stammberger, H. Sacks, P. van Cauwenberge, C. Bachert

    
• • ·Can parents influence clinicians' behavioral changes in asthma therapy?

    Page :S138

    S. Ting, J.L. Garcia, I. Cisnero

    
• • ·Utility of a single survey for case identification and prediction of asthma control in an inner city disease management (Breathmobile) program

    Page :S138

    R. Kachru, C. Jones, S. Kehl, T. Morphew, J. Hanley, K. Kwong, L. Clement

    
• • ·Expression of 5-lipoxygenase-activating protein (FLAP) in allergic rhinitis patients: The effect of allergen exposure and treatment

    Page :S139

    T. Pullerits, I. Oancea, S. Rak, J. Lötvall

    
• • ·The effect and therapeutic mechanism of a Chinese herbal formula Shu-Bi-Lin (SBL) in the treatment of allergic rhinitis—Animal study and In Vitro study

    Page :S139

    Y. Zhao, P.C. Leung, K.S. Woo, G.G. Chen, Y.O. Wong, L.H. Wang, C.A. van Hasselt

    
• • ·Effects of intranasal R112, an inhibitor of syk-kinase, on the symptoms of seasonal allergic rhinitis: A 2 day park study

    Page :S139

    E.O. Meltzer, R. Berkowitz, E. Grossbard, C. Gallet, S. Dion, S. Shaver, D. Bazelmans, C. Lutz, T. Musser

    
• • ·The relationship between serum endothelin (ET)-1 and wheezing status in the children with Mycoplasma pneumoniae pneumonia

    Page :S140

    H. Chung, S. Kim

    
• • ·Effects of stem cell factor (SCF) on human eosinophils

    Page :S140

    A.P. Baptist, N. Lukacs

    
• • ·A disintegrin and metalloproteinase(ADAM33) protein in asthmatics: Relevance to airflow limitation

    Page :S140

    S. Park, J. Lee, H. Chang, H. Kim, T. Rhim, A. Jang, J. Lee, E. Koh, C. Park

    
• • ·Fibroblast growth factor (FGF) 2 and transforming growth factor (TGF) β1 synergism in human bronchial smooth muscle cell proliferation

    Page :S140

    Y. Bossé, C. Thompson, J. Stankova, M. Rola-Pleszczynski

    
• • ·Expression of PGD2 receptor CRTH2 (DP2) on human lung fibroblasts

    Page :S141

    T. Nakajima, K. Asano, Y. Shiraishi, K. Niimi, M. Wakaki, Y. Suzuki, T. Shiomi, T. Oguma, A. Ishizaka

    
• • ·Genetic variants of the T-cell immunoglobin mucin 1 and 3 (TIM1 and TIM3) gene are not associated with asthma in an African American population

    Page :S141

    P.S. Gao, R.A. Mathias, B. Plunkett, A. Togias, K.C. Barnes, T.H. Beaty, S.K. Huang

    
• • ·Short interference RNA for RSV-NS1 gene attenuates virus infection in fischer 344 rats

    Page :S141

    X. Kong, W. Zhang, R. Lockey, A. Auais, G. Piedemonte, S. Mohapatra

    
• • ·Role of calcium in PKC-⍺ activation and RSV infection of normal human bronchial epithelial (NHBE) cells

    Page :S141

    H.G. San Juan Vergara, J. Cuevas, R.F. Lockey, S.S. Mohapatra

    
• • ·Pulmonary remodeling is observed in weanling mice exposed to RSV and allergen

    Page :S142

    J. Erskin, D. Dimina, C. Protheroe, K. O'Neill, E. Lenkiewicz, J.J. Lee, S.A. Cormier

    
• • ·MUC5AC gene expression in upper and lower airway samples following experimental rhinovirus (RV) 16 inoculation

    Page :S142

    R.F. Vrtis, E.A. Hazel, J.E. Gern, W.W. Busse

    
• • ·Th2 cytokines down-regulate cathelicidin expression and increases atopic dermatitis (AD) skin susceptibility to viral infection

    Page :S142

    M.D. Howell, M. Boguniewicz, J.E. Streib, C. Wong, R.L. Gallo, D.Y.M. Leung

    
• • ·Mitogen-activated protein kinases mediate hydrogen peroxide-induced apoptosis

    Page :S142

    J. Lee, J. Jung, J. Kim, Y. Park, C. Kim, J. Shim, D. Rhu

    
• • ·Creation of the United Statesi immune deficiency research network (USIDNET)

    Page :S143

    C. Cunningham-Rundles, J.C. Goldsmith, H.D. Ochs

    
• • ·Rac2 induces tissue destruction in acute lung injury by regulating neutrophil primary granule release

    Page :S143

    P. Lacy, D. Abdel Latif, C. St. Laurent, L. Puttagunta, D. Befus

    
• • ·Plasma kallikrein inhibition: A viable method of treating laryngeal edema secondary to hereditary angioedema (HAE)

    Page :S143

    M. Cicardi, J. Morrison, L. Baird, T. Williams

    
• • ·Expression and function of novel leukocyte immunoglobulin-like receptors on human polymorphonuclear neutrophils

    Page :S143

    C. Lee, J.P. Arm

    
• • ·Reduced activation by systemic glucocorticoid of the AP-1 component c-jun in bronchial mucosal cells of GC sensitive, but not resistant asthmatics

    Page :S144

    C.J. Corrigan, K. Mallett, T. Loke, J. Ratoff, B. O'Connor, T. Lee

    
• • ·Impact of the Breathmobile on Baltimore City children with asthma

    Page :S144

    M.E. Bollinger, M. Foster, D. Mebane, K. Mudd, J. Oakley, M. Ramagopal, C. Blaisdell

    
• • ·Food allergy [FA] is associated with potentially fatal childhood asthma [PFCA]

    Page :S144

    H.T. Katz, N.M. Vogel, D.M. Lang

    
• • ·Prevention of pediatric intensive care unit (PICU) admissions: Focus on improving asthma care early in exacerbations

    Page :S144

    A. Elizur, L.B. Bacharier, R.C. Strunk

    
• • ·School-based asthma education program and impact on quality of life

    Page :S145

    A.A. Khuntia, M.D. Cabana, K.K. Slish, T.M. Ghormley, M.S. McMorris

    
• • ·Compliance with NAEPP asthma guidelines in a hospital based pediatric clinic and school based health clinics after an asthma education program

    Page :S145

    T. Tavarkiladze, S. Kearney, K. Garrett-Szymanski, A. Khadavi, Y. Persaud, W. Mak, R. Giusti, S. Watson, B. Silverman, A.T. Schneider

    
• • ·Medication use prior to and post emergency department (ED) visit for pediatric asthma

    Page :S145

    T.P. McLaughlin, D.A. Stempel, R.H. Stanford

    
• • ·Asthma morbidity and asthma-related risk factors among inner-city school children

    Page :S145

    K. Paris, M. Mvula, C. Moore

    
• • ·Overview of and early effect of a multidisciplinary asthma clinic on pulmonary function testing

    Page :S146

    G. Dhillon, M. Pansare, P. Munzenberger, A. Bahrainwala, P. Siegel, J. Mellesmoen, E. Secord

    
• • ·Performance of the Asthma Control Test™ (ACT) in adolescent patients with asthma

    Page :S146

    R.A. Nathan, M. Schatz, M. Kosinski, C.A. Sorkness, J.T. Li, P. Marcus, J.J. Murray, P. Jhingran

    
• • ·The association between insurance type and emergency room disposition for exacerbation of asthma

    Page :S146

    P. Ponda, E.R. Flaster, P. LoGalbo

    
• • ·Can we improve inhalation efficiency during sleep by physiatric manipulations?

    Page :S146

    M. Nambu, H. Tanaka, A. Hashimoto, M. Nishikawa, M. Kanaya, N. Kuroda

    
• • ·Does asthma clinic attendance improve quality of life in Jamaican children diagnosed with asthma?

    Page :S147

    G. Rose, K. Bailey, K. Brightly, M. Barton

    
• • ·Risk factors for rehospitalizaion of children with asthma in South Korea

    Page :S147

    S. Choi, J. Park, D. Lee, S. Kim, G. Park, Y. Rha

    
• • ·Evaluation of asthma control in subjects participating in a large multi-disease screening project

    Page :S147

    R.H. Stanford, A. Williamson, D.A. Stempel

    
• • ·Does a standardized asthma clinical pathway establish consistent clinical practices between allergist and pediatrician inpatient services?

    Page :S147

    A.T. Donnell, R.G. Wade, R. Seshadri, J.A. Pongracic

    
• • ·Variability in asthma severity in pediatric asthma patients previously receiving short-acting beta₂-agonists

    Page :S148

    B. Chipps, J. Spahn, C. Sorkness, L. Sutton, A. Emmett, P. Dorinsky

    
• • ·Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week, randomized, double-blind study

    Page :S148

    B.A. Knorr, O. Kuznetsova, T.F. Reiss, E. Beckford, O. Johnson, S.B. Dass, A.B. Becker

    
• • ·Improved asthma symptom control and asthma-related quality of life with fluticasone propionate and salmeterol (FS) in a single inhaler

    Page :S148

    R. Manjunath, A.S. Gilmore, R.D. O'Connor, R.H. Stanford, A.P. Legorreta, P.M. Jhingran

    
• • ·Detailed sequence and haplotype analysis of the beta-2 adrenergic receptor gene in Caucasians and African Americans

    Page :S148

    D.A. Meyers, G.A. Hawkins, K. Tantisira, E.J. Ampleford, M. Hernandez, B. Richter, S.P. Peters, S.B. Liggett, S.T. Weiss, E.R. Bleecker

    
• • ·Airways responsiveness and airway remodeling after chronic exposure to procaterol and fenoterol in guinea pigs In Vivo

    Page :S149

    H. Nishimura, K. Tokuyama, H. Arakawa, Y. Ohki, H. Mochizuki, A. Morikawa

    
• • ·The effect of Y-27632, a Rho/ Rho kinase inhibitor, on leukotriene D4- and histamine-induced airway microvascular leage in guinea pigs

    Page :S149

    K. Tokuyama, H. Nishimura, K. Iizuka, M. Kato, H. Arakawa, H. Mochizuki, A. Morikawa

    
• • ·In Vitro comparison of the performance of salmeterol/fluticasone propionate HFA Metered Dose Inhaler (MDI) with and without MDI counter

    Page :S149

    J.J. West, O. O'Brien, J.C. Ellis, C.A. O'Brien

    
• • ·Ventolin HFA MDI safety in children 24-<48 months old with symptoms of bronchospasm

    Page :S149

    A. Davis-Allen, W. Lincourt, R. Trivedi, A. Ellsworth, C. Crim

    
• • ·Formoterol 24 μg provides effective bronchodilation and is well tolerated in patients with persistent stable asthma

    Page :S150

    R.J. Lapidus, J. Wolfe, L.S. Greos, B. Friedman, C. Orevillo, B. Ziehmer, D. Till, S. Stenglein

    
• • ·Design and characteristics of an MDI counter device

    Page :S150

    M. Hailey, P. Rand, J. Godfrey, I. Cude, M. Cox, J. Carranza Rosenzweig

    
• • ·Formoterol 24 μg is not associated with an increase in serious asthma exacerbations in patients with persistent asthma

    Page :S150

    J. Wolfe, C. LaForce, N.K. Ostrom, P. Korenblat, C. Orevillo, B. Ziehmer, D. Till, S. Stenglein

    
• • ·Efficacy of montelukast during allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity

    Page :S150

    W.W. Busse, T.B. Casale, M.S. Dykewicz, E.O. Meltzer, S.R. Bird, C.M. Hustad, R.K. Zeldin

    
• • ·Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: A randomized controlled trial

    Page :S151

    R.S. Zeiger, J.M. Edelman, S.R. Bird, M.S. Kaplan, M. Schatz, D.S. Pearlman, E.J. Orav, C.M. Hustad

    
• • ·Phase I study of MN-001, an oral anti-inflammatory agent for the treatment of asthma

    Page :S151

    K.W. Locke

    
• • ·Ketokonazol treatment prevents the progress of “allergic march” in children with atopic dermatitis—Prospective studies

    Page :S151

    A.M. Hofman, T. Hofman

    
• • ·A randomized, double-blind trial on the effect of treatment with montelukast, budesonide, montelukast with budesonide, formoterol with budesonide on lung function and clinical symptoms in children with asthma

    Page :S151

    I. Stelmach, T. Grzelewski, J. Jerzynska, P. Kuna

    
• • ·Treatment of perennial allergic rhinitis and its impact on quality of life in asthmatic patients

    Page :S152

    K. Shamir, P.F. Birnbaum, R. Thakor, K.M. Wiers, B. Mikolich

    
• • ·Effects of asthma bronchiale and its therapy on bone mass in children

    Page :S152

    J. Novak

    
• • ·An infant with persistent wheezing due to non-acidic esophageal reflux

    Page :S152

    F.M. Schaffer, R. Bhanu Pillai, I.M. Virella-Lowe, C. Michael Bowman, R. Tutuian, D.O. Castell

    
• • ·Case presentation: A case of idiopathic hypereosinophilic syndrome intolerant of or refractory to available medical therapy

    Page :S152

    M. Segal, T. Craig

    
• • ·Utilization of allergy specialty and medication by roadrunners with allergy and asthma symptoms by questionnaire

    Page :S153

    C.C. Randolph, D. Dreyfus, J. Olsen, E.M. Randolph

    
• • ·Russel-Silver syndrome and selective IgM deficiency

    Page :S153

    M. Rawal, T.H. Sher, R.W. Hostoffer

    
• • ·C7 complement immunodeficiency and osteosarcoma

    Page :S153

    S.B. Foster, N. Jaffe, W.T. Shearer, L.M. Noroski

    
• • ·Intracardiac granulomas: A rare complication of cronic granulomatous disease (GD)

    Page :S153

    T.A. Staines-Boone, M.E. Gonzalez-Serrano, A. Morales-Vazquez, N.D. Lopez, F.J. Espinosa-Rosales, V. Hernandez-Bautista

    
• • ·Case report: Cerebral lymphoma in an ADA-deficient SCID patient receiving PEG-ADA

    Page :S154

    D.A. Kaufman, I.J. Moissidis, J.A. Bocchini, M.S. Hershfield, S.L. Bahna

    
• • ·Selective IgM deficiency in 3 patients: Immunology and clinical presentations

    Page :S154

    N.L. Rider, B.P. Groh, T.J. Craig, B.E. Ostrov

    
• • ·Functional IL-12 and IFNg receptors, and isolated low IgM, in an eight-year-old boy with disseminated nontuberculous mycobacterial infection otherwise consistent with the phenotype of IL-12 and IFNg receptor deficiency

    Page :S154

    T.A. Funkhouser, V. Dewyea, M. Nelson, R. Engler

    
• • ·Common variable immunodeficiency (CVID) and cryptosporidiosis of difficult control

    Page :S154

    C.M.A. Jacob, A.P.M. Castro, A.C. Pastorino, E. Ciccone, A.M. Lima, L.V. Rizzo, G.A. Corradi, E.M.G. Carnide

    
• • ·Common variable immunodeficiency and myotonic dystrophy: A case report

    Page :S155

    L.H. Fisher, J.R. Fisher, M. Davies, S. Chegini, T. Craig

    
• • ·Relapsing polychondritis with progressive humoral immunodeficiency

    Page :S155

    W. Goldman, N. Wasserbauer, N. Singer, H. Meyerson, R.W. Hostoffer

    
• • ·A case of Wiskott-Aldrich Syndrome with cutaneous carcinoma

    Page :S155

    A.L. Wagelie-Steffen, B.B. Cunningham, R.O. Newbury, T.C. O'Grady, J.F. Bastian, H.M. Hoffman

    
• • ·Late presentation of agammaglobulinemia

    Page :S155

    T.M. Leath, M.E. Fontana-Penn

    
• • ·Impaired INF-γ production in a patient with disseminated coccidioidomycosis

    Page :S156

    S. Patel, L. Yel, G. Tsai, K. Su, S. Gupta

    
• • ·Differences in the IgG subclass and IgE antibody responses to the outer membrane proteins of haemophilus influenzae in allergic and non-allergic individuals

    Page :S156

    B.J. Hales, W.R. Thomas

    
• • ·Pathogen safety profile of a new 10% liquid, triple virus reduced intravenous immune globulin product, new generation IGIV (NG IGIV)—Further studies

    Page :S156

    T.R. Kreil, G. Poelsler, A.C. Bailey, W. Teschner, H.P. Schwarz

    
• • ·Acquired mannose binding lectin deficiency in Niemann-Pick Disease

    Page :S156

    D. Niami, R.W. Hostoffer

    
• • ·Interpretation of in vitro T cell proliferation data: Optimization for the identification of patients with primary immunodeficiencies

    Page :S157

    K.D. Stone, H.A. Feldman, C. Huisman, F.A. Bonilla

    
• • ·The relative efficacy & safety profile of intravenous immunoglobulins (IVIg) in refractory dermatomyositis (RDM)

    Page :S157

    I. M, M.M. Khan

    
• • ·The diagnostic value of free light chain assays in subjects with a serum IgG of 500mg/dl and less

    Page :S157

    M. Murali, A. Dighe

    
• • ·Review of patients with Mannose Binding Lectin (MBL) deficiency

    Page :S157

    S. Roy, R.W. Hostoffer

    
• • ·The socioeconomic status of adults with X-linked Agammaglobulinemia

    Page :S158

    J. Boyle, C. James, H.M. Lederman, H.D. Ochs, J.A. Winkelstein

    
• • ·Administration of IGIV-C at an increased maximum infusion rate is well tolerated and can shorten overall infusion time in patients with primary immunodeficiency (PIDD)

    Page :S158

    K. Hanna, E.W. Gelfand

    
• • ·Subcutaneous IgG for antibody deficiency: Reasons and rationales

    Page :S158

    K. Duff, N. Wasserbauer, A. Chouksey, M. Berger

    
• • ·Specific polysaccharide antibody deficiency syndrome (SPAD): Clinical and laboratory characteristics of seventy seven patients

    Page :S158

    Y.K. Cheng, P.A. Decker, M.M. O'Byrne, C.R. Weiler

    
• • ·Adult IgG subclass (IgGSC) deficiency in clinical practice

    Page :S159

    V.T. Popa

    
• • ·CD5 PID, multi-center study

    Page :S159

    N. Wasserbauer, H. Chapel, T. Harville, S. Jones, R.W. Hostoffer

    
• • ·Selective antibody deficiency in two children with pulmonary interstitial glycogenosis

    Page :S159

    B.A. Becker, D.E. deMello, B.E. Noyes

    
• • ·Thrombocytopenia associated with common variable immunodeficiency (CVID)

    Page :S159

    S. Mathew

    
• • ·Efficacy, safety and tolerability of a new intravenous immune globulin, 10% liquid, triple virus reduced (IGIV,10%TVR) in patients with primary immunodeficiency (PID)

    Page :S160

    J.A. Church, H. Leibl, M.R. Stein, I.R. Melamed, A. Rubinstein, L.C. Schneider, R.L. Wasserman, B.G. Pavlova, K. Birthistle, M. Mancini, B. Bitman, K. Moore-Perry, H.J. Ehrlich

    
• • ·Lack of seroconversion in a patient with CVID infected with HIV

    Page :S160

    Y.C. Padeh, J. Shliozberg

    
• • ·A novel immunoglobulin phenotype: Profound deficiency of IgM, IgD, IgA, and IgE with normal IgG

    Page :S160

    J.Y. Patel, D.P. Huston

    
• • ·Noonan's syndrome associated with hypogammaglobulinemia

    Page :S160

    R.W. Hostoffer, S. Macleish

    
• • ·Progressive multifocal leukoencephalopathy (PML) in a patient with CVID and abnormal CD8⁺ T cell immunophenotype

    Page :S161

    S. Narula, D. LaRosa, M. Kamoun, A.I. Levinson

    
• • ·Safety and immunological changes during tablet based specific immunotherapy

    Page :S161

    H.J. Malling, L. Lund, H. Ipsen, L.K. Poulsen

    
• • ·Safety of “RUSH” immunotherapy for aeroallergen desensitization

    Page :S161

    M.P. Vaughn

    
• • ·Infection of Human Herpes Virus type 8 (HHV8) in patients with common variable immunodeficiency (CVID) and lymphoproliferative diseases

    Page :S161

    Y. Morimoto, W.H. Wheat, C.D. Cool, P.R. Rai, C.H. Kirkpatrick, B.A. Lindenbaum, C.A. Bates, M.C. Ellison, A.E. Serls, K.K. Brown, J.M. Routes

    
• • ·Rush immunotherapy with inhaled allergens: Observations in a clinic setting

    Page :S162

    C.R. Watson, A.W. Rafi, M. Roberts, W.B. Klaustermeyer

    
• • ·Comparison of skin test reactivity to pollens in patients receiving immunotherapy

    Page :S162

    J. Bishop, B. Miller

    
• • ·Alpha Lipoic Acid—A novel therapeutic agent for intervention of early pediatric allergies

    Page :S162

    P.K.L. Lam

    
• • ·Cloning, expression, and purification of recombinant biotin-tagged Bet v 1a designed for a lectin-mediated antigen delivery to human B cells

    Page :S162

    S. Mutschlechner, M. Himly, B. Jahn-Schmid, C. Ebner, F. Ferreira

    
• • ·Major allergen content of standardized mite and grass allergenic extracts

    Page :S163

    G. Plunkett, N. Noieam, J. Gaswint, R. Lankow

    
• • ·Cutaneous sensitivity to Chortoglyphus arcuatus and Glycyphagus domesticus in Spain

    Page :S163

    I. López-Conde, C. Carballas, F. Carballada, V. Iraola, E. Fernández-Caldas, M. Boquete

    
• • ·Bacterial 16S ribosomal DNA sequences isolated from house dust mites

    Page :S163

    C. Valerio, L.G. Arlian, J.E. Slater

    
• • ·Cloning and analysis of mono-specific single chain fragment variable (scFv) fragments that recognize German cockroach allergens Bla g 1, Bla g 2, Bla g 4, and Bla g 5

    Page :S163

    N.C. deVore, W.J.J. Finlay, E.N. Dobrovolskaia, J.E. Slayter

    
• • ·One-step analysis of IgE antibodies to multiple purified allergens by cytometric bead assay

    Page :S164

    S. Satinover, A. Pomes, T. Platts-Mills, M. Chapman, J.A. Woodfolk

    
• • ·Production of biotinylated Art v 1 for enhanced specific internalization by human antigen presenting cells

    Page :S164

    M. Egger, M. Himly, B. Jahn-Schmid, C. Ebner, F. Ferreira

    
• • ·Component-resolved diagnosis of house dust mite allergy with a large repertoire of purified natural and recombinant allergens from the major species of mites worldwide

    Page :S164

    A.S.L. Tay, H.S. Shang, X.Z. Bi, K. Reginald, Y.F. Gao, S.T. Ong, A.C. Angus, W.L. Wang, K.T. Kuay, D.Y. Wang, A. Mari, F.T. Chew

    
• • ·Competition ELISA can be a sensitive method for the specific detection of small quantities of allergen in a complex mixture

    Page :S164

    E. Dobrovolskaia, A. Gam, J.E. Slater

    
• • ·Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen

    Page :S165

    M.A. Riedl, E.M. Landaw, A. Saxon, D. Diaz-Sanchez

    
• • ·Heteroclitic analogs of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 as candidates for peptide-based allergen immunotherapy

    Page :S165

    A. Immonen, T. Kinnunen, M. Rytkönen-Nissinen, S. Saarelainen, T. Virtanen

    
• • ·Partial characterization of a species-specific stachybotrys chartarum antigen

    Page :S165

    D. Schmechel, J. Hettick, J. Simpson, D. Beezhold

    
• • ·Is tolerance to cats reversible with prolonged decrease in allergen exposure?

    Page :S165

    E.A. Erwin, N.J. Custis, D. Bunyan, T.A.E. Platts-Mills

    
• • ·Prolonged IgE responses in an animal model of Alternaria sensitivity

    Page :S166

    H. Sanchez, R.K. Bush

    
• • ·Intranasal Co-application of lactic acid bacteria (LAB) and Der p 1 promotes a prophylactic Th1 response in a murine model of house dust mite allergy

    Page :S166

    M. Hisbergues, M. Magi, L. Garcia, B. Pot, J. Pestel, A. Jacquet

    
• • ·IgE antibody responses induced in mice by protein allergens: Influence of bacterial endotoxin

    Page :S166

    R.J. Dearman, D. Fox, S. Attenborough, I. Kimber

    
• • ·Primed T Cells from BALB/c mouse exhibit cross reactivity between a bacterial peptide and a peptide containing the immunodominant epitope of lipocalin allergen Bos d 2

    Page :S166

    S.A. Saarelainen, A.K. Immonen, M.A. Rytkönen-Nissinen, T.T. Kinnunen, T.I. Virtanen

    
• • ·Identification of 2S albumin as an allergen in turnip rape and oilseed rape

    Page :S167

    T. Puumalainen, A. Kotovuori, S. Poikonen, K. Vaali, N. Kalkkinen, T. Reunala, K. Turjanmaa, T. Palosuo

    
• • ·Treatment of egg allergy in children through oral desensitization

    Page :S167

    A. Buchanan, S.M. Jones, L. Christie, K.M. Althage, A.M. Sculrock, R.M. Helm, L.A. Pons, S. Andrzejewski, P. Steele, A.W. Burks

    
• • ·Turnip rape and oilseed rape are novel food allergens in children

    Page :S167

    S. Poikonen, T. Puumalainen, H. Kautiainen, T. Palosuo, T. Reunala, K. Turjanmaa

    
• • ·E-CpG ODN: Immune modulatory therapy of allergic asthma

    Page :S167

    S. Jung, M. Moon, W. Park, H. Lee, D. Kim

    
• • ·Threshold dose for egg allergy during egg desensitization procedure

    Page :S168

    L. Christie, K.A. Althage, A.W. Burks, A.M. Scurlock, T.T. Perry, A.D. Buchanan, R.M. Helm, L.A. Pons, S. Andrzejewski, P. Steele, S.M. Jones

    
• • ·Standardizing the interpretation of atopy patch testing to food in children

    Page :S168

    R.G. Heine, A. Verstege, A. Mehl, U. Staden, C. Rolinck-Werninghaus, B. Niggemann

    
• • ·Diagnostic accuracy of skin prick testing in relation to challenge outcome in children with wheat allergy

    Page :S168

    R.G. Heine, V. Pootong, D. Bannister, D.J. Hill

    
• • ·Skin localisation of cow's milk proteins delivered by a new ready-to-use APT

    Page :S168

    D. Soury, G. Ponchel, H. Chacun, P. Legrand, C. Dupont, G. Barratt

    
• • ·Differences in mite specific IgE between asthmatic parents and their offspring are large

    Page :S169

    P.B. Williams

    
• • ·Increment of IgE production in obese children

    Page :S169

    K. Matsuda, H. Tani, Y. Okamatsu, Y. Sakaguchi, K. Kimura, T. Matsuishi

    
• • ·Body mass index and its effects on clinical control of asthma

    Page :S169

    J.B. Saxena, K. Kwong, C. Jones

    
• • ·Anti-helminth treatment lead to a reduction on asthma severity

    Page :S169

    M. Medeiros, M.C.F. Almeida, A.A. Cruz, J.P. Figueiredo, R.R. Oliveira, L.M. Alcantara, C.B. Aquino, E.M. Carvalho, M.I. Araujo

    
• • ·Different birth month pattern according to the presence of concomitant sensitization to other allergen(s) in house dust mite-sensitive asthmatic children

    Page :S170

    Y. Yoo, J. Yu, H. Kang, D. Kim, Y. Koh, C. Kim

    
• • ·Hormone replacement therapy and asthma incidence in menopausal women from the third national health and nutrition examination survey (NHANES III, 1988-1994)

    Page :S170

    L. Elliott, S.J. Arbes, D.C. Zeldin

    
• • ·Emergency department visits for children with asthma exacerbations living in locations with different climates

    Page :S170

    A.P. McLaughlin, M.A. Brown, D.G. Hillman, D. Brice, P.W. Heymann

    
• • ·Children who wheeze with respiratory syncytial virus (RSV) in the first year of life are more likely to have a food sensitization

    Page :S170

    E.L. Anderson, Z. Li, K.A. Roberg, C.J. Tisler, D.F. DaSilva, L.E. Pleiss, K.T. Sullivan Dillie, T.E. Pappas, R.E. Gangnon, J.E. Gern, R.F. Lemanske

    
• • ·Mouse exposure and wheeze in the first year of life

    Page :S171

    J.C. Celedon, W. Phipatanakul, D.L. Sredl, S.T. Weiss, D.L. Gold

    
• • ·Respiratory syncytial virus and rhinovirus in early life and risk of wheeze and atopy at age 3

    Page :S171

    K.A. Roberg, Z. Li, E.L. Sullivan, K.T. Sullivan Dillie, D.F. DaSilva, C.J. Tisler, T.E. Pappas, R.E. Gangnon, J.E. Gern, R.F. Lemanske

    
• • ·Triple asthma prevalence in public housing compared to the general population of the United States

    Page :S171

    E. Horowitz, J. Poyser, D.A. Collins, A. Togias

    
• • ·Reduced IgG antibody to Mycoplasma pneumoniae among subjects with asthma: Results of a five year study

    Page :S171

    T. Atkinson, L.B. Duffy, D. Pendley, Y. Dai, G.H. Cassell

    
• • ·Rhinovirus (RV) plays an etiologic role in acute asthma hospitalizations in adults

    Page :S172

    D.L. Venarske, W.W. Busse, M.R. Griffin, P.A. Minton, E. Weisshaar, R. Virtis, T. Gebretsadik, S.B. Higgins, A.K. Shintani, T.V. Hartert

    
• • ·Efficacy of a school-based screening program for asthma in inner-city children

    Page :S172

    K.W. Lien, J. Lee-Llacer, B. Peralejo, L. McConeghy, A. Wolff, L. Bielory

    
• • ·Rhinovirus and soluble ICAM-1 in nasal washes from children with wheezing or rhinitis in the emergency department (ED)

    Page :S172

    H.T. Carper, J.W. Steinke, M.S. Shaker, L. Borish, F.G. Hayden, T.A.E. Platts-Mills, P.W. Heymann

    
• • ·Asthma in low-income minority children in head start programs and middle schools in Detroit

    Page :S172

    N.M. Clark, J.A. Dodge, B.W. Nelson, L.J. Thomas, R.W. Brown, D.F. Awad, R.H. Roberts

    
• • ·Asthma in childhood as a remodeling disease: The effect of age at entry in Agertoff-Pedersen and CAMP interpretations

    Page :S173

    J.A. Bardelas

    
• • ·Aeroallergen sensitization in healthy children: Ethnicity and socioeconomic correlates

    Page :S173

    M.D. Stevenson, S.L. Sellins, N. Wang, G.K. Khurana Hershey

    
• • ·Early life exposure to antibiotics for non-respiratory infections is associated with asthma

    Page :S173

    A.L. Kozyrskyj, A.B. Becker

    
• • ·Asthma control in Latin America: The Asthma Insights and Reality in Latin America survey (AIRLA)

    Page :S173

    H.E. Neffen, C. Fritscher, F. Cuevas Schacht, J. Soriano, D. Mechali

    
• • ·Natural antioxidant intake and wheeze in 5-year-old children

    Page :S174

    C.S. Murray, A. Simpson, P. Kissen, B. Simpson, A. Woodcock, A. Custovic

    
• • ·Glutathione S-transferase polymorphisms are linked to asthma and low breath condensate pH

    Page :S174

    E. Thaller, N. Moreno, E.G. Brooks, S. Petronella

    
• • ·Allergic sensitization as a predictor of wheezing

    Page :S174

    C.J. Tisler, M. Evans, R. Gangnon, J.E. Gern, R.F. Lemanske

    
• • ·The cincinnati childhood allergy and air pollution study (CCAAPS): Evaluation of atopy at age one

    Page :S174

    K. Wilson, G. LeMasters, D.I. Bernstein, M. Villareal, S. Stanforth, S. Maier

    
• • ·Primary cytomegalovirus infection as a common cause of wheezing in infants

    Page :S175

    Y. Morisawa, A. Maeda, T. Sato, H. Hisakawa, M. Fujieda, H. Wakiguchi

    
• • ·Allergen-containing particles and purified mite allergens modulate TLR expression on airway epithelial cells

    Page :S175

    H.L. Peake, G.A. Stewart, A.S. McWilliam

    
• • ·Clinical features and airway inflammation in mild asthma vs asymptomatic airway hyperresponsiveness

    Page :S175

    P. Prince, L.P. Boulet, H. Turcotte, P. Bégin, C. Lemière, R. Olivenstein, C. Laprise, P. Larrivée, M. Laviolette

    
• • ·Effect of immune response to rhinovirus (RV) on RV-induced bronchial epithelial inflammation, cytotoxicity, and viral load

    Page :S175

    M. Xatzipsalti

    
• • ·The fate of inhaled Der p 1: Interactions with cells in the nasal mucosa

    Page :S176

    V.X. Noronha, H.L. Peake, C.M. Santos, G. Dunlop, J. Rimmer

    
• • ·Thyroid auto-immunity in chronic urticaria

    Page :S176

    L.A. Palma-Carlos, F. Tengarrinha, A. Palma-Carlos

    
• • ·Serum leptin levels in patients with chronic idiopathic urticaria

    Page :S176

    J.V. Garmendia, I. Blanca, N.E. Bianco, J.B. De Sanctis

    
• • ·The Effect of cosensitization with buckwheat flour on the IgE production to house dust mite

    Page :S176

    Y.H. Shin, S.Y. Lee, M.H. Sohn, S.J. Oh, H.S. Yang, K.E. Lee, K.E. Kim

    
• • ·Evaluation and association of anti-thyroid antibodies with Chronic Idiopathic Urticaria

    Page :S177

    R. Farid, J. Ghaffari, M. Taghavi, H. Rafatpanah, F. Jabbari-azad

    
• • ·Prevalence and potencial desencadenants factors of the chronic urticaria and angioedema in an urban area of Northeastern Mexico

    Page :S177

    G.A. Guidos, F. Vázquez Nava, V.M. Almeida, H.R. Sánchez, M. Villanueva

    
• • ·Urticaria and angio-oedema due to the daily 80 mg dose of aspirin (A)

    Page :S177

    H.D. Oei, W.L. Kartanegara, R.L. Oei

    
• • ·Polymorphisms in FCER1B gene may predict the requirement of H1 antihistamines in patients with chronic urticaria

    Page :S177

    J.H. Choi, S.H. Kim, Y.M. Ye, C.H. Suh, D.H. Nahm, H.S. Park

    
• • ·Chronic urticaria: Association with celiac disease

    Page :S178

    G.B. Pajno, G. Magazzù, L. Caminiti, C. Sferlazzas, D. Vita, G. Barberio

    
• • ·CU-QoL: A new specific quality of life questionnaire for patients with chronic urticaria

    Page :S178

    I. Baiardini, M. Pasquali, M. Braga, C. Lombardi, F. Fumagalli, L. Guerra, E. Compalati, F. Braido, G.W. Canonica

    
• • ·Maturing of monocyte derived dentritic cells in the presence of flea antigen extracts in patients with flea-bite induced papular urticaria

    Page :S178

    A. Cuéllar, E. García, A. Rodríguez, E. Halpert, A. Gómez

    
• • ·Chronic urticaria sera increase basophil CD203c surface expression

    Page :S178

    K.M. Yasnowsky, D.J. Schoen, P.K. Vedanthan, R. Alam, S.C. Dreskin, R. Harbeck

    
• • ·Persistent urticaria and eczema caused by use of dry powder inhalers

    Page :S179

    R.M. Harris, M. Johnson

    
• • ·Safety of cephalosporin administration in patients with a history of penicillin allergy and a negative penicillin skin test

    Page :S179

    M.A. Park, P.J. Markus, J.T. Li

    
• • ·The relationship between cutaneous urticaria (CU), helicobacter pylory (HP) infection, and food allergy (FA)

    Page :S179

    A.A. Nakonechna, G.N. Drannik, L.M. DuBuske

    
• • ·Resolution of chronic urticaria following sinus Aspergillus mycetoma removal

    Page :S179

    D.J. Friedman, K.S. Babe, D.D. Hagaman

    
• • ·Infliximab desensitization

    Page :S180

    S. Bangash, D. Kaufman, I. Moissidis, S. Mahmoud, P. Jordan, S.L. Bahna

    
• • ·Case report of tolerance to Telithromycin in Erythromycin allergic patients

    Page :S180

    G.E. Sharon

    
• • ·Drug rash with eosinophilia and systemic symptoms (DRESS) secondary to trimethoprim/sulfamethoxazole

    Page :S180

    A. Kewalramani, L. Wild

    
• • ·Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization

    Page :S180

    E.M. Macy

    
• • ·Identification of allergens of vaccine components that induced immediate-type allergic reactions after vaccination in dogs

    Page :S181

    M. Sakaguchi, K. Ohmori, S. Maeda, K. Masuda, K. Ohno, Y. Kaburagi, K. Kurata, D.J. DeBoer, H. Tsujimoto

    
• • ·Porcine heparin allergy in a pork allergic patient: A case report

    Page :S181

    P.L. Kendall, S.R. Marney

    
• • ·Delayed type hypersensitivity reaction caused by non-ionic Radiocontrast media

    Page :S181

    A. Fiorillo, L. Fonacier, D. Brenner, D. Johnston

    
• • ·DX-88, a novel recombinant protein inhibitor of plasma kallikrein: Safety and immunogenicity in early studies

    Page :S181

    T. Williams

    
• • ·Testing for hypersensitivity reactions to intravenous drug and biologic agents: Recommendations in product labels

    Page :S182

    H. Ko

    
• • ·Comparison of an in-house preparation of the major allergenic determinant of benzyl penicillin G With the commercially produced Pre-Pen

    Page :S182

    D. Matesic, E. Frigas, H. Kita, P.A. Harris, G.W. Volcheck, P.A. Markus, C.R. Weiler, D.E. Maddox, J.T.C. Li, R.G. Van Dellen, J.B. Hagan, J.H. Butterfield

    
• • ·Utility of penicillin major and minor determinants for identification of allergic reactions to cephalosporins

    Page :S182

    P.A. Greenberger, J.C. Klemens

    
• • ·Purpuric dermatosis due to diltiazem

    Page :S182

    M.J. Fernandez-Bohorquez, M.J. De Barrio, E. Martin, V. Agustin, I. Longo, T. Herrero

    
• • ·Diclofenac does not induce basophil CD63 expression in resting basophils from sensitive patients

    Page :S183

    A. Malbran, E. Yeyati, G.L. Rey, N. Galassi

    
• • ·Acute generalized exanthematous pustulosis following clindamycin skin testing

    Page :S183

    R.S. Pabby, C.N. Lawrence, J. Anthony, J.J. Condemi

    
• • ·Positive aspirin challenge with decline in FEV₁ in a non-asthmatic patient

    Page :S183

    T.J. Backenson, L.J. Smith, C.P. Mikita

    
• • ·Severe drug allergy: The first 100 cases declared to allergy vigilance network

    Page :S183

    G. Kanny, L. Guenard, P. Demoly, C. Ponvert, J. Grand, C. Gallen, P. Chalmet, A. Croizier, J. Jacquier, M. Morisset, A. Auffret, V. Cordebar, C. Debavelaere, C. Debavelaere, J. Devoisins, C. Nootens, N. Petit, F. Pirson, A. Sorlin, A. Andrier-Schmitt, A. Andrier-Schmitt, E. Beaudouin, I. Bossé, M. Buard, C. Chappard

    
• • ·Is skin testing helpful for the amide group local anesthetic?

    Page :S184

    S.S. Joo, M. Vo, P. Win, I. Hussain

    
• • ·Sulfonamide hypersensitivity and successful desensitization in a patient with end stage renal disease awaiting renal transplantation

    Page :S184

    C.J. Vital, M. Mabudian, S. Kamboj, P. Kumar

    
• • ·The anti-inflammatory effect of corticosteroids interfere with the in vitro diagnosis of allergic reactions to these drugs

    Page :S184

    R. R-Pena, M.J. Torres, G. Canto, C. Mayorga, C. Antunez, J.A. Cornejo-Garcia, C. Juarez, T. Fernandez, M. Blanca

    
• • ·Cytokine production patterns in immediate, accelerated, and delayed cutaneous reactions to drugs: Comparison of intracellular protein and mRNA expression

    Page :S184

    C. Mayorga, J.A. Cornejo-Garcia, C. Antunez, R. R-Pena, T. Fernandez, M.J. Torres, C. Juarez, M. Blanca

    
• • ·The retrospective documentation of adverse reactions (allergic, phototoxic, necrotizing) associated with oxsoralen

    Page :S185

    M.M. Khan, I. M

    
• • ·Siglec-8 biology in culture-derived human mast cells (MC): Comparison of culture methods

    Page :S185

    H. Yokoi, C.A. Bickel, S.A. Hudson, B.S. Bochner

    
• • ·Local reaction due to pegvisomant (Somavert ®)

    Page :S185

    C.I. Pérez Padilla, T. Herrero, M. De Barrio, M. Fernández, E. Martín, P. De la Cueva, P. Tornero

    
• • ·Ex vivo analysis of airway contraction and relaxation by a beta-agonist

    Page :S185

    L.M. Pittman, S.M. Jones, B.J. Schnackenberg, C. Pate, L.E. Cornett, R.C. Kurten

    
• • ·Lysophosphatidic acid induces human mast cell activation via an LPA₂-mediated pathway

    Page :S186

    D.A. Lin, S. Bagga, J.A. Boyce

    
• • ·Prostaglandin E2 inhibits cytokine production by human mast cells through EP2 and EP4 receptors

    Page :S186

    C. Feng, E. Beller, J.A. Boyce

    
• • ·Signaling effects induced by human recombinant histamine releasing factor (HrHRF) in basophils with the hyperreleasable phenotype

    Page :S186

    S.M. MacDonald, D.W. MacGlashan, R. Sora, J.M. Langdon, B.M. Vonakis

    
• • ·Activation of toll-like receptor 3 (TLR3) inhibits human mast cell adhesion to extra cellular matrix proteins and inhibits adhesion-dependent degranulation

    Page :S186

    M. Kulka, D.D. Metcalfe

    
• • ·Cultivated human lung mast cells express multiple serotonin receptors

    Page :S187

    E.S. Schulman, H.C. Davidson, H. Nishi, B.A. Jameson

    
• • ·Differentiation of a commercial hematopoetic stem cell line (KG-1) into basophilic leukocytes

    Page :S187

    L.H.K. Lim, G.E.K. Fong

    
• • ·Mast cells in the innate immune response of the middle ear

    Page :S187

    J. Ebmeyer, M. Furukawa, K.K. Pak, U. Ebmeyer, H.H. Sudhoff, D.H. Broide, A.F. Ryan, S.I. Wasserman

    
• • ·Primary human mast cells express specific isoforms of SNARE proteins

    Page :S187

    L.E. Sander, S. Bolat, J. Klempnauer, M.P. Manns, S.C. Bischoff, A. Lorentz

    
• • ·Identification of specific gene expression profile in human mast cells via nucleotide-binding oligomerization domain 2 (NOD2)

    Page :S188

    Y. Okayama, S. Okumura, H. Saito

    
• • ·Global cytokine profile of patients with systemic mastocytosis

    Page :S188

    J.H. Butterfield

    
• • ·β2-adrenoceptor agonist induced inhibition of human mast cells is dependent on actin degradation

    Page :S188

    S.C. Bischoff, T. Gebhardt, S. Bedoui, M.P. Manns

    
• • ·Mast cells mediate multiple features of asthmatic responses in a mouse model of chronic asthma

    Page :S188

    M. Yu, M. Tsai, S. Tam, S.J. Galli

    
• • ·T cell-induced mast cell (MC) activation results in IL-8 dependent neutrophil chemotaxis

    Page :S189

    P. Salamon, N.G. Shoham, R. Gavrieli, B. Wolach, Y.A. Mekori

    
• • ·Estrogens potentiate the synthesis and release of mediators of allergy from mast cells by increasing intracellular calcium

    Page :S189

    T. Midoro-Horiuti, M. Zaitsu, K.C. Lambert, J.J. Grady, D.M. Estes, E.M. Curran, E.G. Brooks, C.S. Watson, R.M. Goldblum

    
• • ·Strain specific differences in peribronchial mast cell accumulation in BALB/c vs. C57BL/6 murine models of asthma

    Page :S189

    S. Pae, K. McElwain, J. Cho, M. Miller, D. Broide

    
• • ·Neurotrophin-3, but not nerve growth factor, promotes survival of human intestinal mast cells

    Page :S189

    A. Lorentz, J. Hoppe, H. Worthmann, J. Klempnauer, M.P. Manns, S.C. Bischoff

    
• • ·Plasmacytoid dendritic cell (pDC) activation by CpG-DNA inhibits IL-3-dependent cytokine secretion by human basophils: The role of IFN-alpha

    Page :S190

    J.T. Schroeder, A.P. Bieneman, K.L. Chichester

    
• • ·Cytokine production by skin-derived mast cells: Endogenous proteases responsible for degradation of cytokines

    Page :S190

    W. Zhao, C.A. Oskeritzian, A.L. Pozez, L.B. Schwartz

    
• • ·Expression of CD203 on basophils from allergic and non-allergic subjects

    Page :S190

    B. Arnoux, M. Rongier, J. Vernier, C. Canino, F. Montero-Julian, G. Bouvier, P. Demoly

    
• • ·The dependency of early (EPR) and late phase (LPR) asthmatic reactions on eosinophils and effector functions such as degranulation

    Page :S190

    G. Cieslewicz, S.I. Ochkur, J.J. Lee, N.A. Lee

    
• • ·Fungal antigens from Alternaria stimulate activation and degranulation of human eosinophils through a Gi-coupled PAF receptor

    Page :S191

    Y. Matsuwaki, Y. Inoue, H. Kita

    
• • ·The effect of lipopolysaccharide (LPS) on cord-blood hemopoietic progenitors

    Page :S191

    M.M. Cyr, L. Crawford, J.A. Denburg

    
• • ·Cytokine regulation of early eosinophilopoiesis

    Page :S191

    M.B. Hogan, D. Piktel, K.S. Landreth

    
• • ·Differential roles of an atypical protein kinase C, PKC ζ, on regulation of human eosinophil and neutrophil functions

    Page :S191

    M. Kato, T. Yamaguchi, A. Tachibana, Y. Hayashi, H. Kimura

    
• • ·Eosinophilic esophagitis and eosinophilic gastroenteropathy

    Page :S192

    S.J. McGeady, T. Yan

    
• • ·Expression and functional relevance of platelet-derived growth factor receptor in eosinophils

    Page :S192

    T. Adachi, H. Nagase, J. Nakano, N. Yamashita, K. Ohta

    
• • ·Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)

    Page :S192

    F. Liu, J. Gonzalo, E.R. Fedyk, J. Pulido, O. Tayber, L. O'Connell, K. Burke, W. Cao, M.R. Hodge, Y. Suzuki

    
• • ·Activation patterns of mucosal eosinophils in the digestive tract under resting and inflammatory conditions

    Page :S192

    A. Straumann, J. Kristl, S. Conus, D. Simon, H. Simon

    
• • ·Dual expression of histamine receptors H2 and H4 regulates eosinophil chemotaxis and superoxide generation by histamine

    Page :S193

    T. Fujisawa, Y. Kato, T. Nakayama, K. Hirai, O. Yoshie

    
• • ·Airway eosinophil (EOS) expression of urokinase-type plasminogen activator receptor (uPAR) following segmental allergen challenge correlates with airway reactivity of patients with asthma

    Page :S193

    A.M. Brooks, M. Bates, R.F. Vrtis, W.W. Busse, J.B. Sedgwick

    
• • ·Eosinophils (EOS) enhance CD4+ T-lymphocyte secretion of Th1 and Th2 cytokines

    Page :S193

    S.K. Mathur, L.Y. Liu, E.A.B. Kelly, N.N. Jarjour, W.W. Busse

    
• • ·Rottlerin induces apoptosis of human blood eosinophils: A possible role for PKC-δ in mediating eosinophil survival

    Page :S193

    A.I. Berro, A. Bharadwaj, D.K. Agrawal

    
• • ·Epithelial NGF and BDNF production induce prolonged survival of eosinophils during allergic airway inflammation

    Page :S194

    C. Hahn, B. Schuhmann, S. Mkhlof, A. Pirayesh, H. Renz, W.A. Nockher

    
• • ·Production, regulation and release of M-CSF by human peripheral blood eosinophils

    Page :S194

    K. Matsumoto, S. Fukuda, M. Terakawa, H. Saito

    
• • ·Development of B cell acute lymphoblastic leukemia in a 12 year old girl with hypereosinophilic syndrome (HES)

    Page :S194

    C.S. Koenig, W. Zhao, M.R. Reyes, K.A. DeMuth, A. Irani, L.B. Schwartz

    
• • ·Interactive effects of a cysteinyl leukotriene receptor (CysLT1R) antagonist, montelukast (ML), and IL-5 deficiency in murine experimental allergic rhinitis

    Page :S194

    H. Morikawa, K. Howie, L. Crawford, M.M. Cyr, J.A. Denburg

    
• • ·Markers of airway inflammation during loss of asthma control

    Page :S195

    C.A. Swenson, M.J. Jackson, L.Y. Liu, N.N. Jarjour, W.W. Busse

    
• • ·Successful therapy and regression of splenomegaly in a patient with myeloproliferative hypereosinophilic syndrome (MHES) treated with imatinib

    Page :S195

    S.L. Ridz, D.A. Khan

    
• • ·Effect of IL-13 or TNF-a on eosinophil adhesion to endothelial cell under flow conditions

    Page :S195

    H. Tachimoto, K. Sato, M. Ebisawa

    
• • ·New onset nasal polyposis in a patient with hypereosinophilic syndrome

    Page :S195

    J.E. Knuffman, R.K. Bush

    
• • ·Clinical and bacteriologic efficacy of telithromycin in patients with acute bacterial sinusitis: A pooled analysis

    Page :S196

    S.L. Spector, M. Patel, B. Lavin

    
• • ·Efficacy of levofloxacin 750 mg for 5-days in the treatment of acute maxillary sinusitis: A randomized, double-blind study

    Page :S196

    N. Zadeikis, M.D. Poole, L.G. Portugal, J. Xiang, M. Oross, A. Tennenberg

    
• • ·Pilot study of delayed hypersensitivity testing with fungal allergens in patients with allergic rhinitis and chronic rhinosinusitis

    Page :S196

    G.W. Volcheck, P.A. Harris, H. Kita, D.M. Richardson, M.D.P. Davis, A.L. Schroeter, E. Frigas

    
• • ·Analysis of phase I study of chronic rhinosinusitis

    Page :S196

    A.W. Rafi, W.B. Klaustermeyer, P. Muniyappa

    
• • ·A study to determine the impact of rhinitis on sufferers' sleep and daily routine

    Page :S197

    M. Blaiss, T. Reigel, E. Philpot

    
• • ·Linear relationship between symptoms of rhinosinusitis and asthma in public housing

    Page :S197

    J. Poyser, E. Horowitz, D.A. Collins, A. Togias

    
• • ·Chronic rhinosinusitis (CRS): What constitutes standard of care?

    Page :S197

    S.R. Inamdar, G.D. Marshall, M. Oswalt, J. Phillips, C. Laney, R.D. deShazo

    
• • ·The prevalence of migraine headaches in patients with allergic rhinitis

    Page :S197

    M.J. Ku, N. Prifti, B.A. Silverman, W. Ying, A.T. Schneider

    
• • ·Fungal sinusitis leading to loss of vision in a healthy immunocompetent child

    Page :S198

    A.L. MacDowell, L.B. Bacharier

    
• • ·Allergic fungal sinusitis presenting as visual loss and facial dysmorphia in New York City

    Page :S198

    S. Kearney, M. Ellman, C. Wertenbaker, W. Mak, B. Silverman, A.T. Schneider

    
• • ·Mast cell mediator releasability correlates with AMP airway responsiveness in atopic subjects

    Page :S198

    L. Spicuzza, D. Zeng, C. Russo, G.U. Di Maria, R. Polosa

    
• • ·The evaluation of intranasal and inhaled corticosteroid therapy in patients with allergic rhinitis alone, asthma alone, and allergic rhinitis with concomitant asthma

    Page :S198

    K.C. Khoo, D.K.C. Lee, B.J. Lipworth

    
• • ·Risk factors of airway hyperresponsiveness in childhood allergic rhinitis without asthma

    Page :S199

    S. Satitpimpa, C. Direkwattanachai, S. Benjaponpitak, J. Sasisakulporn, S. Tongpradit

    
• • ·Hayfever symptoms and medication use in UK teenagers

    Page :S199

    S.M. Walker, S. Khan-Wasti, M. Fletcher, A. Sheikh

    
• • ·Prevalence of rhinitis among teenagers

    Page :S199

    A. Teijeiro

    
• • ·Nasopharyngeal lymphoma presenting as intractable nasal congestion in a patient with allergic rhinitis

    Page :S199

    S. Cherian, S. Narula, A. Apter

    
• • ·Kimura disease—What should an allergist know about it?

    Page :S200

    S.I. Krassilnikova, L. Fisher, T. Craig, S. Chegini, S. Milton

    
• • ·Treatment of resistant nasal polyps with intranasal Flovent

    Page :S200

    C. Monge, L. Endo, M. White, M. Kaliner

    
• • ·Relationship between clinical features and rhinoscopic appearance in CRS

    Page :S200

    A. Suryadevara, J.F. Piccirillo, S.E. Thawley, M.A. Kramper, D.L. Hamilos

    
• • ·“Baseline” nasal symptoms and secretions do not change following acute sinusitis despite standard treatment and a nasal steroid

    Page :S200

    M. Ali, J.N. Baraniuk, K. Petrie

    
• • ·Factor analysis of asthma phenotypes from a large collection of Caucasian families

    Page :S201

    Y. Tang, E. van den Oord, K. Lee, M. Klotsman, W.H. Anderson, S.G. Pillai

    
• • ·Asthma-related morbidity among inner city school children without a diagnosis of asthma

    Page :S201

    I.A. Qureshi, M. Mvula, C. Moore

    
• • ·Case series of two anosmic patients with chronic hyperplastic sinusitis with nasal polyposis, who experienced sustained restoration of smell and notable reduction of polyp tissue within nose and maxillary sinus using zileuton

    Page :S201

    R. Ravikumar

    
• • ·Assessment of the association between cesarean section and subsequent development of childhood asthma: A population-based cohort study

    Page :S201

    Y.J. Juhn, S.K. Katusic, A.L. Weaver, J.W. Yunginger

    
• • ·Clinical studies of recombinant human C1 inhibitor in subjects with hereditary angioedema

    Page :S202

    J. Nuijens, R. Verdonk, M. van Doorn, K. Burggraaf, A. Cohen, G. Choi, M. Soeters, E. Hack, M. Levi, E. Sisk, P. Pinciaro

    
• • ·Acute asthma among younger versus older adults presenting to emergency department

    Page :S202

    C.A. Camargo, S. Clark

    
• • ·Ex vivo gene therapy of two children with X-linked severe combined immunodeficiency

    Page :S202

    J. Chinen, J. Davis, G.F. Linton, N.L. Theobald-Whitting, P.C. Woltz, R.H. Buckley, H.L. Malech, J.M. Puck

    
• • ·X-linked agammaglobulinemia: Clinical features of 148 patients from a United States national registry

    Page :S202

    J.A. Winkelstein, M.C. Marino, H.D. Ochs, C. Cunningham-Rundles, A.W. Burks, M.E. Conley, K. Sullivan, H.M. Lederman

    
• • ·Plasma kallikrein inhibition: A viable method of treating Laryngeal edema secondary to hereditary angioedema (HAE)

    Page :S203

    J. Morrison, M. Cicardi, L. Baird, A. Williams

    
• • ·Early life mouse allergen exposure and risk of mouse skin test sensitivity

    Page :S203

    E.C. Matsui, P.A. Eggleston, P. Breysse, J. Curtin-Brosnan, G.B. Diette

    
• • ·The Cincinnati childhood allergy and air pollution study (CCAAPS): Evaluation of respiratory symptoms at age 1

    Page :S203

    D. Bernstein, L. Levin, K. Wilson, S. Stanforth, K. Kenner, M. Villareal, J. Lockey, G.M. Lemasters

    
• • ·Occurrence of wheezing and being overweight in the first three years of life in a birth cohort at high risk for the development of asthma/allergy

    Page :S203

    Z. Zhang, H. Lai, K.A. Roberg, M.D. Evans, R.E. Gangnon, E.L. Anderson, J.E. Gern, R.F. Lemanske

    
• • ·Major peanut allergen, Ara h 2, IgE and IgG₄ epitope determination by peptide microarray immunoassay

    Page :S204

    D.A. Lencer, W.G. Shreffler, L. Bardina, H.A. Sampson

    
• • ·The herbal formula FAHF-2 desensitizes basophil/mast cells in vivo and in vitro

    Page :S204

    C. Qu, K.D. Srivastava, Z.M. Zou, H.A. Sampson, X.M. Li

    
• • ·Leisure-time activity and asthma in young people

    Page :S204

    T.M.H. Hirsch, C. Vogelberg, K. Radon, D. Nowak, E. von Mutius, S.K. Weiland

    
• • ·Structural and immunological characterization of a Pen a 1 mutant, carrying amino acid substitutions in all major IgE-binding sites

    Page :S204

    G. Reese, J. Viebranz, S. Randow, M. San-Miguel, I. Lauer, S.B. Lehrer, S. Vieths

    
• • ·IL-10 transfected lactoccocus lactis prevent food allergy in a mouse model of food-induced anaphylaxis

    Page :S205

    P.A. Eigenmann, C.P. Frossard

    
• • ·Acute (LPS) and chronic airways inflammation blunts phagocytosis in vivo: Evidence of phenotype switching to a dendritic cell phenotype

    Page :S205

    N. Alexis

    
• • ·Inflammation and remodelling of distal airways in a murine model of chronic experimental asthma

    Page :S205

    M. Wegmann, H. Fehrenbach, A. Ferhenbach, T. Held, C. Schramm, H. Garn, H. Renz

    
• • ·Infection with Litosomoides sigmodontis suppresses allergen-induced sensitization and pulmonary inflammation in a murine asthma model

    Page :S205

    A. Dittrich, A. Erbacher, F. Diesner, B. Ahrens, D. Quarcoo, W.H. Hoffmann, E.H. Hamelmann

    
• • ·Toll-like receptor response to rhinovirus infection in airway epithelial cells of healthy subjects

    Page :S206

    P.C. Avila, S. Donnelly, G. Dolganov, N. Lopez-Souza, A. Xu, T. Ward, H. Boushey

    
• • ·The inhibition of epithelial repair by mast cell chymase

    Page :S206

    P. Gordins, J.R. Purkiss, P.M. Lackie, E.C. Adam, A.R. McEuen, A.F. Walls

    
• • ·Induction of mucin gene expression in human airway epithelial cells by FcεRI-mediated-amphiregulin production from human mast cells

    Page :S206

    S. Okumura, H. Sagara, T. Fukuda, H. Saito, Y. Okayama

    
• • ·IRp60 modulates an array of human mast cell functions

    Page :S206

    I. Bachelet, A. Munitz, A. Nagler, A. Moretta, L. Moretta, F. Levi-Schaffer

    
• • ·Co-localization of FcεRI and Kit with phosphorylated NTAL in lipid rafts following mast cell activation

    Page :S207

    S. Iwaki, C. Tkaczyk, D.D. Metcalfe, A.M. Gilfillan

    
• • ·A 3-year randomized controlled study with sublingual immunotherapy in mite-induced respiratory allergy

    Page :S207

    C. Lombardi, G. Passalacqua, R. Ariano, M. Pasquali, I. Baiardini, A. Giardini, G. Majani, M. Bruno, P. Falagiani, G.W. Canonica

    
• • ·Sublingual immunotherapy (SLIT) in sensitised mice induces mucosal IgA antibodies

    Page :S207

    J. Kildsgaard, J. Brimnes, H.H. Jacobi, K. Lund

    
• • ·Omalizumab plus rush immunotherapy (RIT) is more effective than RIT alone in preventing ragweed-induced seasonal allergic rhinitis (SAR) symptoms

    Page :S207

    J.N. Kline, T.B. Casale, W.W. Busse, Z.K. Ballas, M. Mokhtarani, C. Bromstead, V. Seyfert-Margolis, A. Asare, K. Bateman, M.H. Moss, R.G. Townley

    
• • ·Incidence and characteristics of near-fatal reactions to immunotherapy injections (IT)

    Page :S208

    H.S. Amin, G.M. Liss, D.I. Bernstein

    
• • ·Nasal fluticasone reduces exhaled bronchial cysteinyl leukotrienes in allergic patients

    Page :S209

    M. Failla, G. Biondi, M. Pistorio, C. Mastruzzo, C. Vancheri, N. Crimi

    
• • ·Systemic effects, bioavailability, and pharmacokinetics of fluticasone propionate (FP) diskus and mometasone furoate (MF) twisthaler in healthy and asthmatic subjects

    Page :S209

    M.G.M. Derks, A.T. Weeks, R.S. Mehta, M. Beerahee, A. Sousa, P.T. Daley-Yates

    
• • ·Physician responses to oropharyngeal adverse events caused by inhaled corticosteroids in adults with asthma

    Page :S209

    M. Kaliner, C. Crivera, J. Szwarcberg, T. Bramley, E. Chiao

    
• • ·The novel budesonide/formoterol pMDI is therapeutically equivalent to budesonide/formoterol Turbuhaler® in children with asthma

    Page :S209

    A.H. Morice, Z. Kukova, L. Arheden, O. Beckman

    
• • ·Effect of ciclesonide 40 μg and 80 μg on early and late asthmatic reaction, and sputum eosinophils after allergen challenge in patients with mild asthma

    Page :S210

    G.M. Gauvreau, R.M. Watson, D.S. Postma, J.G.R. de Monchy, F. Deschesnes, L. Boulet

    
• • ·High dose corticosteroid exposure in adult members of a large health maintenance organization

    Page :S210

    M. Che, B. Ettinger, M. Nguyen

    
• • ·Ciclesonide, a new inhaled corticosteroid, significantly improves asthma-related quality of life in patients with severe, persistent asthma

    Page :S210

    D. Bernstein, R. Nathan, D. Ledford, E. Ledoux, A. Pedinoff, C. Crivera, J. Williams, S. Kundu, J. Fish, D. Banerji

    
• • ·A novel inhaled corticosteroid ciclesonide significantly improves quality of life in patients with mild-to-moderate asthma

    Page :S210

    A. Nayak, B.L. Charous, A. Finn, W. Lumry, C. Crivera, J. Williams, S. Kundu, J. Fish, D. Banerji

    
• • ·Once-daily ciclesonide improves quality of life in pediatric patients with asthma

    Page :S211

    D. Miller, P. Ratner, J. Condemi, M. Lawrence, C. Crivera, M. Lloyd, J. Williams, S. Kundu, J. Fish, D. Banerji

    
• • ·The effect of Risedronate sodium hydrate (benet®) in patients with or without asthma, employing different doses of steroid

    Page :S211

    M. Haida

    
• • ·In vitro comparison of an electronic micropump and jet nebulizer with budesonide

    Page :S211

    R. Simmons

    
• • ·Safety profile of fluticasone propionate HFA in pre-school age children with asthma

    Page :S211

    P.Y. Qaqundah, J. Maspero, E. Ceruti, C.A. Scott, D.S. Clements, W. Wu, C. Crim

    
• • ·Qualitative study on the barriers to adherence to inhaled corticosteroids among iranian asthmatic patients

    Page :S212

    A. Parsikia, M. Ghargazlou, N. Assasi, G. Zamani, M. Shidfar

    
• • ·Acute asthma in children: Treatment with oral prednisone vs. intravenous methylprednisolone

    Page :S212

    A.G. Alizo

    
• • ·Once-daily ciclesonide is effective and well-tolerated in adult and adolescent patients with mild-to-moderate asthma

    Page :S212

    D. Pearlman, P. Creticos, K. Lampl, R. Gower, S. Kundu, J. Fish, J. Williams, D. Banerji

    
• • ·Classification of dose response studies of fluticasone propionate and budesonide based on asthma severity

    Page :S212

    Z. Mikhak

    
• • ·The novel inhaled corticosteroid ciclesonide is efficacious and has a favorable safety profile in adults and adolescents with severe persistent asthma

    Page :S213

    W. Busse, M. Kaliner, D. Bernstein, A. Nayak, S. Kundu, J. Williams, J. Fish, D. Banerji

    
• • ·Improved compliance with fluticasone propionate and salmeterol (FS) in a single inhaler

    Page :S213

    R.D. O'Connor, A.S. Gilmore, R.H. Stanford, R. Manjunath, A.P. Legorreta, P.M. Jhingran

    
• • ·Which is more effective, inhaling aerosol through nose or through mouth?

    Page :S213

    A. Hashimoto, M. Nishikawa, N. Kuroda, M. Nambu

    
• • ·Ciclesonide, administered once daily, has a low incidence of oropharyngeal adverse events in pediatric asthma patients

    Page :S213

    E. Gelfand, M. Boguniewicz, S. Weinstein, C. Bernstein, M. Lloyd, P. Zhang, J. Williams, D. Banerji, P. Hamedani

    
• • ·A new off-line model of exhaled nitric oxide (eNO) measurement for preschool children

    Page :S214

    A. Thatayatikom, L.B. Bacharier, P. Lee, K.L. Hodgdon, G.R. Bloomberg, R.C. Strunk

    
• • ·Effect of tobacco smoke exposure on exhaled nitric oxide levels in healthy African Americans

    Page :S214

    D.W. Hauswirth, C.A. Fernandez, S. Mervin-Blake, K.B. Patch, K.E. Morgan, M.C. Levesque, J.S. Sundy

    
• • ·Exhaled breath condensates nitrite levels inversely correlate with pH

    Page :S214

    A.H. Liu, W.J. Morgan, A.M. Schiltz, R.L. James, S.J. Szefler, H. Mitchell, W.W. Busse

    
• • ·Applicability of interrupter resistance measurements in evaluation of exercise-induced bronchospasm

    Page :S214

    D. Song, H. Kim, J. Choung

    
• • ·Is pulmonary function testing (spirometry) a good parameter for asthma severity evaluation?

    Page :S215

    M. Malucelli, L. Kovalhuk, C.A. Riedi, J.C.C. Celi, D.L. Bartmann, M.L. Cat, N.A. Rosario

    
• • ·Prolonged asthma causes decline of peripheral airway function but not bronchial hyperresponsiveness in children

    Page :S215

    S.A. Shin, J.W. Oh, H.B. Lee

    
• • ·The effect of D-4F, an Apolipoprotein A-1 mimetic, on airway hyperresponsiveness in experimental asthma

    Page :S215

    S.D. Nandedkar, K.S. Konduri, S. Deenamsetty, D.A. Rickaby, K.A. Pritchard

    
• • ·Pathological-radiological correration of small airway disease in asthma

    Page :S215

    H. Tanaka, S. Sahara, S. Abe

    
• • ·Comparative assessment of asthma control with both ACT™ and spirometry in subjects attending community events

    Page :S216

    D.A. Stempel, A. Williamson, R.H. Stanford

    
• • ·Viral-induced wheezing during early childhood is associated with abnormal spirometry at age 5

    Page :S216

    L.E. Pleiss, M.D. Evans, E.L. Anderson, D.F.G. DaSilva, R. Kelly, T.E. Pappas, K.A. Roberg, K.T. Sullivan Dillie, C.J. Tisler, M.E. Krawiec, R.E. Gangnon, J.E. Gern, R.F. Lemanske

    
• • ·An improved administrative measure for pediatric “persistent asthma” based on an audit of the current HEDIS measure in a large health care program

    Page :S216

    G.R. Mendoza, E. Macy, M. Schatz, T. Stibolt, D. Mosen

    
• • ·Provoking dose of mannitol to assess airway hyperresponsiveness in asthma: A retrospective analysis

    Page :S216

    S.D. Anderson, J.D. Brannan, H. Koskela, R. Freed-Martens, J.D. Leuppi, K. Holzer, B. Lipworth, G.P. Currie, M. Sue-Chu, C.P. Perry

    
• • ·Adjustment period in lung function parameters following bilateral lung transplantation

    Page :S217

    S. Park, P. Win, M. Amin, I. Hussain

    
• • ·Comparison of the administration of methacholine by hand held nebulisers and by dosimeter to assess bronchial hyper-responsiveness in schoolchildren aged 15 to 17 years

    Page :S217

    M. Levin

    
• • ·ROC curve analysis of IgE antibodies values to predict clinical allergy to cat dander in asthmatic subjects

    Page :S217

    R. Cárdenas, C. Fernández, M. Garcimartin, S. Romero, A. Gómez de la Cámara, D. Martín, P. Casasnovas, R. Vives

    
• • ·Relationship between duration of disease and bronchial responsiveness in 6-8 year old children with asthma

    Page :S217

    J. Yu, Y. Yoo, D. Kim, Y. Koh

    
• • ·Acceptability of pulmonary function testing maneuvers in a pre-school cohort

    Page :S218

    K.T. Sullivan Dillie, B.A. Anderson, D.F. DaSilva, M. Evans, R. Kelley, M. Krawiec, T.E. Pappas, K.A. Roberg, C.J. Tisler, J.E. Gern, R.F. Lemanske

    
• • ·Interactions among predisposition genotypes for asthma in chinese children

    Page :S218

    T.F. Leung, N.L. Tang, I.H. Chan, C.Y. Li, C.W. Lam, G.W. Wong

    
• • ·Efficacy of chest physiotherapy (CPT) in pediatric patients with acute asthma exacerbations

    Page :S218

    M.A. Whelan, W.H. Hwan, T. Shaffer, R. Padman, T. Cox, H. Oldham, E. Yousef, S.J. McGeady

    
• • ·IL-5 gene polymorphism is associated with decreased pulmonary function in Korean children with atopic asthma

    Page :S218

    S. Hong, S. Koo, S. Lee, H. Kim, J. Kim, B. Kim, M. Kang, S. Lee, E. Shin

    
• • ·Identification of asthma susceptibility genes using cluster analysis

    Page :S219

    W.S. Oetting, M.N. Blumenthal, C. Reilly, M.B. Miller, R. Willaert, S. Luah, R.A. King

    
• • ·5-lipoxygenase (ALOX5) promoter polymorphism is not associated with asthma in a Caucasian isolate

    Page :S219

    M. Munoz, S. Zhang, A. Grant, K. Held, F. Chilton, M. Surrette, H. Allayee, K.C. Barnes

    
• • ·Analysis of ADORA3 as a possible candidate gene for asthma

    Page :S219

    M.N. Blumenthal, M.B. Miller, C. Reilly, W.S. Oetting, M. Brott, R. Willaert, S. Luah, R.A. King

    
• • ·The impact of pre-transplant flow cytometry crossmatches on renal allograft outcome: A pilot study

    Page :S219

    R.G. O'Brien, L. Yao, B. Arora, D. Frey, P. Boudreaux, I. Daley, R. Thiagarajan, P. Kumar

    
• • ·Diagnostic value of CD14⁺ CD16⁺ monocytes in neonatal sepsis

    Page :S220

    Y.M.E. El-Gamal, N.M.A. Heshmat, A.E.A. Shehab, A.F.M. Hasaneen

    
• • ·Mechanisms of isotype determination during immunoglobulin class switch recombination in human B-cells

    Page :S220

    D.J. Fear, N. McCloskey, G. Felsenfeld, H. Gould

    
• • ·Activated T cells secrete histamine releasing factor

    Page :S220

    H. Lu, Y. Yang, D.P. Huston, X. Yang

    
• • ·Histamine and its antagonist (desloratadine) influence apoptosis of CD4⁺CD25⁺ cells in atopic patients and healthy individuals

    Page :S220

    I. Kaidashev, N. Kutsenko, O. Borzih, L. Mular, L.M. DuBuske

    
• • ·Effect of fungal antigen exposure on airway allergen sensitization

    Page :S221

    V. Mehta, T. Kobayashi, H. Kita

    
• • ·Imatinib mesylate (Gleevec, STI-571) suppresses cytokine production by normal T-cells activated through T-cell receptor (TCR) signaling

    Page :S221

    H. Gao, B. Lee, N.J. Donato, M. Talpaz, J.M. Reuben

    
• • ·P. aeruginosa lipopolysaccharide (PsLPS) and A. fumigatus (Asp) stimulated TNF-⍺, RANTES and nitric oxide (NO) from peripheral blood mononuclear cells (PBMCs) from cystic fibrosis (CF) patients with bronchial epithelial cells (BECs): Modulation by rhDNase

    Page :S221

    A.R. Narayan, Y.C. Huang, X.P. Wang, L. Goodwin, L. Guida, M. Frieri

    
• • ·Gene expression in a murine model of aspergillosis

    Page :S221

    V.P. Kurup, R. Raghavanpillai, P. Manickam

    
• • ·Primary cutaneous T-cell lymphomas: Immunomodulation by photochemotherapy with analysis of the inflammatory-expansive cellular dynamic

    Page :S222

    L.W. Bandeira, A.M. Manhães, E.A. Pagani, A.L. Filgueira

    
• • ·Timing of acute stress hormone exposure produces variable effect on human peripheral blood mononuclear cells

    Page :S222

    A.N. Salicru, G.D. Marshall

    
• • ·Acidic oligosaccharides enhance systemic cellular immune responsiveness in mice via a different mechanism than galacto- and fructooligosaccharides

    Page :S222

    A.P. Vos, A. Buco, M. Haarman, J. Knol, M. Govers, B. Stahl, G. Boehm, J. Garssen, L. M'Rabet

    
• • ·Gantrez® AN nanoparticles do not alter allergenicity of Lollium extract

    Page :S222

    M. Ferrer, S. Gomez, M.L. Sanz, E. Luquin, A. Grau, A. Molina, S. Beatriz, C. Gamazo, J.M. Irache

    
• • ·New adjuvant for immunotherapy: Gantrez® AN nanoparticles

    Page :S223

    S. Gomez, C. Carlos, E. Luquin, B. San Roman, S. Espuelas, M.L. Sanz, M. Ferrer, J.M. Irache

    
• • ·Effects of sleep disorders and fatigue on HIV disease progression in older children and adolescents

    Page :S223

    M.E. Paul, P.Y. Brouwers, D.G. Glaze, J.M. Reuben, B. Lee, L.L. Harris, C.A. Kozinetz, M.W. Kline, H.L. Schwarzwald, S.B. Foster, C.D. Jackson, W.T. Shearer

    
• • ·A comparison of lymphocyte responses in PBMC, by human and chimpanzees in response to PMA/I stimulation, or anti-CD3/anti-CD28 costimulation, using microarray analysis

    Page :S223

    J.A. DeVoti

    
• • ·Effects of oral ingestion of Nigella sativa seeds (black cumin) on murine immune system

    Page :S223

    A.K.Y. Daoud

    
• • ·Human immunodeficiency virus (HIV) education and careers according to fellows-in-training (FITs) and training program directors (TPDs) from accredited allergy and immunology (AI) training programs across the United States

    Page :S224

    L.M. Noroski

    
• • ·Purified IgE anti-HIV-1 from healthy nonatopic pediatric long term survivors with severely decreased blood CD4+ T cells mediate cytotoxicity against an HIV-1+ cell line and PBMC from HIV-1+ donors, and inhibit HIV-1 production in vitro

    Page :S224

    M.H. Bluth, M.G. Pellegrino, D.J. Volsky, H. Moallem, T.A. Smith-Norowitz, M. Nowakowski, H.G. Durkin

    
• • ·Hypersensitivity to environmental allergens in HIV-infected patients: Is atopy more frequent?

    Page :S224

    P. Mantilla Guevara, D.D. Delgado Chacón, A. Monzón de Orozco, P. Salazar, G. González, C.M. Galizia Zambrano, Y. Millán, V.A. Qintero Parada, G.R. Hernandez Vivas

    
• • ·Effect of HAART (highly active anti-retroviral therapy) on serum IgE levels and IgE Anti-HIV-1 in nonatopic pediatric long term survivors (LTS) of HIV-1 infection

    Page :S224

    M. Nowakowski, H. Moallem, H.G. Durkin

    
• • ·Two cases of fat redistribution in HIV infected persons on ritonavir and fluticasone: Lipodystrophy versus cushing syndrome

    Page :S225

    N. Mireku, K. Wright, A. Bahrainwala, E.A. Secord

    
• • ·Quantification of cells CD38+ in peripheral blood of HIV positive patient

    Page :S225

    M.E. Flores Chávez, G. Montoya, M.R. Chacon de Petrola, A. Torres, M.T. Pacheco, L.M. Montagne, G. Molina

    
• • ·Selective increases in serum IgE and HIV-1 specific IgE in nonatopic pediatric long term survivors of HIV-1 infection

    Page :S225

    H.G. Durkin, H. Moallem, M.G. Pellegrino, D.J. Volsky, M.H. Bluth, M. Nowakowski

    
• • ·Acute adrenal crisis after a steroid burst in a patient with HIV disease: A case report

    Page :S225

    M.A. Shah, G.G. Sofowora, K.L. Nguyen

    
• • ·Idiopathic CD4 T-lymphocytopenia—Treatment strategies and analysis of 19 patients

    Page :S226

    H. Yarmohammadi, C. Cunningham-Rundles

    
• • ·Quantification of CD34+ cells in peripheral blood of HIV positive patient

    Page :S226

    M.D.R. Chacón de Petrola, S. Meza, M.E. Flores Chávez, A. Torres, M. Pacheco, L.M. Montagne, G. Molina

    
• • ·A critical role for dendritic cells in immunosuppression caused by the respiratory syncytial virus (RSV)

    Page :S226

    B. Chi, M. Alston, K.M. Spann, P.L. Collins, R.L. Rabin

    
• • ·Monocytes derived dendritic cells of women with cervical squamous intraepithelial lesions (SIL) are less capable of presenting HPV-specific antigens

    Page :S226

    B. Lee, G. Rodriguez, M. Follen, J.M. Reuben

    
• • ·Comparison of fungal glucan and bacterial endotoxin levels in dust from rural homes

    Page :S227

    P.S. Thorne, N. Metwali

    
• • ·Lower FEV1/FVC predicts asthma re-exacerbations after hospital discharge

    Page :S227

    J.A. Krishnan, Z. Permutt, M.C. Liu, R.H. Brown, C.S. Rand, A.L. Bilderback, S. Permutt

    
• • ·Curcumin inhibits allergen-sensitized lymphocyte function ex vivo and in vitro

    Page :S227

    G. Vass, P. Kinniry, E. Arguiri, S.M. Albelda, M. Christofidou-Solomidou, A. Haczku

    
• • ·Up-regulated apoptosis in the skin of a 15 year old boy with disseminated papillomatosis and idiopathic CD4+ lymphocytopenia

    Page :S227

    D.F. Soteres, J.M. El-Dahr

    
• • ·Effects of home residential setting, air quality, and season on emergency department (ED) revisits for children with asthma

    Page :S228

    H.C. Wang, S.J. McGeady, M.A. Majeed, E. Yousef

    
• • ·The role of the ⍺-1-protease inhibitor in Puerto Rican high frequency ED asthmatics: A pilot study

    Page :S228

    F.J. Montealegre, M. Bayona, A. Delgado, W. Vargas, D. Chardon, D. Zavala

    
• • ·Reduced FEV1/FVC in obese versus normal weight children with asthma

    Page :S228

    S.R. Roy, A.B. Yates, J.E. Moffitt, G.D. Marshall

    
• • ·Non-asthmatic children with eczema have elevated exhaled nitric oxide levels

    Page :S228

    C. Dinakar, A. Nopper, K. Wible, D. Laskowski

    
• • ·Frequent infections in early childhood in children living in orphanage prevent atopy

    Page :S229

    I. Stelmach, K. Smejda, W. Stelmach, P. Kuna

    
• • ·Cord blood stimulated T-cell interferon γ production varies by race in a birth cohort

    Page :S229

    C.C. Johnson, M.M. Maliarik, M.J. McCabe, E.L. Peterson, G.R. Wegienka, D.M. Smolarek, L.K. Williams, K.J. Woodcroft, C.L. Joseph, C.J. Barone, D.R. Ownby, E.M. Zoratti

    
• • ·Cat and dog exposure during pregnancy increases cord blood stimulated T-cell interferon-γ production

    Page :S229

    D.R. Ownby, M.M. Maliarik, M.J. McCabe, E.L. Peterson, G.R. Wegienka, L.K. Williams, K.J. Woodcroft, C.L.M. Joseph, C.J. Barone, E.M. Zoratti, C.C. Johnson

    
• • ·Evaluating relationships between mental health and asthma

    Page :S229

    J. Pongracic, C. Weil

    
• • ·Environmental tobacco smoke exposure during gestation is associated with decreased interferon γ production at birth

    Page :S230

    K.J. Woodcroft, M.M. Maliarik, M.J. McCabe, E.L. Peterson, G. Wegienka, D. Smolarek, L.K. Williams, C.L.M. Joseph, D.R. Ownby, E.M. Zoratti, C.C. Johnson

    
• • ·Self-reported asthma prevalence among high school students in the United States–2003

    Page :S230

    S.L. Merkle, S. Everett Jones, D.M. Mannino, L.S. Wheeler

    
• • ·Interferon γ production in maternal blood pre- and post delivery

    Page :S230

    M.J. Maliarik, E.L. Peterson, M.J. McCabe, A. Koprowski, D. Smolarek, K. Kesterson, E.M. Zoratti, D.R. Ownby, C.C. Johnson

    
• • ·The Pasadena Community Asthma Project

    Page :S230

    B.K. Ariue, M. Perera, L. Dimen, P. Verette, A. Tulleners Lesh

    
• • ·A comparison of the prevalence of allergen sensitization between asthmatic children and adults in the inner city

    Page :S231

    J.C. Klemens, L.A. Weiselberg, K.E. Harris, C.H. Sheen, L.C. Grammer

    
• • ·Prevalence of positive skin prick testing to Alternaria alternata and clinical outcome in Mexican asthmatic children.

    Page :S231

    J.A. Luna-Pech, L. Avila-Castañon, B.E. Del Rio-Navarro, J.J. Sienra-Monge

    
• • ·Asthma in childhood: Clinical aspects of 3077 outpatients in a pediatric allergy unit

    Page :S231

    R. Miyagi, N.A. Rosario, L. Kovalhuk, C.A. Riedi, M.L. Cat

    
• • ·Prevalence of symptoms related to asthma and risk factors for asthma of the adult in an urban area in Northeastern Mexico

    Page :S231

    F. Vazquez-Nava, A.H. Saldivar-González, J. Perez-Martin, H.R. Sanchez-Nuncio, J. Varon, F.J. Beltran-Guzman

    
• • ·Relationship of transient wheezing in young children to atopic sensitization and risk factors which influence atopic sensitization

    Page :S232

    M.R. Simon, S.L. Havstad, D.R. Ownby, E.L. Peterson, C.C. Johnson

    
• • ·The IgE antibody response to specific allergens can make an important contribution to total IgE

    Page :S232

    E. Ronmark, E.A. Erwin, K. Wickens, M.S. Perzanowski, B. Lundback, J. Crane

    
• • ·Risk factors for eczema and sensitization differ in German preschool children 1994-2000

    Page :S232

    U. Krämer, T. Schäfer, M. Möhrenschlager, J. Ring, H. Behrendt

    
• • ·A 17 year trend for the prevalence of asthma and allergic diseases among children in Saudi Arabia

    Page :S232

    A.S. Al Frayh

    
• • ·Impairment of small airways in COPD with and without exacerbations

    Page :S233

    G. Riario-Sforza, C. Incorvaia, F. Paterniti, N. Dugnani

    
• • ·Is the delayed introduction of highly allergenic foods effective in primary prevention of food allergy?

    Page :S233

    B.J. Vlieg-Boerstra, S.A.A. Wolt-Plompen, C.M.A. Bijleveld, S. van der Heide, B.J. Beusekamp, J. Kukler, E.J. Duiverman, A.E.J. Dubois

    
• • ·Increased hospitalizations for angioedema in New York between 1990 and 2000

    Page :S233

    A.G. Cannon, A.D. Teitel, R.Y. Lin

    
• • ·Viral infections are the sentinel event for asthma diagnosis and treatment in elementary and adolescent school-age patients

    Page :S233

    J. Carranza Rosenzweig, D.A. Stempel, T. McLaughlin

    
• • ·The role of HLA genes in Allergic Bronchopulmonary Aspergillosis using a “humanized” transgenic mouse model

    Page :S234

    C.J. Bellone, S. Koehm, E. Hembrador, P.S. Hutcheson, T. Trejo, C.S. David, D.E. deMello, R.G. Slavin

    
• • ·Outcome of childhood asthma in 105 asthmatic children

    Page :S234

    M. Herrag

    
• • ·The most prevalent cause of autumnal asthma in North China

    Page :S234

    J. Yin, F.M. Yue, L.L. Wang, H.J. He, H. Li, J.L. Sun, L.P. Wen, J.Q. Gu, H.Y. Zhang, S.T. Ye

    
• • ·Validation of a questionnaire to study asthma prevalence in adults

    Page :S234

    A. Yáñez, M. Reyes, H. Neffen, N. Aramayo

    
• • ·Characteristics of children with acute asthma in the emergency department in Rabat

    Page :S235

    M. Herrag

    
• • ·Indoor allergens exposure in Syrian homes

    Page :S235

    W.M. Al-Ali, M. Craven, A. khoury, A. Custovic, A. Woodcock

    
• • ·Sensitization to fungi: Epidemiology, skin tests, and specific IgE in patients with respiratory diseases from Caracas

    Page :S235

    P.A. Tassinari, D. Galante, A. Conesa, N. Bianco

    
• • ·Low- versus high-energy use buildings and mite allergens

    Page :S235

    F. Spertini, M. Berney, N. Cousin, A. Oostra, F. Foradini, C. Roulet

    
• • ·Home characteristics and skin test sensitivity of school-aged children with asthma or asthma-like symptoms

    Page :S236

    K.L. Willie, D. Salazar, L.C. Roy, R.S. Gruchalla

    
• • ·Home indoor pollutant and allergen exposures in inner city children with and without asthma

    Page :S236

    G. Diette, P. Breysse, T. Buckley, J.A. Krishnan, J. Curtin-Brosnan, P.A. Eggleston

    
• • ·Importance of the personal endotoxin cloud in school-age children with asthma

    Page :S236

    N. Rabinovitch, A.H. Liu, L. Zhang, C.E. Rodes, K. Foard, S.J. Dutton, J.R. Murphy, E.W. Gelfand

    
• • ·Influence of diet on Fel d 1 production by cats

    Page :S236

    L.G. Arlian, M.S. Morgan, J.S. Neal, D.L. Vyszenski-Moher, M.A. Tetrick

    
• • ·Reduction of house dust mite allergen Der f 1 after cleaning with the Kirby cleaning system

    Page :S237

    S.G. Lau, S. Kim, G. Schulz, T. Keil, U. Wahn

    
• • ·Incidence of allergy at a mold-contaminated police station

    Page :S237

    J. Santilli, W.J. Rockwell

    
• • ·Thermophilic fungal allergens in an atmosphere of Solid Waste Dumping site

    Page :S237

    U. Nyayiru Kannaian, V. Balamuri Pandu Ranga

    
• • ·Examination of used non-woven mattress and pillow encasings for dust-mites and mite allergen

    Page :S237

    J.D. Miller

    
• • ·Detection of allergenic conidia and hyphae of Alternaria alternata and Aspergillus fumigatus using a novel double immunostaining technique

    Page :S238

    B.J. Green, J.K. Sercombe, D. Schmechel, E.R. Tovey

    
• • ·Controlling indoor fungal contamination using essential oils

    Page :S238

    C.A. Townsend, E. Levetin

    
• • ·Cypress allergy in Portugal

    Page :S238

    S. Lopes Silva, R. Rodrigues Alves, A. Spínola Santos, A. Pregal, A. Mendes, E. Pedro, G. Palma-Carlos, M. Branco-Ferreira, C. Santos, M. Pereira Barbosa

    
• • ·Clinical spectrum of sensitisation to Olea europea in a group of patients in Mexico City

    Page :S238

    B. Morfin-Maciel

    
• • ·Less variability of symptom scores for placebo nasal spray in an environmental exposure chamber (EEC) study versus a traditional seasonal allergic rhinitis (SAR) study

    Page :S239

    T. Bibi, P. Patel, D. Dubins, M. Brubaker, M. Wall, M. Drake, S. Beezley

    
• • ·Influence of clean air directly in the breathing zone on allergy and asthma patients during night-time

    Page :S239

    P. Svensson

    
• • ·Effect of ‘priming’ on predose symptom scores in environmental exposure chamber (EEC) study design

    Page :S239

    P. Patel, K. Rai, P.J. Benninger, Y. Kaji, H. Margalias, R. Moisan

    
• • ·Etiologies of chronic cough in a population of children reffered to a paediatric pulomonologist

    Page :S239

    M. Herrag, C. Maharoui

    
• • ·Prevalence of food allergy in children from East Harlem allergy clinic

    Page :S240

    J.M. Maloney, A. Nowak-Wegrzyn

    
• • ·Idiopathic eosinophilic esophagitis (EE): Clinical and histologic correlates

    Page :S240

    F.M. Schaffer, K.A. Hetherington, R. Shannon, T.C. Hulsey, D. Lewin, R. Bhanu Pillai

    
• • ·A comprehensive analysis of peptide match frequencies as they relate to the assessment of protein allergenicity

    Page :S240

    A. Silvanovich, M.A. Nemeth, G.A. Bannon

    
• • ·Mucosal mast cell protease-1 (MMCP-1) as a marker of intestinal immunopathology in food allergy model

    Page :S240

    K. Vaali, T. Puumalainen, H. Wolff, H. Alenius, T. Palosuo

    
• • ·Exploring the link between eosinophilic esophagitis and esophageal foreign bodies in the pediatric population

    Page :S241

    P. Vannelli, N. Youssef, J. Rosh, J. Oppenheimer

    
• • ·DRESS syndrome associated with colchicine, insulin glargine, and cefotaxime

    Page :S241

    S.J. McEldowney, H.N. Subramanian, I. Hussain

    
• • ·Split-dosing of subcutaneous alpha and beta interferon reduces local cutaneous complications

    Page :S241

    N.S. Ogden, P. Benincasa, L. Bielory

    
• • ·The role of allergy in migraine: Fact or fiction

    Page :S241

    A.F. Kalpaklioglu, F.U. Tan, R. Koc, M. Tunckol

    
• • ·Allergic eosinophilic gastroenteritis (AEG) with protein-losing enteropathy (PLE): Intestinal pathological characteristics and long-term clinical follow-up

    Page :S242

    M. Chehade, S. Mofidi, M.S. Magid, A. Nowak-Wegrzyn, S.H. Sicherer, H.A. Sampson

    
• • ·Food allergen sensitization in inner city asthmatic children

    Page :S242

    J. Wang, C. Visness, H.A. Sampson

    
• • ·The risk of developing food allergy in premature/low birthweight children

    Page :S242

    J.J. Liem, A.L. Kozyrskyj, A.B. Becker

    
• • ·The natural history of food allergies in children: An evaluation of clinical tolerance and severity of reactions to food challenges (FC)

    Page :S242

    J.M. Campbell, T.T. Perry, L. Christie, K.A. Althage, S.K. Carlisle, A.W. Burks, J.G. Parker, S.M. Jones

    
• • ·Impact of ingredient labeling practices for food-allergic consumers

    Page :S243

    E. Simons, C. Weiss, T. Furlong, S.H. Sicherer

    
• • ·Bovine serum albumin is one of common allergens in dogs with spontaneous beef allergy

    Page :S243

    K. Ohmori, K. Masuda, K. Ohno, M. Sakaguchi, H. Tsujimoto

    
• • ·The natural history of tree nut allergy

    Page :S243

    D.M. Fleischer, M.K. Conover-Walker, E.C. Matsui, R.A. Wood

    
• • ·Upper gastrointestinal mucosal mast cells in infants with persistent distress and gastroesophageal reflux

    Page :S243

    R.G. Heine, M. Chehade, C.W. Chow, D.J.S. Cameron, G.P. Davidson, D.J. Moore, H.A. Sampson, D.J. Hill

    
• • ·Identification and standardization of the anti food allergy Chinese herbal formula, FAHF-2, by HPLC chromatographic fingerprint

    Page :S244

    Z. Zou, H.A. Sampson, X. Li

    
• • ·Total and food specific IgE values in relation to food challenge outcomes in a highly atopic pediatric population

    Page :S244

    J.E. Scott, W. Phipatanakul, D. Kinnamon, L. Schneider

    
• • ·Safety of oral food challenges in the office setting

    Page :S244

    V.S. Mankad, W.J. Sheehan, V.S. Labelle, L.A. Lee, L.W. Williams, A.W. Burks

    
• • ·Isolated Macrobrachium rosenbergii (M. rosenbergii) allergy apart from Penaeus monodon (P. monodon) allergy in shrimp allergic children

    Page :S244

    S. Chinratanapisit, N. Visitsunthorn, P. Vichyanond, O. Jirapongsananuruk

    
• • ·Prevalence of food allergy during infancy in Japan

    Page :S245

    M. Ebisawa, C. Sugizaki, Y. Ikeda, H. Tachimoto

    
• • ·Critical appraisal of the population data in food allergy/crossreactivity studies: A systematic review

    Page :S245

    C.H. Larramendi, J. García-Abujeta

    
• • ·Food allergic reactions in kindergartens in Japan

    Page :S245

    Y. Adachi, Y.S. Adachi, M. Nakabayashi, T. Fuchizawa, T. Itazawa, G. Murakami, T. Miyawaki

    
• • ·Differences in recognition of water-soluble and -insoluble wheat allergens in two varieties of wheat flour between wheat-allergic and wheat-sensitized but clinically tolerant patients

    Page :S245

    K. Beyer, L. Bardina, H.A. Sampson

    
• • ·Lupine allergy: A cross-reactive allergy but also a separate entity

    Page :S246

    K. Peeters, J.A. Nordlee, S.L. Hefle, C.A.M. Bruijnzeel-Koomen, A.C. Knulst

    
• • ·Safety of oral peanut immunotherapy for peanut allergic patients

    Page :S246

    A.M. Scurlock, P.H. Steele, S.S. Andrzejewski, L.A. Pons, K.A. Althage, L. Christie, S.K. Carlisle, A.D. Buchanan, S.M. Jones, A.W. Burks

    
• • ·Identification of major food allergens by health care providers

    Page :S246

    E.S. Stieb, K.E. Haver, E.C. TePas

    
• • ·Evaluation of maternal and infant dietary history in pediatric patients with peanut allergy

    Page :S246

    C.L. Ogilvie, A.H. Assa'ad

    
• • ·French Allergovigilance Network report about severe anaphylactic reactions to foods from 2001 To 2004

    Page :S247

    D. Moneret-Vautrin, M. Morisset, L. Parisot, G. Kanny, +. other members of the Allergovigilance Network

    
• • ·Pericarpium Zanthoxyli—A new food allergen

    Page :S247

    H. Li, H. Zhang

    
• • ·Superior vena cava (SVC) syndrome: A differential diagnosis not to be forgotten by an allergist

    Page :S247

    R. Dworski, S. Marney

    
• • ·Role of Penicillium molds in three cases of food allergy

    Page :S247

    M. Lombardero, C. Díaz-Donado, B. Añibarro, M.Á. Núñez, D. Barber

    
• • ·Immunomodulating effect of dental materials employed as root canal filling

    Page :S248

    A.A. Babakhin, A.I. Volozhin, L.N. Kazarina, O.O. Gushchina, L.M. DuBuske

    
• • ·Integral diagnosis and classification of adult mastocytosis: A prospective study of 151 cases

    Page :S248

    L. Escribano, R. Núñez, A. García-Montero, A. Prados, M. García-Cosío, L. Sánchez-Muñoz, M. Cuevas, C. Bellas, A. López, M. Angulo, A. Orfao

    
• • ·Elevated total serum tryptase levels in patients with postural orthostatic tachycardia syndrome (POTS): A case series

    Page :S248

    F.H. Hsieh, M.M. Alam, A.E. Lichtin

    
• • ·Mice allergic immune response to different administration routes of anisakis simplex (As)

    Page :S248

    M.L. Baeza, L. Conejero, Y. Higaki, E. Martín, S. Infante, M. Rubio, J.M. Zubeldia

    
• • ·Diffuse cutaneous mastocytosis in children not associated with systemic disease in the presence of an elevated serum tryptase

    Page :S249

    M.C. Carter, C.N. Kocabas, D.D. Metcalfe

    
• • ·Immune system parameters in patients with suspected adverse effects from dental alloys

    Page :S249

    P.L. Titov, L.P. Titov, L.M. DuBuske

    
• • ·Cardiovascular responses in patients with acute allergic reactions treated with parenteral epinephrine

    Page :S249

    R.Y. Lin, A. Curry, V.I. Pitsios, J.P. Morgan, H.S. Lee, M. Nelson, R.E. Westfal

    
• • ·The histamine induced cutaneous response and the skin blood flow in allergic patients during 24 weeks of treatment with cetirizine—A double-blind, placebo control trial

    Page :S249

    K. Klos, J. Kruszewski, A. Zakrzewski, K. Sulek, M. Dudziak

    
• • ·Evaluation of IP mouse models for assessing the allergenic potential of proteins

    Page :S250

    K. Thomas, C. Herouet, G. Bannon, G. Ladics, S. MacIntosh, L. Privalle, M. Woolhiser

    
• • ·Studies of oral mold challenge in mold sensitive subjects

    Page :S250

    S. Luccioli, J. Malka-Rais, T.M. Nsouli, L. Chiazze, J.A. Bellanti

    
• • ·A case of angioedema following the administration of recombinant tissue plasminogen activator

    Page :S250

    S.S. Mohan, I. Veksler-Offengenden

    
• • ·Influenza vaccine in 55 patients with egg allergy

    Page :S250

    M.J. Dorsey, L. Song, T. Geha, A. Timmons, H. Oettgen, L. Schneider

    
• • ·Epidemiologic characteristics of rhinitis in Turkish school children: An international study of asthma and allergies in childhood(ISAAC) phase II study

    Page :S251

    S. Kuyucu, Y. Saraçlar, P. Özdemir, B.E. Şekerel, G. Adalıoğlu, A. Tuncer

    
• • ·Incidence of atopic disease in Korean-American children in Chicago

    Page :S251

    A.S. Kim, B. Yu

    
• • ·Higher mean serum IgE levels in an isolated Hungarian population: Identification of a possible genetic founder effect

    Page :S251

    K. Nekam, L.A. Rethy, Z. Andrasofszky, G. Papp

    
• • ·Correlates of asthma diagnosis among individuals in same-sex relationships

    Page :S251

    J.E. Heck, J.S. Jacobson

    
• • ·Characteristics of patients with nasal polyps

    Page :S252

    L.M. Endo, C. Monge, M. White, M. Kaliner

    
• • ·Interstitial lung disease in childhood: A clinical review

    Page :S252

    M. Herrag

    
• • ·Caucasians fare worse than blacks after hospitalization for invasive group A streptococcal disease: Lack of confounding by an HLA class II haplotype

    Page :S252

    Z.D. Mulla, S.G. Gibbs

    
• • ·Does atopy last forever?

    Page :S252

    D. Zauli, R. Bortolotti, A. Grassi, G. Ballardini, A. D'Ecclesia, F.B. Bianchi

    
• • ·Study for epidemiological change of allergic disease in kindergarten aged children in Korea

    Page :S253

    H. Yoon, W. Kim

    
• • ·An assessment of C1 inhibitor (C1-INH) functional assay ordering patterns

    Page :S253

    R.A. Koelsch, D.M. Lang

    
• • ·The knowledge of side effects of Angiotensin Converting Enzyme inhibitors: Questionnaire survey

    Page :S253

    C. Lombardi, M. Crivellaro, A. Dama, G. Senna, S. Gargioni, G. Passalacqua

    
• • ·Evaluation of allergic rhinitis by patient care group: relationship between testing, symptoms, activities, quality of life, and productivity

    Page :S253

    S.L. Szeinbach, P. Williams, S. Kucukarslan

    
• • ·Gender differences in cytokine immune response profiles and wheezing phenotypes during the first three years of life

    Page :S254

    S.J. Uekert, G. Akan, M. Evans, Z. Li, K. Roberg, C. Tisler, D. DaSilva, E. Anderson, R. Gangnon, J. Gern, R.F. Lemanske

    
• • ·Levalbuterol increases IL-4 and IL-5 and decreases IFN-gamma release from respiratory syncytial virus (RSV)-stimulated peripheral blood mononuclear cells (PBMCs)

    Page :S254

    J.A. Wendt, M. Peeples, J. Faro, R. Gandy, L. Phillips, J.N. Moy

    
• • ·Decreased IL-10 production in cord blood mononuclear cells in preterm infants

    Page :S254

    E. Speer, D. Gentile, A. Patel, D. Skoner

    
• • ·Comparison of quality of life before and after treatment in children with allergic rhinoconjunctivitis.

    Page :S254

    N. Siriwaradon, W. Rangchaikul, T. Thongkaew, P. Chatchatee, J. Ngamphaiboon

    
• • ·Effect of glucocorticoid on the expression of RANTES and MIP-1⍺ in the bronchus of mice with asthma

    Page :S255

    W. Zhang, C. Li, R. Wu, Z. Zhang, Y. Luo, M. Li, L. Dong, X. Cai

    
• • ·Association between cytokine gene polymorphisms and otitis media (OM) in children with acute respiratory syncytial virus (RSV) infection

    Page :S255

    D. Skoner, D. Gentile, E. Kairis, K. Barnoski, C. Buzzard, A. Patel, W. Doyle

    
• • ·Role of CCR4 and CCR8 in antigen specific T helper 2 cell trafficking into allergic lung

    Page :S255

    M. Fukui, A.M. Tager, A.D. Luster

    
• • ·Human type 1 CD4 T cell cytokine responses are selectively dependent on multidrug resistance protein1

    Page :S255

    J. Zhang, M.A. Alston, H. Huang, R.A. Houghtling, R.W. Pastor, R.L. Rabin

    
• • ·IgE anti-Borrelia Burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with lyme disease

    Page :S256

    J. Robin, M.H. Bluth, M. Ruditzky, K. Norowitz, S. Chice, E. Pytlak, M. Nowakowski, H.G. Durkin, T.A. Smith-Norowitz

    
• • ·TCR epitope mapping of Asp f3 in allergic bronchopulmonary aspergillosis

    Page :S256

    B. Kariuki, J.K. Smick, V.P. Kurup, A.P. Knutsen

    
• • ·Flt3L attenuates allergic airway inflammation and airway hyperresponsiveness by increasing regulatory T cells

    Page :S256

    A.S. Bharadwaj, J.H. Edwan, S. Kurz, J.E. Talmadge, D.K. Agrawal

    
• • ·CCR4 and CXCR3 on CD3⁺ cells in the skin following intradermal allergen compared with Purified Protein Derivative (PPD)

    Page :S256

    G.K. Banfield

    
• • ·Responses of fresh and cryopreserved PBMCs to in vitro mitogen and allergen stimulation

    Page :S257

    Z.Y. Kucuk, R.R. Castro, W.G. Schreffler, C. Visness, J. Gern, H.A. Sampson

    
• • ·Low thresholds for activation and apoptosis of Th1 cells as a mechanism of Th2 predominance in atopic diseases

    Page :S257

    T. Akkoc, J. Zumkehr, P. de Konig, I.B. Barlan, K. Blaser, M. Akdis, C.A. Akdis

    
• • ·CD8+CD60+ TCR ⍺/β+CD45RO+ T Cells and CD4+ T cells are required for induction of human ragweed specific memory IgE responses

    Page :S257

    T.A. Smith-Norowitz, K.B. Norowitz, M.H. Bluth, S. Chice, R.O. Joks, K. Liao, M. Nowakowski, H.G. Durkin

    
• • ·Heterogeneity of CD4+CD25+ T cells among subjects with distinct allergic phenotypes

    Page :S257

    A.J. Reefer, S. Satinover, B. Wilson, J.A. Woodfolk

    
• • ·Enhanced expression of CTLA-4 and concurrent downregulation of CD28 on lung cells of mice exposed to Aspergillus antigen

    Page :S258

    C.S. Barrios, B.D. Johnson, J.D. Henderson, J.N. Fink, K.J. Kelly, V.P. Kurup

    
• • ·C57Bl/6 and BALB/c mice do not represent default Th1 and Th2 strains in allergen-driven immune responses

    Page :S258

    K.T. HayGlass, B. Nashed, S. Haile, A.J. Marshall, W. Thomas

    
• • ·T-cell profiles in asthmatic and non-asthmatic children in response to exercise

    Page :S258

    C.D. Schwindt, F. Zaldivar, D. Nemet, J. Larson, D. Cooper

    
• • ·IgE, CD8+CD60+ T cells and IFN-alpha in human immunity to parvovirus B19

    Page :S258

    K.B. Norowitz, M.H. Bluth, S. Chice, V. Shah, M. Nowakowski, H.G. Durkin, T.A. Smith-Norowitz

    
• • ·Kinetics of cytokine production in human T-cell cultures

    Page :S259

    A.H. Millner, J. Kildsgaard, P.A. Würtzen

    
• • ·Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-sensitive asthma

    Page :S259

    G.P. Shome, M. Shearer, J. Tarbox, J. Starnes, R.M. Kennedy, E. Goldwater

    
• • ·Lysophosphatidic acid stimulates inflammatory cascade in airway epithelial cells

    Page :S259

    J.W. Steinke, E. Barekzi, K. Hise

    
• • ·Pyruvate kinase and annexin I modulating granule generation in nerve growth factor (NGF)-cultured HMC-1 cells

    Page :S259

    J. Kim, J. Ro

    
• • ·High levels of tryptase are associated with greater bone density in patients with mastocytosis.

    Page :S260

    N.M. Kushnir-Sukhov, C. Akin, J. Reynolds, D. Metcalfe

    
• • ·IgE mediated release of ³H-5HT from human mast cells (LAD cells)

    Page :S260

    Y. Wu, D. Metcalfe, A. Kirshenbaum

    
• • ·A role for the Mycoplasma pneumoniae adhesin P1 in Interleukin (IL)-4 Synthesis and release from mast cells

    Page :S260

    K.L. Hoek, L.B. Duffy, G.H. Cassell, T. Atkinson

    
• • ·Excess sputum eosinophilia found in patients with asthma

    Page :S260

    T. Bingemann, P.A. Harris, J.E. Foss, C.R. Grafe, J.B. Hagan

    
• • ·Sputum vs bronchoalveolar lavage (BAL) eosinophils (EOS) as markers of airway dysfunction in asthma

    Page :S261

    J.B. Sedgwick, C.A. Swenson, W.W. Busse

    
• • ·Eosinophilic fasciitis in a child presenting as peripheral eosinophilia and pitting edema

    Page :S261

    W.E. Molis, M.F. DeBolt, A.M. Reed

    
• • ·Intranasal administration of CpG oligodeoxynucleotides and antigen tolerizes against atopic responses

    Page :S261

    K. Kitagaki, T.R. Businga, J.N. Kline

    
• • ·β₂-agonist does not modulate eosinophil superoxide generation induced by LTD₄

    Page :S261

    M. Nagata, M. Kushiya, I. Kikuchi, K. Hagiwara, M. Kanazawa

    
• • ·Prenatal exposure with lipopolysaccharides prevents allergen sensitization and eosinophilic airway inflammation in a murine model

    Page :S262

    K. Gerhold, A. Avagyan, K. Beier, B. Ahrens, D. Quarcoo, E. Hamelmann

    
• • ·Serum soluble CD14 in the development of atopic disease in infancy—A potential target for specific probiotics

    Page :S262

    S. Rautava

    
• • ·TLR9 agonist second-generation immunomodulatory oligonucleotides reverse OVA-triggered Th2 responses in mice

    Page :S262

    F. Zhu, E.R. Kandimalla, D. Yu, J.X. Tang, S. Agrawal

    
• • ·Intravenous immune globulin inhibits airway inflammation in a murine model of allergic asthma

    Page :S262

    G.N. Kaufman, Y. Wang, J.G. Martin, C.T. McCusker, B.D. Mazer

    
• • ·Intranasal tolerance induction in an established model of asthma limits eosinophils recruitment and IgE production via CD4-dependent mechanisms

    Page :S263

    C. Longaretti, C. Barbey, E. Pradervand, F. Spertini

    
• • ·Preventive use of the co-administration of immunostimulatory DNA sequences (ISS-ODN) with olive pollen proteins in a mouse model of allergic asthma

    Page :S263

    L. Conejero, Y. Higaki, M.J. Fernandez-Bohorquez, I. Varela-Nieto, M.L. Baeza, J.M. Zubeldia

    
• • ·Inhibitory effect of fluvastatin on T cells from patients with allergic asthma

    Page :S263

    K.R. Samson, K. Minoguchi, H. Matsuo, A. Tanaka, N. Oda, T. Yokoe, T. Tazaki, M. Adachi

    
• • ·Fexofenadine reverses established allergen-induced airway disease

    Page :S263

    A. Joetham, K. Takeda, E.W. Gelfand

    
• • ·Oxidative Stress in allergic airway disease

    Page :S264

    E.E. Fouda, M.M. Aboul-Khair, M.M. Barakat, N.A. El Bogdady, S.S. Ebrahim

    
• • ·Decreased allergen extract stability with dilution and ambient temperature change: Effect of shipping temperature on prescription extract stability and potency

    Page :S264

    T.A. Funkhouser, M. Nelson, T. Song, B. Martin, R. DeGuzman, R. Engler

    
• • ·A limited RAST panel may replace the extensive northeast regional RAST panel (NERAST) in Central and Northeast Pennsylvania

    Page :S264

    M.A. Koleilat, M. Fleetwood, C. Wood, P.L. Sutton

    
• • ·Evaluation of a flow-cytometry and histamine release method for determining allergy activated basophils

    Page :S264

    J.S. McClain, J.F. Halsey

    
• • ·Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT)

    Page :S265

    L.K. Wilcock, P.A. Wachholz, D.H. Na, S. Klunker, J.N. Francis, J.N. Larsen, S.R. Durham

    
• • ·Long-term benefit of allergen immunotherapy in clinical practice

    Page :S265

    J.M. Fahrenholz, B.L. Wolf, J. Smith, D. Keedy

    
• • ·A prospective study on safety of sublingual immunotherapy in children aged 3 to 6 years

    Page :S265

    A. Fiocchi, G. Paino, S. La Grutta, F. Pezzuto, C. Incorvaia, L. Sensi, F. Marcucci, F. Frati

    
• • ·Post marketing survey on the safety of sublingual immunotherapy in children below the age of 5

    Page :S265

    G. Passalacqua, V. Di Rienzo, M. Minelli, A. Musarra, R. Sambugaro, S. Pecora, G.W. Canonica

    
• • ·Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses

    Page :S266

    G. Paraskevopoulos, M.R. Jacobson, V. Carr, M. Calderon, S.J. Till, J.N. Francis, S.R. Durham

    
• • ·Clinical safety of a grass pollen allergen tablet for specific immunotherapy

    Page :S266

    J. Kleine-Tebbe, D.A. Herold, M. Ribel

    
• • ·Tolerability of cluster immunotherapy with an alum adsorbed mite extract

    Page :S266

    M. Mauro, M. Russello, R. Alesina, V. Sillano, A. Dama

    
• • ·Effects of oral bacterial immunotherapy in children with atopic eczema/dermatitis syndrome

    Page :S266

    R. Tesse, P. Fiermonte, C. Massagli, P. Loria, P. D'Ambra, F. Fiore, L. Armenio, L. Brunetti

    
• • ·Redefining the late phase reponse in allergic rhinitis

    Page :S267

    J. Rimmer, M. Lean, H. Peake, C. Santos, N. Owens, M. Handel, P. Bardin, R. Robson

    
• • ·A sinusitis questionnaire to assess longitudinal changes during acute sinusitis

    Page :S267

    J.N. Baraniuk, M. Ali, K. Petrie

    
• • ·Growth velocity and HPA axis function during 1-year treatment with Triamcinolone Acetonide Aqueous (TAA) nasal spray in children with allergic rhinitis (AR)

    Page :S267

    S. Ober, D. Gentile, E. Kairis, K. Barnoski, W. Doyle, D. Skoner

    
• • ·Efficacy of montelukast for treating perennial allergic rhinitis

    Page :S267

    G.C. Garrett, G. Philip, P. Patel, W.H. Yang, L. Gilles, B.A. Knorr, T.F. Reiss

    
• • ·Effect of benzalkonium chloride on nasal mucociliary clearance in normal volunteers: A double blind, cross-over, randomized study

    Page :S268

    J.A. Rizzo, A. Rego Silva, D. Medeiros, M.F. Motta, E. Sarinho

    
• • ·Exhaled nitric oxide (eNO) as a tool for asthma screening in military recruits

    Page :S268

    R. Arora, C.E. Thornblade, P. Dauby, L.L. Hagan

    
• • ·Montelukast and desloratadine in the treatment of perennial allergic rhinitis: A randomized, double blind, placebo controlled study

    Page :S268

    M. Ciebiada, M. Górska-Ciebiada, L.M. DuBuske, P. Górski

    
• • ·Simple application of allergen-impermeable bed covers for adult patients with allergic rhinitis in Korea

    Page :S268

    C. Kim, C. Hong, S. Choi, D. Kim

    
• • ·Lung function, sputum, and exhaled breath characteristics of severe asthmatics compared to nonsevere asthmatics

    Page :S269

    A.T. Hastie, W. Moore, M. Larj, J. Krings, M. Wu, G.A. Hawkins, D.A. Meyers, S.P. Peters, E.R. Bleecker

    
• • ·Importance of large particles in bronchial challenge test in mite allergic asthmatics

    Page :S269

    A. Casset, E. Birba, A. Purohit, F. Lieutier-Colas, P. Meyer, G. Pauli, F. de Blay

    
• • ·LPS-binding protein is an essential component of LPS-induced IFN-beta signaling pathway in human monocytes

    Page :S269

    A. Kato, T. Ogasawara, T. Homma, H. Saito, K. Matsumoto

    
• • ·Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma

    Page :S269

    E.M. Hossny, H.M. El-Awady, S.I. Bakr, A. Labib

    
• • ·Immunological and biochemical characterization of recombinant group 1 dust mite allergens

    Page :S270

    N.K. Soni, S.T. Lyngstrand, S. Patkar, L.L.H. Christensen, M. Schlein, E.P. Friis, V. Batori, P.S. Skov, L.K. Poulsen, E.L. Roggen, U. Bødtger, H. Draborg

    
• • ·Oligonucleotide costimulation of mouse CD4+ T cell proliferation is dependent on the Toll-like receptor adaptor molecule MyD88

    Page :S270

    D.F. LaRosa, A.E. Gelman, L.A. Turka

    
• • ·Interactions between mast cells and dendritic cells

    Page :S270

    Z. Allakhverdi, S. Mecheri, C. Demeure, G. Delespesse

    
• • ·Double-stranded RNA-induced CC chemokine synthesis in human bronchial smooth muscle cells and toll-like receptor 3

    Page :S270

    K. Niimi, K. Asano, Y. Shiraishi, M. Wakaki, T. Nakajima, J. Kagyo, Y. Suzuki, T. Shiomi, T. Oguma, K. Sayama, K. Yamaguchi, A. Ishizaka

    
• • ·A single recombinant hybrid molecule consisting of the major timothy grass pollen allergens to replace natural pollen extracts for skin test diagnosis

    Page :S271

    C. Metz-Favre, B. Linhart, A. Purohit, F. de Blay, R. Valenta, G. Pauli

    
• • ·Superantigens (SAgs) subvert T regulatory (Treg) cell activity by inducing expression of GITR-L on monocytes

    Page :S271

    I.D. Cardona, L.S. Ou, E. Goleva, D.Y.M. Leung

    
• • ·The sum of specific IgEs to indoor allergens at age 3 years predicts persistence of wheeze at age 5 years

    Page :S271

    A. Woodcock, L. Soderstrom, S. Ahlstedt, A. Custovic, A. Simpson

    
• • ·A deglycosylated recombinant Der p 1 with improved mAb and IgE antibody binding activity

    Page :S271

    J.D. Lewis, L.D. Vailes, R. Varasteh, A. Pomes, M.D. Chapman

    
• • ·Clinical utility of serum TARC/CCL17 levels in children with atopic dermatitis

    Page :S272

    M. Nagao, T. Fujisawa, Y. Kato, Y. Noma, H. Katsumata, H. Nishimori, J. Atsuta, K. Iguchi, I. Ogawauchi, H. Tanaka, M. Higashiura, H. Kamiya

    
• • ·Effects of topical pimecrolimus on skin histology, inflammatory infiltrate, and cytokine production in atopic dermatitis

    Page :S272

    D. Simon, E. Vassina, S. Yousefi, L.R. Braathen, H. Simon

    
• • ·Cationic steroid antibiotics (CSA) exhibit cytotoxic activity against vaccinia virus (VV)

    Page :S272

    D.Y.M. Leung, J.E. Streib, P.B. Savage, M.D. Howell

    
• • ·Inhaled corticosteroid beliefs and treatment adherence in patients with asthma

    Page :S272

    T.T. Le, A. Bilderback, B. Bender, F.S. Wamboldt, C.F. Turner, C.S. Rand, S.J. Bartlett

    
• • ·Recruitment of CD4 cells during peptide-induced isolated late asthmatic reactions is associated with increased TARC expression

    Page :S273

    F. Ali, J.R. Barkans, F. Benyahia, E. Tsen-Teng Ou, S. Ying, M. Larché, A. Kay

    
• • ·Medication nonadherence and depressive symptoms in children with asthma

    Page :S273

    B. Bender, S. Bartlett, A. Immele, C. Rand, Z. Tran, C. Turner, F. Wamboldt

    
• • ·Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma

    Page :S273

    L. Williams, M. Pladevall, H. Xi, E.L. Peterson, C.L. Joseph, J. Elston Lafata, D.R. Ownby, C.C. Johnson

    
• • ·The role of direct observed therapy (DOT) at school by non-medical school personnel to improve outcomes among asthmatic children

    Page :S273

    L.M. Sullivan, J.N. Moy, G.S. Mosnaim

    
• • ·Inhibitory effects of novel GATA-3 decoy oligodeoxynuleotides on IL-5 expression in CD3⁺T cells

    Page :S274

    Y. Nakamura, H. Ito, Y. Tanifuji, K. Yamauchi, H. Inoue

    
• • ·De Novo induction and recruitment of allergen-specific effector CD8⁺ T cells in a mouse model of IgE-mediated allergy and airway inflammation

    Page :S274

    J.A. Aguilar Piementel, K. Huster, F. Alessandrini, J. Gutermuth, T. Jakob, H. Behrendt, J. Ring, D. Busch, M. Mempel, M. Ollert

    
• • ·Stimulation of IL-2 by superantigens (SAgs) subvert T regulatory (Treg) cell activity

    Page :S274

    L.S. Ou, I.D. Cardona, E. Goleva, D.Y.M. Leung

    
• • ·Toll-like receptors expression in the healthy and allergic conjunctiva

    Page :S274

    A. Micera, S. Bonini, A. Lambiase, A. Iovieno, S. Bonini

    
• • ·Nasal cytokine pattern in allergic and viral rhinitis

    Page :S275

    C. Klemens, M.F. Kramer, T.R. Jordan, E. Pfrogner, G. Rasp

    
• • ·IFN and IL-4 regulate the expression of CC-chemokines (RANTES, MCP-4, TARC) by TLR ligands stimulated nasal fibroblasts

    Page :S275

    M. Nonaka, N. Ogihara, R. Pawankar, A. Fukumoto, A. Sakanushi, T. Yagi

    
• • ·Staphylococcal Superantigens and Eosinophilic Inflammation in Chronic Rhinosinusitis/Nasal Polyposis

    Page :S275

    A. Tripathi, D.B. Conley, R.C. Kern, K.A. Seiberling, G.K. Haines, J. Huang, L.C. Grammer

    
• • ·Scientific Abstract Sessions

    Page :S276

    Plan Plan
• • ·Alphabetic index to abstract authors

    Page :S331

    
• • ·Keyword index

    Page :S357